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   Abstract 
   Mononuclear phagocytes are crucial arms of the innate immune system, performing 
various fonctions, from clearance of pathogenic microorganisms, to maintenance of 
tissue homeostasis. Two cell types have been studied; first, monocytes, bone marrow-
derived cells, of which two main subsets have been described. Ly6C+ monocytes are 
short-lived circulating cells that have the ability to quickly migrate into tissues, and 
produce a range of molecules, or differentiate into inflammatory cells. Ly6Clow 
monocytes are a patrolling cell type, which crawls on the luminal side of vessels where 
they perform a monitoring of the vasculature. In a collaborative effort, using nucleoside 
analogs and experimentally parameterised, computer-assisted modeling, the dynamics 
of these two subsets has been re-examined, in the light of genetic data obtained 
previously in the laboratory. The results suggest that the transition between a Ly6C+ to a 
Ly6Clow phenotype occurs more prominently in the bone marrow, rather than the blood 
as suggested by the literature. 
   Second, macrophages in the kidney were investigated in the context of circulating 
small immune complexes. Macrophages are large, resident cells which develop during 
embryonic life, maintaining their numbers locally and independently from bone 
marrow-derived cells in most tissues. Kidney resident macrophages perform a constant 
monitoring of the circulation, in collaboration with the endothelial cells they underlie. 
The experimental model for the study of their response to immune complexes was 
studied, and the results provide insight into the unique character of this function for 
kidney resident macrophages, as well as clarifying the means of access of the immune 
complexes to the macrophages.  
   Together, the work presented in this thesis sheds light on particular aspects of the 
biology of myeloid populations, in steady state and inflammatory settings.  
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1 - Introduction 










1.1 Historical perspective 
   This work describes an attempt to further the understanding of the biology of myeloid 
populations in mice. The study of immune cells has been a focus of research for well 
over a century, and this thesis will start by going over a few of the main steps leading to 
the current understanding of mononuclear phagocyte development and function. 
Immunity is a concept that has been known for a surprisingly long time, and 
explanations provided over the centuries much varied. Here, this thesis will briefly try 
to cover the main aspects of earlier views on immunity, before moving to the late 19th 
to 20th century works that lead to our current understanding of monocyte and 
macrophage biology. 
   1.1.1 Immunity to disease as a passive phenomenon 
   Although the Latin words “immunitas” and “immunis” were first used for legal 
concepts (in ancient Rome, the exemption from duty or service, during the Middle Ages 
the exemption of the Church’s properties and personnel from civil control), the concept 
of immunity to disease has been known for over two millenia. Thucydides already 
mentions this phenomenon in his desciption of a plague that struck Athens in the 5th 
century B.C. (in The History of the Peloponnesian War, 431 B.C.). There, acquired 
immunity, although not explained nor theorized, was a phenomenon known well 
enough to influence people’s behaviour when facing disease, as described by Arthur 
Silverstein in A history of Immunology: “Yet it was with those who had recovered from 
the disease that the sick and the dying found most compassion. These knew what it was 
from experience, and had now no fear for themselves ; for the same man was never 
attacked twice – never at least fatally” (Silverstein A.M. A History of Immunology, 2nd 
Edition, 2009). 
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   The Hippocratic school of medicine explained the occurrence of diseases by the 
imbalance of what they belived were the main bodily fluids, termed the four humours 
(blood, phlegm, yellow and black bile). Galen (129 – 216 AD) added qualitative aspects 
to that dogma, saying that temperature, consistency, fermentation state would influence 
disease appearance and progression (Silvertein A.M. A History of Immunology, 2nd 
Edition). It is based on this premise that the first theory of acquired immunity was 
developed, by Islamic physician Abu Bekr Mohammed Ibn Zakariya al-Razi (880-932, 
also known as Rhazes), in his Treatise on the Smallpox and Measles. It was principally 
concerned with smallpox, which he said affects blood in a drying fashion: blood would 
lose some moisture quality, which was expelled from the body via the formation of 
pustules on the skin. However, it was believed that this drying of blood was a natural 
process, occurring slowly throughout the life of every healthy individual. Therefore, the 
disease merely accelerated this process. Hence, the fact that no patient would be 
affected a second time was because the excess moisture had already been expelled, 
leaving the blood too dry to be affected another time.  
   This is only the first of a long series of theories that aimed at explaining the long 
lasting observation of acquired immunity. After the Scientific Revolution of the 16th 
and 17th centuries (lead by Galileo, Descartes, Kepler and Newton, notably), physics 
left its mark in the fields of biology (Silverstein A.M.), and the schools of iatrophysics 
and iatrochemistry emerged, each with its set of theories on immunity. As a 
representative of the school of Iatrophysics, James Drake (1707, Anthropologia Nova : 
Or, a New System of Anatomy) proposed that smallpox induced a concoction of the 
blood, which could only be expelled from the blood by forcing its way through the skin, 
thereby forming the pustules. Because the symptoms and disease were not disjointed, 
his view of acquired immunity would make sense. The expulsion of the blood 
concoctions induced by the disease would alter the skin « tone » in such a way that after 
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the first forcing of the concoction, the altered skin would not “be able any more to arrest 
the Matter [the blood concoction] in its course outward long enough, or in such 
quantity” to create new pustules. Therefore, one could be infected again but not suffer 
the symptoms any more, because of the altered anatomy of the injured tissue (cited in 
Siverstein A.M.).  
   The practice of “variolation”, an early form of vaccination for smallpox where the 
content of skin pustules would be introduced into healthy patients via various 
techniques as a preventive measure, has been reported from very early times, and was 
introduced into Western medicine with increasing success around the 17th century. This 
also prompted several theories of immunity trying to explain its efficacy. One concept 
emerged, that of the Innate Seed, defended notably by Thomas Fuller in 1730 
(Exanthematologia : or, an attempt to give a rational account of eruptive fevers, pp175 
ff. London, 1730), postulated that individuals possess specific, and single, “ovulae” for 
each disease, which were fertilized by the disease agent, which could therefore only 
occur once in a lifetime.  
   All the theories discussed above involved either changes in quality of humours, 
anatomical changes or exhaustion of inner seeds, would impact the state of mind when 
the scientific debate saw the rise of cellular theories.  
   1.1.2 The emergence of a cellular immune system 
   Although earlier scientists and physicians had already challenged the idea of an all 
humoral view of immunity, it was in 1858 that Rudolph Virchow claimed that 
pathology is due to the malfunction of cells rather than a disproportion or alteration of 
the humors. It is also important to note that for a comprehensive view of immunity, 
there had to be an acceptance that diseases are specific and reproducible. This view 
could only prevail if the idea of spontaneous generation was disproven which, after 
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centuries of dispute, came about largely due to the experimentations and argumentation 
of Louis Pasteur. Another important aspect for the understanding of a specific and 
reproducible disease has been the germ theory, which stemmed from Girolamo 
Fracastoro (1546) and gained acceptance with the works of Pasteur and Robert Koch in 
the late 1870s. Therefore, the work of Elie Metchnikoff (1845 – 1916) constituted an 
important component of a new view of pathology, rather than a step further within an 
established conceptual framework (Silverstein A.M.).  
   Metchnikoff’s contribution came in the context of understanding the pathology of the 
inflammatory reaction, which had been a matter of intense debate for decades. Cells at 
inflammatory sites had been observed, although they were believed to be, with the 
inflammatory reaction as a whole, detrimental for the patient. As his colleague Varchow 
(Life of Elie Metchnikoff, O. Metchnikoff, 1921) pointed out to him in a letter: “Most 
pathologists [did] not believe in the protective role of inflammation”. Phagocytosis had 
also previously been observed before, but inflammatory cells were viewed by most, 
though not all (Ambrose, 2006), as a means of transportation of disease vectors 
throughout the body.  
   Metchnikoff made experiments in various organisms. As a zoologist, he was 
influenced by the Theory of Evolution by Darwin, still fairly new at the time (Origin of 
Species, Darwin, 1859). This had an impact on Metchnikoff’s experimental methods, 
following the premise that observations in simple animals would be relevant to more 
complex organisms. In Invertebrates, he described phagocytes as being cells that have 
“the power of ingesting and sometimes absorbing food particles” (Metchnikoff, 1883), 
and recalled the observation that the process of digestion in invertebrates is seemingly 
carried out by phagocytic activity of amoeboid corpuscles. He therefore put forward the 
idea that this was to be seen as a “true act of feeding”. He then moved on to saying that 
there must be examples of such activity in Vertebrates. He then studied the development 
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of Bombinator toads : the tail of the larvae is digested during the metamorphosis stage 
of development. At that time, Metchnikoff observed amoeboid cells accumulating 
around the muscle tissue, before seeing muscle tissue remains inside these amoeboid 
cells. The now-intracellular components were observed to maintain their characteristic 
striation for a certain time, before losing this characteristic as the process of 
phagocytosis went on. Metchnikoff carried out a number of experiments inducing 
damage to different anatomical locations of various vertebrates and invertebrates, and 
during different developmental stages. These experiments led to the observation that 
phagocytic cells undergo morphological changes from “a superficial resemblance to an 
Actinophrys” (i.e. with filopodia), to round, amoeboid and motile cells (Metchnikoff, 
1883). He summarizes his findings as follows : “My whole series of observations, on 
Vertebrates and Invertebrates together, is hardly compatible with the current theory, 
which regards inflammation as primarily due to a morbid condition of the walls of the 
blood-vessels. I rather believe that the essence of the whole process is a struggle 
between the phagocytes and the septic material, whether the latter be a dead or dying 
cell, or a fungus, or other foreign body”. The work of Metchnikoff prompted the birth of 
cellular immunology, and research that continues to this day on the biology of 
phagocytes. Metchnikoff understood that macrophages not only constituted the first line 
of defence against infectious agents (rather than being deleterious to the individual 
during inflammatory responses), but were critical for maintaining tissue homeostasis as 
well : two aspects of macrophage biology that have only been confirmed since their 
discovery in the late 19th century. 
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Figure 1.1: Metchnikoff’s representation of phagocytosis (Metchnikoff, E. Lectures 
on the Comparative Pathology of Inflammation.)  Observed in the caudal fin of a Triton 
embryo 
 
 1.1.3 Classification of phagocytes into unified systems : from the Reticulo-
Endothelial System, to the Mononuclear Phagocyte System 
   Although Metchnikoff is widely regarded as the father of cellular immunity, many 
investigators of the 19th and 20th century contributed to the study of phagocytes and 
our understanding of the immune system. Paul Ehrlich, co-recipient with Metchnikoff 
of the 1908 Nobel Prize « in recognition of their work on immunity » (Nobel Prize 
official statement), had a critical impact on the understanding of humoral biology, with 
his side-chain theory of anti-toxins. Metchnikoff and Ehrlich were the respective 
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epicentres of a vivid debate during the late 19th century about the nature of the 
inflammatory response, opposing the cellular and humoral views on the matter 
(Silverstein A.M. A History of Immunology). However, Ehrlich also made crucial 
contributions to the understanding of phagocytes, developing staining methods that 
would allow him to distinguish mononuclear and different subsets of 
polymorphonuclear phagocytes – neutrophils, basophils and eosinophils (Ehrlich, P. 
1956, Collected papers of Paul Ehrlich). Other investigators found phagocytes in 
various organs, such as in the liver by Kupffer in 1876 (Yona and Gordon, 2015), and 
interstitial cells in the brain discovered by Virchow in 1846, some of which were later 
coined “microglia” by the Spanish pathologist Pio Del Rio-Hortega in 1919 (Rezaie and 
Male, 2002). As data accumulated showing the existence of phagocytes throughout the 
tissues (brain, liver, lungs, bones, germinal centre of the spleen) of several species, the 
need for a unified nomenclature of all these cells became important. To this end, Karl 
Albert Ludwig Aschoff and his colleague Kiyono, performing a systematic study of 
tissues stainings in 1913, coined the term “Reticulo-Endoplasmic System” (RES) to 
describe the cells whose function was to clear particulate matter from the blood and 
lymph (Yona and Gordon, 2015 ; Halpern, 1959), and that could take up staining dyes 
form the circulation. The cells of the reticulo-endothelial system were extensively 
studied for their phagocytic activity for several decades, and were divided into 
“wandering” and “sessile” cells (Halpern, 1959). At the time, these phagocytic cells 
were believed to emerge from their organ of residence. 
This unified system however became less and less in touch with accumulating in vitro 
and in vivo data showing particular developmental and functional relationships between 
the cells it was describing as one whole.  
   In vitro studies as early as 1926 started to investigate the behaviour of monocytes 
from circulation, amoeboid cells with small filipodiae, and macrophages from tissues, 
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large (several tens of microns) cells with long processes, in the context of various 
culture conditions. Monocytes and macrophages were seen “as functional variations of a 
single type” (Carrel and Ebeling, 1926), based on the similarity in morphological 
structure when in culture for long enough, with the same conditions.  
   Several groups performed in vivo investigations on the dynamics of mononuclear 
phagocytes. In 1939, Ebert and colleagues used intravital microscopy in the ears of 
rabbits to show that circulating monocytes could give rise to inflammatory macrophages 
in the skin and subcutaneous region (Ebert and Florey, 1939). Similar results were 
found in the skin of rats (Volkman and Gowans, 1965), or in mouse lungs (Pinkett et al., 
1966) and liver (Howard et al., 1965) in various inflammatory conditions. Although it 
was postulated for some years that lymphocytic cells (small round cells with round 
nuclei and small cytosol/nucleus size ratio) may be a precursors of monocytes in the 
circulation, before turning into macrophages in the tissues (a model reminiscent of 
Metchnikoff’s hypothesis as described in his Lectures on the Comparative Pathology of 
Inflammation, 1892), this hypothesis was dismissed and the following paradigm was put 
forth by van Furth and Cohn in a 1968 study on peritoneal macrophages: promonocytes 
in the bone marrow gave rise to monocytes in the circulation, which would differentiate 
into the macrophages observed in the tissues. After a Conference on Mononuclear 
Phagocytes in Leiden in September 1969, Van Furth and colleagues published a 
Memorandum describing the Mononuclear Phagocyte System in a version taking into 
account the discussion with numerous researchers of the field (van Furth et al., 1972). 
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   Figure 1.2. A monocyte, form Rebuck and Crowley, 1955 
   During the following years, Steinman and colleagues carried out seminal work that 
resulted in the identification of a new type of mononuclear phagocyte, depicted in a 
series of papers in the Journal of Experimental Medicine from 1973 to 1975 : the 
Dendritic Cell (DC). These papers described the morphology, quantification and local 
distribution, as well as their functional properties in vitro and in vivo (Steinman and 
Cohn, 1974, 1973; Steinman et al., 1974). It also provided a description of the cells in 
the spleen and tools to study these cells (Steinman et al., 1975, 1979). As a newly 
described mononuclear phagocyte, it was incoporated in the MPS. Thanks notably to 
seminal work carried out in the early 80s by Steinman and his colleagues at the 
Rockefeller, DCs were characterized during the following years as the (until then) 
elusive “accessory” cell type that linked innate and adaptive immunity, by presenting 
antigens to lymphocytes (Nussenzweig and Steinman, 1980; Steinman et al., 1983).  
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   Figure 1.3. A dendritic cell. From Steinman and Cohn, 1973   
   1.1.4. New paradigm and the contribution of studies on fetal hematopoiesis 
   As pointed out above, the construction of the MPS was based on knowledge acquired 
mostly thanks to studies of inflammatory situations, and this formed the basis for the 
understanding of macrophage ontogeny. However, this paradigm was challenged as 
studies in adults and embryos of several species were performed. Many studies found 
that macrophages were still present in tissues of monocytopenic mice (Morahan et al., 
1986; Sawyer, 1986; Yamada et al., 1990). Furthermore, tissue macrophages do not 
exchange between parabiotic mice (Ajami et al., 2007; Merad et al., 2002). This points 
to macrophages being less dependent on monocytes than suggested by the MPS model.  
   The development of hematopoietic cells during embryogenesis has been a subject of 
study for over a century (Sabin, 1917). The first myeloid potential was discovered in the 
yolk-sac (YS) by seminal work carried out by Moore and Metcalf (Moore and Metcalf, 
1970). In 1992, Sorokin and colleagues described the appearance in the embryo of 
macrophages before hematopoietic stem cells (HSC) emerge (Sorokin et al., 1992). In 
the zebrafish, development of macrophages was shown to by-pass the monocyte stage 
(Herbomel et al., 1999). Over the last two decades, many studies have firmly 
established that most tissue macrophages emerge during embryogenesis before, and 
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independently of HSCs (Ginhoux et al., 2010; Schulz et al., 2012; Yona et al., 2013), 
and emerge from a progenitor with myeloid and erythroid potential, therefore termed 
erythro-myeloid progenitor, or EMP (Bertrand et al., 2005; Gomez Perdiguero et al., 
2014; Palis et al., 1999; Schulz et al., 2012). 
   The work presented in this thesis focuses on two aspects of phagocyte biology : one 
relates to the development of monocytes from the bone marrow, and the other 
participated in the description of the function of monocytes and tissue resident 
macrophages in the kidney. Therefore an overview of the current knowledge on 
monocytes and on macrophages will now be presented, separately. 
 
1.2. Monocyte Subsets and Functions 
1.2.1. Human subsets 
   Monocytes are part of the three main types of mononuclear phagocytes of the innate 
arm of the immune system (the others being macrophages and dendritic cells), and 
represent 4 to 11% of blood circulating cells (Sluss et al., 2004). The heterogeneity of 
this cell type has been recognized since the late 1980s. It had been known for a long 
time that these cells were able to migrate into inflamed tissues to give rise to 
inflammatory macrophages, and it was suspected at the time that the heterogeneity of 
macrophages in tissues may be a result of monocyte heterogeneity. This prompted the 
examination of monocytes by various techniques, and flow cytometry uncovered a new 
human monocyte subset. Monocytes in human were stained with an antibody generated 
against myelo-monocytic leukemia cells, My4 (CD14) ; it was found that their 
expression of CD14 was not homogeneously high (Ziegler-Heitbrock et al., 1988), nor 
was their size and granularity profile. A year later, the staining of human Peripheral 
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Blood Mononuclear Cells (PBMC) with an antibody against CD16 (already used in the 
1988 paper by Ziegler-Heitbrock et al.) uncovered that monocytes in human peripheral 
blood consisted of two main subsets, CD14hi CD16- and CD14dim CD16+ monocytes 
(Passlick et al., 1989); although it was unclear then whether the latter was a bona fide 
subset of monocyte or rather just a distinct maturation state of CD16- monocytes, these 
cells were shown to have monocyte characteristic: morphology, esterase reactivity and 
Reactive Oxygen Species (ROS) production capacity (Ziegler-Heitbrock et al., 1988). 
Many studies have since then found specific functions of this subset, identifying it as 
such. The two subsets can be distinguished based on several surface markers, including 
the Fc-Receptor gamma 1 (FcγRI, or CD64, Grage-Griebenow et al., 2001a, 2001b).  
Given the wide range of CD14 expression by CD16+ cells and functional studies, a later 
nomenclature has been developed to categorise human blood monocytes : the 
“classical” CD14+ CD16- monocytes; the “intermediate” CD14+ CD16+ and the “non-
classical” CD14dim CD16+, (Ancuta et al., 2006; Heron et al., 2008; Ziegler-Heitbrock 
et al., 2010). The intermediate subset of monocytes has been shown to be specifically 
increased and show an anti-inflammatory phenotype (CD163 expression) in severe 
asthmatic patients (Moniuszko et al., 2009), and to produce large quantity of the 
interleukin (IL) -10 upon lipopolysaccharide (LPS) stimulation (Skrzeczynska-
Moncznik et al., 2008), compared to the other subsets. Recently, it has even been 
proposed that this intermediate population may be heterogeneous itself, based on single 
cell RNA-sequencing analysis, leading to four subsets of monocytes in human blood 
rather than the known three (Villani et al., 2017).  
   Heterogeneity in monocyte populations is recognized across several species (Ziegler-
Heitbrock, 2014). In non-human primates, the anti-human CD16 antibody was used to 
detect intermediate and non-classical monocytes in proportions similar to human blood 
subsets (Munn et al., 1990), with similar chemokine receptor expression patterns, 
	 30	
response to M-CSF (Munn et al., 1990; Munn et al., 1996), and expansion after 
infection with immunodeficiency virus than observed in humans (Jaworowski et al., 
2006; Kim et al., 2010). In pigs (Fairbairn et al., 2013; Ziegler-Heitbrock et al., 1994), 
cows (Hussen et al., 2013), and horses (Kabithe et al., 2010; Noronha et al., 2012), 
classical and non classical subsets of monocytes have been described, either with the 
anti-human antibodies to CD14 and CD16, or with species-specific ones, and there 
seems to be a comparable distribution of these subsets. They have also been described 
in rodents, notably in rats (Scriba et al., 1997). The study of monocytes in mice has 
been a very active field of research and these animals also present heterogeneity in their 
monocyte compartment, which will be presented in the next section.  
1.2.2.  Mouse subsets 
   In mice, the first hint at monocyte heterogeneity in mice may be found in a 2001 
article where the authors were studying the recruitment of monocytes to draining lymph 
nodes (LN) of the skin (Palframan et al., 2001). The authors were analysing the role of 
the C-C chemokine Monocyte Chemoattractant Protein-1 (MCP-1, or CCL2), in their 
recruitment to skin draining LN via High Endothelial Venules (HEV). They found, 
using the recently generated Cx3cr1gfp/+ mice (Jung et al., 2000) that monocytes of 
various intensities of Green Fluorescent Protein (GFP) expression under the control of 
the C-X3-C chemokine receptor 1 (CX3CR1) gene expression, were infiltrating the LN 
in an MCP-1 dependent manner. 
   However, the proper description of two phenotypically and functionally distinct 
subsets of monocytes was published two years later (Geissmann et al., 2003). Because 
CX3CR1 is expressed not only by myeloid but also lymphoid populations of cells, the 
authors generated Cx3cr1gfp/+ Rag2-/- mice, which also had the advantage that 
monocytes constituted 45-50% of circulating cells, instead of the usual 2% of mouse 
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blood (Mouse Phenome Database, Jackson Laboratories). Subsets of circulating 
monocytes were identified based on the level of CX3CR1 as well as Ly6C, CCR2, L-
selectin (CD62L) and various other markers : one subset expressed high levels of Ly6C 
(stained with a Gr-1 antibody), intermediate levels of CX3CR1, high levels of CCR2 
and was positive for CD62L. The other subset was found to be Ly6Clow CX3CR1high 
CCR2- CD62L-. Upon adoptive transfer into non-irradiated hosts, these cells had also 
different half lives in the circulation and tissue homing properties in vivo : while 
transferred Ly6Clow monocytes were observed in the host’s blood for 4 days, the Ly6C+ 
subset was only observed in the host’s blood for 24h, not after.  Upon transfer into an 
inflamed host (after intraperitoneal – i.p. – injection of thioglycollate), the two subsets 
showed different responses, with the Ly6Clow staying mainly in the blood and homing to 
non-inflamed tissues, while the Ly6C+ subset invaded the peritoneum, acquired DC 
markers (MHC-II and CD11c) and could induce T cell proliferation in vivo, suggesting 
these cells could differentiate into functional DC in the context of inflammation 
(Geissmann et al., 2003). 
   Based on these observations, the Ly6C+ CX3CR1int monocytes were termed 
‘inflammatory’ monocytes, while the Ly6Clow CX3CR1hi subset was termed ‘resident’. 
Other terms have been used since then to designate these cells, such as ‘classical’ and 
‘non-classical’ ; this thesis will mainly refer to them as Ly6C+ and Ly6Clow monocytes. 
Gene expression patterns were found to be very similar between, on one hand the mouse 
Ly6C+ monocytes and the human CD14+ CD16- monocytes, and on the other hand 
between the Ly6Clow and CD14dim CD16+ subsets (Cros et al., 2010; Ingersoll et al., 
2010). 
   Monocytes have been further characterized thanks to the use of flow cytometry, and 
the two main subsets can be distinguished based on the differential expression of Ly6C, 
	 32	
CX3CR1, CCR2 and CD43, while they express similarly high levels of CD115, the M-
CSF receptor (Sunderkotter et al., 2004). 
   Monocytes have been further characterised over the years, with regards to their 
development, phenotype, function, and fate in vivo, of which an overview will now be 
given. 
   1.2.3. Ly6C+ monocytes functions  
   During microbial tissue invasion, Ly6C+ monocytes are mobilized form the bone 
marrow, circulate in the blood until they extravasate at the site of infection, where they 
play critical roles in pathogen phagocytosis, cross-talk with other innate cells and 
eventually may participate in the activation of adaptive immunity. Here a summary of 
these different roles in the context of various microbial threats, as well as sterile 
inflammation and cancer, will be given. 
   1.2.3.1. In bacterial infections 
   In response to bacterial infections, Ly6C+ monocytes have most notably been studied 
in the context of Listeria monocytogenes infection. They first exit the bone marrow via 
CCR2-dependent mechanisms, and mice deficient for CCR2 have a markedly increased 
susceptibility to L. monocytogenes infection (Serbina and Pamer, 2006 ; see also section 
1.3.4.2). Once in the circulation, chemokine signalling via G-coupled proteins seems 
dispensable for their localisation into sites of infection (Shi et al., 2010) as pertussis 
toxin pre-treatment of monocytes before their transfer into infected host does not disturb 
their recruitment; they rather rely on the integrin CD11b, also known as Mac-1 or 
Complement Receptor 3 (CR3), CD44 and the adhesion molecule ICAM-1 
(Intercellular Adhesion Molecule -1) (Rosen et al., 1989; Shi et al., 2010). Once at the 
site of L. monocytogenes infection, Ly6C+ monocytes were shown to differentiate into 
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Tumor Necrosis Factor alpha- (TNFα) and inducible-Nitric Oxide Synthase (iNOS) –
producing cells, which prompted the term “Tip-DCs” to designate them (Serbina et al., 
2003b).  
   The detection of bacterial products via Toll-Like Receptors (TLR) is crucial for host 
defence and mice lacking the intracellular signalling MyD88 downstream of many 
TLRs leads to a worsen survival of infected mice (Serbina et al., 2003a). However, 
MyD88 is not required in Ly6C+ monocytes for their recruitment to sites of infection, 
nor for their differentiation into Tip-DCs. However, it is necessary in other cell types 
(possibly classical DCs) for the proper function of Tip-DCs (Serbina et al., 2003a ; 
Arnold-Schrauf et al., 2014). During a secondary encounter with L. monocytogenes, 
memory CD8+ T cells produce CCL-3, which induces the production by Ly6C+ 
monocytes of TNFα, and eventually of Reactive Oxygen Species (ROS), thus mediating 
crucial bacterial clearance (Narni-Mancinelli et al., 2007, 2011).  
   The role of CCR2-expressing Ly6C+ monocytes was also shown in the clearance of 
Klebsiella pneumoniae (Xiong et al., 2015), as well as during Brucella melitensis 
infection, where cells with similar phenotypical and functional features as Tip-DCs 
were found during the first days post infection (Copin et al., 2007). The response to 
Mycobacterium tuberculosis also requires CCR2 for monocytes to leave the bone 
marrow (Peters et al., 2001), and although the injection of poly I:C, leading to an 
increased recruitment of Ly6C+ monocytes during infection, has shown to worsen the 
M. tuberculosis bacterial load (Antonelli et al., 2010), Ly6C+ monocytes participate 
positively to the decrease in bacterial load at specific times after infection, through the 
delivery of the pathogen to the draining lymph nodes, but not the priming of T-cells 
(Samstein et al., 2013). In addition, it is also important to mention Legionella 
pneumophila infection in the lungs, during which monocyte-derived cells seem to play a 
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critical role in cooperation with other cell types during various stages of infection 
(Brown et al., 2016; Casson et al., 2017). 
   1.2.3.2. In parasitic infections 
   Toxoplasma gondii is a protozoan parasite that invades the intestinal epithelium and 
can reside in a variety of hosts, including humans, in muscle and neural tissues without 
causing symptoms to immune-competent hosts. However immuno-deficient individuals, 
such as AIDS patients, can develop toxoplasmosis, which can lead to major brain 
damage. Initial reports pointed to neutrophils as the principal early responders by rapid 
production of IL-12p40 (Bliss et al., 2000), although the use of Gr-1 (clone RB6-8C5, 
targets both Ly6C and Ly6G) to deplete innate immune cells lead to some confusion as 
to which cell type was most influential during the early phases of infection. Later, 
reports showed the critical role of Ly6C+ monocytes in the control of infection (Dunay 
et al., 2010; Neal and Knoll, 2014; Robben et al., 2005).  
   Ly6C+ monocytes have also been shown to be involved in the response to many other 
parasites, such as strains of Leishmania : Leishmania mexicana was shown to target the 
recruitment of inflammatory monocytes, which resulted in a lessen Th1 induction by 
monocyte-derived dendritic cells on the sites of infection (Petritus et al., 2012). During 
the blood stage of malaria infection (Plasmodium chabaudi), Ly6C+ monocytes were 
shown to be critical to the control of the parasite through production of iNOS, Reactive 
Oxygen Intermediates (ROI) and phagocytic activity, all without any sign of 
differentiation into DC (Sponaas et al., 2009), and the role of monocytes in this 
pathology is a matter of investigation at many stages of the disease in several organs of 
the infected patients (Chua et al., 2013). Infection by the helminth Schistosoma mansoni 
induces an increased production of Ly6C+ monocytes in the bone marrow that are found 
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in the circulation and then in the liver (together with other phagocytes), where they 
seem to differentiate into macrophages (Girgis et al., 2014; Nascimento et al., 2014).  
   1.2.3.3. In fungal infections 
   Inhalation of fungal spores (conidia) happens daily, and it has been measured for 
Aspergillus fumigatus that 0.2 to 15 spores were present in each cubic meter of air 
(VandenBergh et al., 1999). Once deposited in the upper and lower airways, the 
epithelial cells of the lung usually clear these spores, and most invaded hosts never 
develop any symptoms. However, immuno-deficient or critically ill patients are 
susceptible to disease form A. fumigatus (Stevens and Melikian, 2011). The early 
response to this fungus is mediated by a number of innate cells such as neutrophils 
(Bonnett et al., 2006), plasmacytoid DCs (Ramirez-Ortiz et al., 2011), and Natural 
Killer cells (Park et al., 2009). In this context too, the CCR2-dependent exit of Ly6C+ 
monocytes from the bone marrow and their recruitment on the infection site is critical 
for the host protection (Espinosa et al., 2014). Ly6C+ monocytes have a direct role in 
taking up the spores and differentiation in monocyte-derived DCs, as deciphered with 
the use of fluorescent conidia (Espinosa et al., 2014; Jhingran et al., 2012), as well as an 
indirect role, as promoters of neutrophil-mediated killing and mounting of CD4+ T cell 
responses. 
   The importance of Ly6C+ monocytes has also been well established in the context of 
infection by Candida albicans, a fungus that mostly targets the kidney (although its 
presence can be detected in most organs upon infection), and can cause sepsis 
(Spellberg et al., 2005). In response to infection, Ly6C+ monocytes accumulate in most 
organs (Lionakis et al., 2011), and become the predominant inflammatory cell type in 
the kidney during early infection (Ngo et al., 2014), where they are crucial for the 
killing of C. albicans and the control of its growth. Ly6C+ monocytes were also found 
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to upregulate MHC-II, CD11c and down-regulate Ly6C, migrate into draining lymph 
nodes and gain the ability to prime CD4 T cells ex vivo, suggesting they could also have 
an antigen-presenting role in the context of this infection (Trautwein-Weidner et al., 
2015). Finally, it was recently shown that Ly6C+ monocytes were the primary source of 
IL-15 during C. albicans infection, which results in the activation of the NK 
cell/neutrophil axis in the liver and spleen, which in turn is critical for the fungus killing 
(Domínguez-Andrés et al., 2017). 
   1.2.3.4. In viral infections 
   Ly6C+ monocytes also participate to the anti-viral response, such as studied in the 
context of influenza virus. It was shown in a 2009 study that several strains of Influenza 
A virus could induce the CCR2-dependent monopoiesis and subsequent recruitment to 
the lung of, among other cell types, Ly6C+ CD11b+ cells, producing TNFα and iNOS 
(Aldridge et al., 2009). These cells were shown to be important players in the response 
to influenza, although the dose used in models of influenza can impact the outcome of 
Ccr2-deficiency (Aldridge et al., 2009; Dawson et al., 2000; Lin et al., 2008). It seems 
“Tip-DCs” recruited to the lungs can act as local antigen-presenting cells to induce a 
stronger CD8 T cell response (Aldridge et al., 2009), which impacts the outcome of 
disease, as CD8 T cells are thought to be the main mediators of virus-producing 
epithelial cells killing (Doherty et al., 1997).   
   Additionally, Ly6C+ have been shown to have a detrimental impact during early 
phases of West-Nile Virus infection, which infects the brain. Within the first week of 
infection, Ly6C+ monocytes have been shown to be recruited from the BM and to cross 
the Blood-Brain Barrier (BBB), and infiltrate the brain, with both these steps CCR2-
dependent (Getts et al., 2008), based on a CCL-2 blockade strategy, while competitive 
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transfer experiments of CCR2-potent and CCR2-deficient monocytes argue for a CCR2-
independent infiltration of monocytes from blood to brain (Lim et al., 2011). 
   Finally, it can be mentioned that CD14+ monocytes (of which the mouse Ly6C+ 
monocytes are analogues) circulating in humans were found to be reservoirs for the 
Human Immunodeficiency Virus (HIV) -1 (McElrath et al., 1991; Quiros et al., 1995), 
and these cells, as well as CD14dim CD16+, are involved in the virus latency, even in 
patient under anti-retroviral therapy (Zhu et al., 2002). 
   1.2.3.5. During cancer 
   Cancer progression occurs as a succession of events. First, cells autonomously acquire 
and accumulate mutations that lead to their transformation, then these transformed cells 
perform clonal expansion in their organ of origin, which becomes the primary cancer 
site; finally, some cancer cells can circulate and engraft other organs, and proliferate in 
situ to constitute metastasis. During these developments, tumour cells acquire various 
properties that can be designated as hallmarks of cancer, that allow their growth and 
escape from various defence mechanisms (Hanahan and Weinberg, 2011). There is a 
tremendous variability regarding whether a particular immune cell type is associated 
with a good or bad prognosis, and this depends on the immune cell type, cancer primary 
site and stage of disease. Consistent with this general observation, monocyte responses 
to cancer have been shown to be variable.  
   Adding a layer of complexity, myeloid populations of different origins (see section 
1.4.1 about macrophage development) can populate tumours at various stages 
(Perdiguero and Geissmann, 2014). This issue has notably been tackled in a study on 
myeloid cell response in a mouse model of spontaneous mammary gland cancer, where 
Ccr2-deficient mice, gene expression profiling and transfer techniques were used to 
decipher the identity and origin of tumor-infiltrating cells. The authors found that upon 
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tumor growth, Ly6C+ monocytes exited the BM in a CCR2-dependent manner, and 
contributed to myeloid populations found in the tumor, where they differentiated into 
tumor associated macrophages (TAM), in a Notch-dependent manner (Franklin et al., 
2014). Several studies have suggested a role for extramedullary haematopoiesis in the 
spleen, and this organ considered a potential reservoir for inflammatory monocytes in 
the context of cancer (Cortez-Retamozo et al., 2012). The use of photo-convertible 
protein-bearing mice revealed that spleen monocytes made only a marginal contribution 
to tumour-infiltrating monocytes, and that their origin was mainly in the bone marrow 
(Shand et al., 2014). 
   1.2.3.6. During sterile inflammation or injury 
   Beyond pathogenic stimuli or cancer, monocytes are involved in a number of other 
inflammatory settings. For example, although graft rejection is typically associated with 
T cell responses, it has long been recognized that the infiltration of myeloid cells in 
renal transplant had a strong impact as well (Girlanda et al., 2008; Hancock et al., 
1983). Swirski and colleagues found that Ly6C+ monocytes were the predominant 
myeloid infiltrating cells present in rejected grafts in a mouse model of heart 
transplantation (Swirski et al., 2010). 
   Atherosclerosis is a complex progressive disease characterised by the formation, on 
large and medium-sized arteries, of plaques with a defined structure of lipid-rich 
necrotic core, covered by a fibrous cap, which contains inflamed smooth-muscle cells, 
and collagen fibres (Usman et al., 2015). These plaques have the capacity to block 
blood flow leading to ischemia of the heart, brain or extremities. It has long been 
recognized that atherosclerosis is an inflammatory disease (Ross, 1999), and the lesions 
are also populated with cells referred to as ‘foam cells’, the origin of which is still a 
matter of research (Woollard and Geissmann, 2010). The infiltration of monocytes, 
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among other immune cells, has been observed as early as 1979 by Gerrity and 
colleagues, who found mononuclear cells in the plaques by light microscopy, and 
monocytes extending microvilli into endothelial cells, by electron microscopy (Gerrity 
et al., 1979).  
   Apolipoprotein E (ApoE) is critical for lipid transport and metabolism, and is the 
primary ligand for low-density lipoprotein receptor-mediated removal of circulating 
lipoproteins. ApoE-/- mice (Nakashima et al., 1994) have been instrumental in the study 
of the initiation and progression of atherosclerosis, as they develop similar lesions as 
humans, which occur faster when fed a lipid-rich, Western-type diet (Nakashima et al., 
1994; Plump and Breslow, 1995). Monocytes are found inside the plaques thus formed, 
and although other cells have been proposed as precursors for the foam cells (Paulson et 
al., 2010), Ly6C+ monocytes in ApoE-/- mice were found to be produced in greater 
number in the bone marrow, adhere to the arterial wall and infiltrated the lesions, where 
they differentiated into plaque macrophages (Swirski et al., 2007).  
   Finally, recent reports have used intravital microscopy to try unravel the in situ 
behaviour of Ly6C+ monocytes after sterile injury in the liver, showing they are rapidly 
recruited (within hours) to the focal point of injury, together with, but independently of, 
neutrophils (Dal-Secco et al., 2015), where they upregulate CX3CR1 and down-regulate 
Ly6C. Some studies, as in the context of heart ischemia, have proposed that the 
different subsets of monocytes were recruited sequentially to the necrotic tissue and 
started with a wave of Ly6C+ monocytes that would participate to the inflammatory 
milieu, followed by a second wave of pro-repair Ly6Clow monocytes (Nahrendorf et al., 
2007), recruited separately, rather than the product of an in situ conversion of Ly6C+ 
monocytes into Ly6Clow monocytes. However, this view has been challenged some 
years later by the same group (Hilgendorf et al., 2014), showing that Ly6C+ monocytes 
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were involved in both inflammatory and reparative phases or myocardial infarction 
progression. 
   1.2.4. Ly6Clow monocyte functions 
   1.2.4.1. Patrolling activity 
   When they were first described, Ly6Clow monocytes were found to have a longer life 
span in the circulation than their Ly6C+ counterparts (Geissmann et al., 2003) ; 
however, their function remained unclear. These cells develop independently of the 
lymphoid lineage, as they are present in normal numbers in Recombination Activated 
Gene 2 (Rag2) -deficient, Il2rg (gamma chain of the IL-2 receptor) –deficient mice 
(Auffray et al., 2007a; Geissmann et al., 2003), as well as Il2rg-/- patients (Cros et al., 
2010). In 2007, Frederic Geissmann’s laboratory published work that characterised their 
behaviour in vivo (Auffray et al., 2007). Utilising Cx3cr1gfp/+ crossed to a Rag2-/- Il2rg-/- 
background mice allowed the visualisation of monocytes as the only GFP expressing 
cells, the authors found that Ly6Clow monocytes crawl on the luminal side of the 
endothelium in different organs (skin, mesenteric vessels). This crawling is relatively 
slow (about 12µm/min in average), compared to other cells rolling on endothelium 
(Springer, 1994), and does not depend on the direction of the blood flow, with their 
track showing various patterns, including loops, hairpins and waves. Their confinement 
ratio was found to be low, 0.5 in average, meaning that the distance travelled by 
individual cells was only half the total length of their tracks. These characteristics of 
their crawling was suggestive that these cells may be surveying the endothelium, which 
coined the term ‘patrolling’ to describe their behaviour. It also implied a firm 
attachment of the crawling monocytes to the endothelium, which was found to be LFA-
1 (Lymphocyte Function-associated Antigen 1) -dependent and partially CX3CR1-
dependent. Patrolling monocytes seem to extravasate rarely in the steady state, although 
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they can do so rapidly in response to tissue damage with tissue irritants, sterile 
injury and infection with L. monocytogeneses, after which the authors measured a 
strong TNFα production by these cells, 2h post infection, which is before the full 
recruitment of either neutrophils or Ly6C+ monocytes (Auffray et al., 2007).  
   A few years later, human CD14dim CD16+ monocytes were also found to have a 
patrolling activity, as pre-labelled transferred monocytes of that phenotype were found 
crawling on the luminal side of blood vessel of mice alongside mouse Cx3cr1-gfp+ 
Ly6Clow monocytes (Cros et al., 2010).  
   This Ly6Clow patrolling monocyte subset was found crawling in the capillaries of the 
kidney, in an ICAM-1 (InterCellular Adhesion Molecule -1) -dependent manner, where 
these cells are able to phagocytose microbeads injected intravenously (Carlin et al., 
2013). The interaction between patrolling monocytes with the endothelium is dynamic 
at steady state, where it was estimated that at any time, one third of Ly6Clow monocytes 
are crawling on the luminal side of vessel, from which they attach and detach 
constantly. Upon topical application, or ‘painting’, of a TLR7 agonist on the kidney, 
Ly6Clow monocytes were found to be retained by the endothelium via a CX3CR1-
CX3CL1 dependent mechanism, with a decreased instantaneous velocity, lower 
confinement ratio and increased track length and duration, leading to their accumulation 
over a few hours in the kidney. This leads to the recruitment, by the retained monocytes, 
of neutrophils, whose numbers are greatly increased following TLR7 agonist painting of 
the kidney. In turn, these recruited neutrophils induce the endothelial cells to necrose 
(Carlin et al., 2013). A set of experiments presented in Chapter 4 focused on a certain 
aspect of this inflammatory response of Ly6Clow monocytes. Of note, in this study by 
Carlin and colleagues, the authors stained MHC-II on monocytes in order to separate 
the steady state MHCII+ and MHC-II- within the CD11b+ CD115+ blood monocytes, 
identifying an MHC-II+ fraction that expresses a range of levels of Ly6C. The 
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‘patrolling’ subset of monocytes was hence defined as CD11b+ CD115+ Ly6Clow MHC-
II- (Carlin et al., 2013). This separation is not performed in most articles published to 
date (to our knowledge), so is not accounted for in the studies we will mention from 
here.  
   These studies demonstrated a role of Ly6Clow monocytes as « housekeepers » of the 
vasculature, which has been confirmed by several other groups, who have described 
patrolling monocytes in other settings. Ly6Clow monocytes have also been observed in 
larger vessels than kidney capillaries, such as in the carotid arteries, crawling at higher 
velocities during steady state (average of 36µm/min, versus an average of 8µm/min in 
the kidney – Carlin et al., 2013 - or 12µm/min in the skin – Auffray et al., 2007), where 
they are increased by TLR7 agonist application (Quintar et al., 2017). In the brain, 
Ly6Clow CX3CR1hi monocytes have been found patrolling in the cerebral vasculature 
where small aggregates of amyloid β (Aβ) deposited in mouse models of Alzheimer 
disease, but not during steady state or in arteries where Aβ is surrounding the vessels 
(Michaud et al., 2013). Development of endoscopic imaging techniques of the heart 
allow the longitudinal analysis of this organ over several days, and allowed the 
observation of steady state crawling of CX3CR1hi Ly6Clow monocytes (Jung et al., 
2013), where they were found to crawl at similar velocities than in the kidney capillaries 
(Li et al., 2012a). Finally, LFA-1 mediated crawling of Ly6Clow monocytes has been 
described in the mouse cremaster muscle (Sumagin et al., 2010). Taken together these 
observations suggest that the patrolling behaviour of Ly6Clow CX3CR1hi monocytes is a 
feature that seems universally found in the vasculature, which allows this subset to 
perform specific functions in the circulation. 
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   1.2.4.2. Ly6Clow monocytes in infectious diseases and cancer 
   Ly6Clow monocytes have been implicated in the response to infection in some cases, 
although it has not yet been as much studied as in the case of Ly6C+ monocytes. First, 
as mentioned above, they extravasate rapidly after intraperitoneal infection with Listeria 
monocytogenes (Auffray et al., 2007). Following infection, they are found in great 
numbers in the peritoneal cavity, where they produce TNFα, and upregulate genes 
associated with a differentiation program towards macrophage-like phenotype, such as 
cMaf and MafB, but not RelB nor Pu.1 (Auffray et al., 2007) ; this is in contrast to 
Ly6C+ monocytes, which upregulate genes associated with DC differentiation (Auffray 
et al., 2007), consistent with their described extravasation and differentiation to TNFα 
and iNOS producing Tip-DCs, as described by the group of Eric Pamer (Serbina et al., 
2006). 
   Recently, the mouse cytomegalovirus (MCMV) was found to ‘hijack’ patrolling 
Ly6Clow monocytes to use them has Trojan horses to disseminate to the salivary glands, 
in an experimental model of infection of the footpad (Daley-Bauer et al., 2014). 
Consistent with the CX3CR1-dependent steady-state crawling and retention of Ly6Clow 
monocytes (Auffray et al., 2007 ; Carlin et al., 2013), this dissemination was impaired 
in Cx3cr1gfp/gfp mice, which are Knock-Out (KO) for Cx3cr1. Studies on the response to 
virus by human CD14dim CD16+ monocytes revealed they can respond to nucleic acids 
from Herpes Simplex Virus 1 and measles via TLR7/TLR8, which signal through the 
MYD88-MEK pathway, to produce IL-1β, TNFα and CCL3 (Cros et al., 2010). 
   In models of cancer development, a fraction of Ly6Clow monocytes have been shown 
to express Tie-2, and promote angiogenesis in the tumor microenvironment (De Palma 
et al., 2005). Equivalents of these Tie-2 expressing monocytes have been characterised 
in human among the CD14dim CD16+ (Murdoch et al., 2007; Venneri et al., 2007). 
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Angiogenesis is one of the hallmarks of cancer (Hanahan and Weinberg, 2011), and 
participates to tumor progression, which points to a detrimental role of patrolling 
monocytes in certain cancers or cancer models. However, a fraction of Ly6Clow 
monocytes expressing neuropilin-1 has been shown to hinder tumor growth when 
injected by intratumoral route, by promoting a certain pathway of vessel maturation, 
thereby increasing tumor perfusion ; this limited hypoxia, which is a factor that can 
promote tumoral growth (Carrer et al., 2012). In a recent report, Ly6Clow monocytes 
were found patrolling the vasculature of lung tumors, and several models of Nr4a1 
deficiency, in which the Ly6Clow subset of monocytes is lacking (Hanna et al., 2011 ; 
see section 1.3.4.1), showed enhanced metastasis to the lung in a model of spontaneous 
mammary tumors (Guy et al., 1992) ; together with the observation of fluorescently 
labeled cancer cells being ingested by Ly6Clow monocytes, these results suggested they 
participate in the clearing of metastasizing cancer cells (Hanna et al., 2015). 
   1.2.4.3. Role of Ly6Clow monocytes in other immunological disorders 
   Ly6Clow monocytes have also been shown to be part of the response to various non-
pathogenic nor cancerous diseases, such as atherosclerosis, Systemic Lupus 
Erythematosus (SLE) or Rheumatoid Arthritis (RA). 
   As mentioned above, ApoE-/- mice rapidly develop atherosclerotic plaques in their 
arteries when fed a high fat diet (HFD, Nakashima et al., 1994). During this process, 
Ly6Clow also enter the lesions, though less frequently than Ly6C+ monocytes, in a 
CX3CR1-independent, but CCR5-dependent manner (Tacke et al., 2007). Consistently, 
using this same model of ApoE-/- mice fed a HFD, Combadière and colleagues found 
that combined deficiency in CCL2, CX3CR1 and blocking of CCR5 was enough to 
almost completely abrogate atherosclerotic plaque formation (Combadière et al., 2008), 
suggestive of an overall deleterious effect of monocyte influx into lesions.  However, 
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other reports suggest otherwise, in mice lacking Ly6Clow monocytes, in the context of 
ApoE-/- mice fed a HFD, Chao and colleagues found no correlation with outcome in 
terms of arterial lesion formation (Chao et al., 2013). Finally, a number of studies from 
different groups suggest that Ly6Clow monocytes have a protective effect in the context 
of atherosclerosis. Combined deficiency in Nr4a1 (on which Ly6Clow depend for their 
development, see Hanna et al., 2011 and section 1.3.4.1) and ApoE (Nakashima et al., 
1994) resulted in an increase of atherosclerosis (Hamers et al., 2012; Hanna et al., 
2012). Intravital imaging of the steady state and atherosclerotic arteries also suggested a 
protective role of Ly6Clow monocytes, which patrolled the endothelium of large arteries 
as mentioned before, and improved the proper disposal of dying endothelial cells during 
lesion formation (Quintar et al., 2017).  
   Systemic Lupus Erythematosus is a chronic, systemic autoimmune disorder involving 
multiple organs, and the diagnostic of which can call to many different clinical signs, 
and during which autoantibodies are produced against double-stranded DNA (Rahman 
and Isenberg, 2008). Increase in production of monocytes has long been recognised in 
genetic mouse models of spontaneous development of this disease (Wofsy et al., 1984). 
In certain murine models of lupus, Ly6Clow monocytes seem to expand more than their 
Ly6C+ counterparts (Amano et al., 2005). A study where the authors developed an 
antagonist of CX3CR1 found it delayed and ameliorated lupus (Inoue et al., 2005). 
Consistently, Nakatani and colleagues found that CX3CR1 ligand and the accumulation 
of CD16+ monocytes were associated with the severity of lupus (Nakatani et al., 2010). 
Finally, increased generation of Ly6Clow monocytes with an activated phenotype was 
observed in lupus-prone mice, which was associated with the dysregulation of auto-
reactive B cells (Santiago-Raber et al., 2009). The ‘hyperactive’ phenotype of these 
monocytes was based notably on their pattern of expression of Fc-gamma receptors, 
which will be discussed in the next section. 
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   Of note, Ly6Clow monocytes have also been found to play an important role in 
rheumatoid arthritis (RA), which is one of the most prevalent chronic autoimmune 
diseases (Helmick et al., 2008). Misharin and colleagues obtained results suggesting 
that Ly6Clow monocytes were a driving force for the initiation of RA, by being recruited 
to the joints, where they upregulate genes associated with pro-inflammatory activity, 
before ‘switching’ to a more ‘healing’ transcriptional profile (Misharin et al., 2014). 
However, a recent study shows that initiation of arthritis was not massively impacted in 
Cx3cr1-deficient mice, despite the fact that these mice have significantly lower Ly6Clow 
monocytes patrolling the vasculature (Auffray et al., 2007), suggesting that Ly6Clow 
monocytes, or at least their patrolling activity, was not critical to the onset of disease 
(Brunet et al., 2016). Furthermore, the authors conducted experiments suggesting that 
Nr4a1-dependent Ly6Clow monocytes participated to the activation of regulatory T cells 
(T-reg) in the joint, therefore promoting a reduction of disease severity (Brunet et al., 
2016). Therefore, further study will be needed to decipher the precise role of Ly6Clow 
monocytes at various stages of RA in different disease models. 
   1.2.4.4. Ly6Clow monocytes as mediators of IgG-dependent functions 
   Receptors recognizing the Fc (fragment crystallisable) of the constant fraction of 
immunoglobulins, and notably the Fc receptors (FcR) to IgG (FcγR) play a major role in 
immune responses (Nimmerjahn and Ravetch, 2011). They constitute a critical link 
between the specific response mediated by adaptive immune cells (B cells) and the 
innate arm of the immune system. To date, four FcγR have been characterised in mice : 
the activating FcγRI, FcγRIII and FcγRIV, and the inhibitory FcγRIIB (Nimmerjahn et 
al., 2005). Co-expression of activating and inhibitory FcγRs and their variable 
engagements sets a threshold of activation and determines the strength of the response 
by innate immune cells such as ADCC (Antibody Dependent Cellular Cytotoxicity).  
	 47	
   Ly6Clow monocytes were found to express the broadest range of FcγRs, as they 
express both all the activating (FcγRI, FcγRIII and FcγRIV) and inhibitory (FcγRIIB) 
ones (Biburger et al., 2011). In a series of experiments designed to address the FcγR-
mediated functions of different immune cell populations, the authors found that Ly6Clow 
monocytes had the highest capacity to perform ADCC-mediated killing of B cells in 
vitro, as well as efficient uptake of fluorescent liposomal vesicles and platelet depletion 
in vivo (Biburger et al., 2011). This suggested Ly6Clow may be of general importance in 
IgG-mediated functions in various settings. This is consistent with their involvement in 
several autoimmune disorders such as SLE, as mentioned above (Santiago-Raber et al., 
2009). 
 
1.3. Monocyte development 
1.3.1. Hematopoiesis, overview 
   Hematopoiesis, the production of all blood cells, of the innate and adaptive arms of 
the immune system, as well as red blood cells and platelets, takes place mainly in the 
bone marrow of adult vertebrates. This production is a sequential process, during which 
cells progress from multipotent to mature, differentiated states, progressively losing this 
multilineage potential. At the top of this hierarchy reside hematopoietic stem cells 
(HSC), which are characterised by two major properties: multipotency, the ability to 
give rise to all blood lineages, and self-renewability. Indeed, these cells are generated 
once in the lifetime during the embryonic and fetal life, and then undergo asymetric 
mitotic divisions : one daughter cell differentiates while the other retains its HSC 
identity and properties. The founding work of Till and McCulloch (Till and McCulloch, 
1961; Till et al., 1964) demonstrated that cells present in the BM have the potential to 
form clonal expansion of progenitors giving rise to Colony-Forming Units – Spleen 
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(CFU-S), in irradiated hosts. The founding clone could give rise to several blood 
lineages, hence was a multipotent progenitor. Their self-renewability was evidenced by 
experiments showing that these CFU-S could form not only mature cells, but also other 
CFU-S with the same functionality as the original CFU-S (Worton et al., 1969; Wu et 
al., 1968). These were the first observations of what would thereafter be termed 
Hematopoietic Stem Cells. 
   HSC have been mainly defined functionally by their ability to reconstitute the 
hematopoietic compartments of fully irradiated hosts (mice have been instrumental as a 
model for these studies, Weissman and Shizuru, 2008), giving rise to all blood lineages 
over a long period of time. The identification of HSCs using surface phenotypic 
markers was critical for their functional study; the laboratory of Irving Weissman, 
among others, has been carrying out seminal work in this direction. In 1986, it was 
found that B cell producing progenitor did not express B220 (Muller-Sieburg et al., 
1986), a marker identified as specific for B cells (Coffman and Weissman, 1981). This 
was the basis from which a Lineage negative gating strategy was adopted (Weissman 
and Shizuru, 2008), and lead to the finding that all identified clonal lineage progenitors 
were contained in Lin- cells, which were enriched for reconstituting cells (Muller-
Sieburg et al., 1986). A little later, Thy-1 and Sca-1 (Spangrude et al., 1988), and finally 
c-Kit, the receptor for Stem Cell Factor (Ikuta and Weissman, 1992) were shown to be 
expressed by a mixture of cells enriched for cells with repopulation capacity (Morrison 
et al., 1994). This was then termed the LSK compartment, for Lin- Sca-1+ c-Kit+. It 
contained Long-Term HSCs (LT-HSC), Short Term HSCs (ST-HSC) as defined by the 
extent of their self-renewal capacity, as well as the multipotent progenitors (MPP), 
identified in 1997 as having the potential to reconstitute all blood lineages but with no 
self-renewal capacity (Morrison et al., 1997). The use of the SLAM family receptors 
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CD48, CD150 and CD244 allowed an easier identification of these hierarchical stages 
(Kiel et al., 2005). 
   Beyond cells that can give rise to all blood lineages with various levels of self-renewal 
capacity, several other more restricted progenitors were discovered during the 1990s 
and 2000s. The separation of progenitors from the LSK cells, based on their expression 
of the alpha chain of the IL-7 receptor (IL-7Rα), allowed the identification of a 
clonogenic Common Lymphoid Progenitor (CLP), restricted to lymphoid cells, i.e. T 
cells, B cells and NK cells (Kondo et al., 1997). Within cells negative for IL-7Rα, the 
differential expression of Fcγ Receptors (FcγR) II / III (stained with a single 2.4G2 
antibody clone) and CD34 identified a IL-7Rα- FcγRlo CD34+ cell population able to 
give rise to myeloid and erythroid cells, termed the Common Myeloid Progenitor, or 
CMP (Akashi et al., 2000). This CMP could differentiate into either FcγRhi CD34hi cells 
that gave rise to granulocyte and macrophage colonies upon culture with various growth 
factors, and therefore termed Granulocyte/Macrophage lineage-restricted Progenitors 
(GMP), or into FcγRlo CD34lo Megakaryocyte/Erythrocyte lineage-restricted 
Progenitors – MEP (Akashi et al., 2000). The work of Nakorn in 2003 identified a CD9+ 
progenitor population in the mouse bone marrow, more restricted than the MEP, as they 
could selectively give rise to megakaryocytes, the precursor giant cells to platelets, that 
was termed MKP, for Megakaryocyte-committed Progenitor (Nakorn et al., 2003). 
   The view that, after losing self-renewability from LT-HSC to MPP stages, progenitors 
would directly engage in well segregated myeloid/erythroid or lymphoid differentiation 
pathways through CMP or CLP respectively (Miyamoto et al., 2002), has since then 
been challenged. First, the identification of a new cell population termed the LMPP 
(Adolfsson et al., 2005; Månsson et al., 2007), for Lymphoid-primed Multipotent 
Progenitor, which expressed Flt3 and had both myeloid and lymphoid potential but little 
to no megakaryocytic/erythroid potential. But beyond the identification of cell 
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populations that would constitute a step within the differentiation tree, heterogeneity has 
been shown for other aspects of hematopoiesis. For example, the SLAM family markers 
allow the distinction within the LSK cells of potentially seven subsets of HSCs, MPPs 
and more restricted progenitor cells (Oguro et al., 2013). Additionally, the potential of 
these various progenitor cells can vary depending on the experimental conditions, and 
the irradiation of mice has been shown to greatly influence the outcome of progenitor 
cell differentiation compared to steady state (Pietras et al., 2015). The ability to self-
renew was found to not be restricted to the most undifferentiated HSCs, but also in early 
myeloid-restricted repopulating progenitors that can by-pass the usual stepwise process 
of hematopoiesis (Yamamoto et al., 2013). The development of genetic barcoding 
techniques has allowed investigators to revisit lineage potential of individual cells in 
vivo in mice; a group showed that individual CMP tended to selectively give rise to 
either myeloid or megakaryocytic/erythroid progeny, which argued against its 
MEP/GMP pluripotency, and suggested a more pluripotent progenitor population may 
actually reside upstream, within the MPPs (Perié et al., 2015). Finally, analysis of the 
transcription profiles of individual cells sorted based on small phenotypic variations 
(i.e. intensities of expression of markers) suggested a vast heterogeneity of known 
progenitor populations (Paul et al., 2015). Therefore, the classical road map identifying 
distinct progenitor populations with fixed lineage potential and self-renewal capacity is 
to be considered with caution. 
   Monocyte development has been unveiled over the years and a brief summary of the 
knowledge gathered about the known monocyte progenitors will now be given. 
   1.3.2. MDP and cMoP are steps towards differentiated monocytes 
   Further downstream from the GMP, a progenitor restricted to mononuclear 
phagocytes was identified in 2006 and was termed the MDP, for Macrophage/Dendritic 
	 51	
cell Progenitor (Fogg et al., 2006). Until then, results from various laboratories over 
many years had suggested different hypothesis. Some results suggested that 
macrophages and dendritic cells were derived from a common progenitor (Inaba et al., 
1993). However a number of studies pointed toward separated pathways of 
differentiation, for example the fact that while macrophages rely of M-CSF 
(Macrophage-Colony Stimulating Factor) for their development, DCs don’t (Witmer-
Pack et al., 1993), and are rather Flt3-dependent (McKenna et al., 2000). Progenitor 
populations identified until then did not allow a clear pathway for DC lineage, as 
dendritic cells could be generated both from the CMP (Akashi et al., 2000) and CLP 
(Karsunky et al., 2008; Kondo et al., 1997).  
   Based on the knowledge that CX3CR1 is expressed widely by monocytes, DCs and 
macrophages (Jung et al., 2000 ; Geissmann et al., 2003), t he study of Fogg and 
colleagues (Fogg et al., 2006) identified a c-Kit+ population that expressed CX3CR1-
GFP in the Cx3cr1gfp/+ mouse. These cells were also negative for CD11b and markers of 
lineage, did not express IL-7Rα (associated with lymphoid restricted progenitors, 
Kondo et al., 1997), and expressed CD34 and FcγR, as do GMP (Akashi et al., 2000), 
from which they were still distinct due to their expression of CSF-1R and CX3CR1 
(GMPs don’t express these). They were small cells with a progenitor morphology, i.e. 
large nucleus to cytoplasm ratio, and proliferated rapidly in culture, though stromal cell 
lines supporting their growth would efficiently sustain them if they expressed M-CSF, 
unlike OP9 cells. Single MDP cells would give rise to colonies with macrophage and 
DC morphology, but not granulocytes, and were devoid of lymphoid potential. 
Cultivating these cells without stroma but with M-CSF would give rise to CD11b+ 
CD11c+ macrophage-morphology cells that could engulf heat-killed bacteria, while 
culture with GM-CSF would give rise to CD11bint CD11c+ DC-morphology cells with 
the ability to process and present antigens. Upon transfer into irradiated hosts, MDPs 
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gave rise to monocytes, DC subsets and macrophages in the spleen. Interestingly, 
donor-derived DCs were present in the host even when the host was not irradiated, 
which argued against the generation of monocyte-derived DCs because of the 
inflammation that irradiation may cause. This gave way to the hypothesis of the MDP 
being a progenitor for steady-state DCs (Fogg et al., 2006). Given its phenotypical 
features of Lin- IL-7Rα- CSF-1R+ CX3CR1+ CD34+ FcγR+ and lineage restriction to 
myeloid, mononuclear phagocytes (but not polymorphonuclear granulocytes), the MDP 
was defined as a downstream population of the CMP, and GMP.  
   Further analysis of the MDP revealed that they were the precursors of both monocyte 
subsets in the blood and bone marrow, as well as conventional DC subsets without a 
monocyte intermediate (Auffray et al., 2009; Varol et al., 2007). Transfer experiments 
and the study of inflammatory situations showed that the MDP could give rise to Ly6C+ 
monocytes that could respond to L. monocytogenes by migrating to infected spleens and 
produce TNFα and iNOS, thus differentiating into Tip-DCs as observed previously 
(Serbina et al., 2003), and also give rise to conventional DCs (cDCs) as well as 
plasmacytoid DCs (pDCs) (Auffray et al., 2009). Therefore, it showed a broader lineage 
potential than the then recently described CDP (Common Dendritic cell Progenitor), 
which could give rise to cDCs and pDCs but not monocytes (Onai et al., 2007). 
Consequently, it was suggested that MDPs are slightly upstream the CDPs, though their 
phenotypes are very similar (Auffray et al., 2009).  
   A population downstream of the MDP was recently identified, termed the cMoP, for 
common Monocyte Progenitor (Hettinger et al., 2013). Prospective analysis of the bone 
marrow revealed the presence of an actively proliferating population similar in 
phenotype to MDPs, with the exception of Ly6C and Flt3, and in morphology. In vitro, 
a single cMoP cell only had the ability to generate clonal colonies of macrophages but 
not DCs. In vivo, following MDP transfer into non-irradiated hosts, the authors 
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observed the successive appearance of donor-derived cMoP, then Ly6C+ monocytes and 
finally Ly6Clow monocytes, but not DCs or macrophages. The generation of the two 
populations of monocytes in that order in time, together with transfer experiments and 
kinetic studies (Hettinger et al., 2013; Tamura et al., 2017; Yona et al., 2013), are part 
of the body of work that suggests Ly6C+ monocytes, beyond their ability to respond to 
inflammatory situations and extravasate, also constitute a precursor population to 
Ly6Clow monocytes (such as, recently, Mildner et al., 2017). This monocyte 
‘conversion’ has also been suggested recently for the human monocyte populations, 
where CD14+ monocytes gave rise to CD14dim CD16+ monocytes, through the CD14+ 
CD16+ intermediate stage (Patel et al., 2017). We will see later in this section that, 
although this conversion has been observed in several conditions, the distinct genetic 
requirements and mechanisms of bone marrow egress for the two main populations of 
monocytes are also consistent with potentially distinct pathways of differentiation in 
mice (see section 1.3.4). Actually, testing various possibilities, whether monocytes 
convert from one population to the other, or whether another hypothesis is possible, is 
the point of the strategy we have followed, and will be presented in section 3. 
   The use of co-culture systems (Lee et al., 2015a) has recently allowed the 
identification of the human equivalents to GMP, MDP and CDP in the cord blood and 
bone marrow (Lee et al., 2015b). A human equivalent to the cMoP has also been 
recently proposed (Kawamura et al., 2017). 
   1.3.3. Relationship of monocytes with dendritic cells and macrophages 
   Monocytes have long been considered solely as circulating precursors for 
macrophages and dendritic cells (van Furth et al., 1972). This view has been slowly 
altered by accumulating evidence that, although there are links between monocytes and 
macrophages and DCs, it is not a simple precursor / progeny relationship. 
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   In steady state, monocytes and dendritic cells share a common bone marrow 
progenitor as presented above, termed the MDP (Fogg et al., 2006 ; Auffray et al., 
2009), which has also been reported in human bone marrow and cord blood, termed 
human MDP (hMDP, Lee et al., 2015b). However, monocyte and dendritic cell lineages 
downstream branch out to, on the one hand, the cMoP (Hettinger et al., 2013 ; 
Kawamura et al., 2017), and the CDP (Naik et al., 2007 ; Onai et al., 2007), supporting 
further the idea that the production of dendritic cells from the MDP does not go through 
a monocyte stage (Varol et al., 2007).  
   Of note, in a number of studies on response to pathogens (see Section 1.2.3), Ly6C+ 
monocytes are shown to extravasate and upregulate DC-like markers (such as MHC-II 
and CD11c) and/or produce TNFα and iNOS. This is the base on which some articles 
have used the term “Tip-DCs” to name these cells. However, it is important to 
remember that dendritic cells are in essence antigen-presenting cells that kick-start the 
adaptive immune response. Therefore, when this function is not performed by 
extravasated monocytes, it is not entirely justified to term these cells “dendritic cells”. 
   Furthermore, accumulating evidence over the past two decades has firmly established 
that most tissue-resident macrophages arise from embryonic origin, as will be further 
discussed later (see section 1.4.1, Bertrand et al., 2005; Ginhoux et al., 2010; Gomez 
Perdiguero et al., 2014; Kierdorf et al., 2013; Palis et al., 1999; Schulz et al., 2012). 
Steady state contribution from monocytes to tissue macrophages is minimal for many 
tissues, in which their numbers are maintained locally, through proliferation (Chorro et 
al., 2009; Merad et al., 2002; Perdiguero and Geissmann, 2015). As we will discuss, the 
intestine is a counter example to that trend, for monocyte influx into this tissue 
overcomes the embryonic-derived resident macrophages throughout adult life (Bain et 
al., 2014). 
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   Monocytes have been known to differentiate into macrophages in in vitro culture for 
many years (Carrel and Ebeling, 1926). In vivo, in the context of inflammation caused 
by pathogens or sterile insults, to extravasate from vessels, and for example to engage in 
a DC-like transcriptional program, produce TNFα and iNOS after infection with L. 
monocytogenes (Auffray et al., 2007b; Serbina and Pamer, 2006; Serbina et al., 2009). 
Recently, heterogeneity among Ly6C+ monocytes has been recognised in mice; 
separating Ly6C+ monocytes with Flt3, CD11c, MHC-II and PU.1 levels of expression, 
the authors were able to identify committed subsets, which were direct precursors to 
iNOS-producing macrophages on the one hand, and to Granulocyte-Macrophage 
Colony Stimulating Factor (GM–CSF) -induced dendritic cells on the other (Menezes et 
al., 2016). 
   It is therefore important to keep in mind the different situations that drive the 
production of either steady state populations or inflammation-driven ones, as well as 
ontogeny, i.e. generation of cells during adulthood or embryonic development.  
   1.3.4. Molecular control of monocyte development and exit from the bone marrow 
   1.3.4.1 Molecular control of monocytes development 
•  CSF-1/CSF-1R axis 
   In the 1970’s a spontaneous mutation occurred at the Jackson laboratory, in two mice 
of a transgenic C57BL/6 strain, which resulted in shorten limbs and an absence of teeth. 
The description of mice bearing only this mutation was first done by Marks and Lane, 
estimating they may carry it on Chromosome 12, leading to osteopetrosis, a skeletal 
condition in which the bone is excessively mineralized because of a lack in bone 
resorption, due to a reduced number of osteoclasts (Marks and Lane, 1976). Osteoclasts 
are the professional bone-resorbing cells, that are thought to be of myeloid-monocytic 
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origin (Jacome-Galarza et al., 2013). These mutated mice, termed op/op mice, have a 
retarded growth, and lack a proper bone marrow cavity (Marks and Lane, 1976). A few 
years later, op/op mice were analysed for their hematological features, and were found 
to have vastly decreased numbers of monocytes and macrophages in vivo, as well as a 
hindered capacity to generate macrophages in vitro upon culture of their splenocytes 
(Wiktor-Jedrzejczak et al., 1982). Later genetic studies found that these mice carry a 
mutation on the proto-ocongene c-fms in Chromosome 3 (Yoshida et al., 1990), which 
codes for the Macrophage Colony Stimulating Factor (M-CSF), also called CSF-1, 
which is absent in these mice (Wiktor-Jedrzejczak et al., 1990; Yoshida et al., 1990). 
The study of both Csf1op/op mice and mice deficient for the receptor for CSF-1, CSF-1R 
(Csf1r-/- mice), showed they both lack circulating monocytes and tissue macrophages in 
many tissues, showing the fundamental role for the growth factor in the development 
and function of blood monocytes and tissue macrophages ; introduction of CSF-1 via a 
transgene into op/op mice resulted in a rescued phenotype (Cecchini et al., 1994; Dai et 
al., 2002; Witmer-Pack et al., 1993).  
   Studies of the expression patterns of CSF-1R gene c-fms, using both whole mount in 
situ hybridization (Hume et al., 1995) and in c-fms-eGFP mice (Sasmono et al., 2003), 
revealed its expression very early during murine embryogenesis, and in adults 
throughout myeloid populations of the blood and bone marrow, and tissue 
macrophages. CSF-1R is notably expressed by the MDP (Fogg et al., 2006). CSF-1 was 
shown to instruct the GMP (Granulocyte/Macrophage Progenitor) towards the 
monocytic lineage (Rieger et al., 2009). It was more recently shown that this lineage 
“instruction” toward myeloid fate can be induced as early during hematopoiesis as the 
HSC stage (Mossadegh-Keller et al., 2013). This allowed to give credit to the 
hypothesis that cytokines can influence lineage specification in HSCs, something that 
had been debated for a long time (Cross and Enver, 1997; Enver et al., 1998), and has 
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been conforted since then (Endele et al., 2014). The instruction of HSCs by CSF-1 
towards a myeloid fate is induced through the activation of the master regulator PU.1 
(Mossadegh-Keller et al., 2013), which is the focus of the next section. 
• PU.1 
   PU.1 is a transcription factor involved in the development of all hematopoietic 
lineages except erythroid. Its coding gene was first identified as an oncogene, as it was 
induced by the acute leukaemogenic retrovirus spleen focus forming virus (SFFV), and 
was therefore termed Spi-1, for SFFV proviral integration 1 (Moreau-Gachelin et al., 
1988). Mice deficient for PU.1 died at late embryonic stages (E18 at latest), due to 
severe anemia, and showed severe lack of T and B cells, monocytes and granulocytes 
(Scott et al., 1994). Mice with a defective PU.1 DNA binding domain were generated 
and, although they were born, died within 48 hours after birth and showed important 
defects again in T cells, B cells, granulocytes and monocytes (McKercher et al., 1996). 
PU.1 deficient myeloid progenitors do not form colonies in response to CSF-1, and this 
absence of responsiveness could be reversed by transgenic re-introduction of c-fms 
(DeKoter et al., 1998). To allow the study of PU.1 role in adult hematopoiesis, a system 
was developed in which PU.1 could be inactivated in adults, which also resulted in loss 
of responsiveness to CSF-1, and dramatic increase in the production of granulocytes 
(Dakic et al., 2005). 
   PU.1 is a master regulator of lineage commitment through its interactions with other 
transcription factors. For example, PU.1 and GATA-1, another transcription factor, can 
inhibit each other’s activity (Nerlov et al., 2000; Zhang et al., 2000), and are both 
expressed early during hematopoiesis (Miyamoto et al., 2002). A recently developed 
mouse model, in which PU.1 and GATA-1 levels of expression are monitored through 
the level of expression of fluorescent proteins, shows that the balanced expression of 
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these two proteins, rather than influencing the lineage commitment, enforced lineage 
decisions already adopted by differentiating hematopoietic progenitors (Hoppe et al., 
2016).  
   Beyond myeloid cell development, many other roles have been found for PU.1 
throughout the hematopoietic system, notably in the development of T cells 
(Champhekar et al., 2015). 
• Role of the IRF8 / KLF4 cascade in the lineage specification towards monocytes 
   Interferon regulatory factor 8 (IRF8) is a part of the IRF transcripton factor family, 
which comprises 9 members in mammals (Tamura et al., 2008). It was originally cloned 
in 1990 by Driggers and colleagues (Driggers et al., 1990) as an Interferon gamma 
(IFNγ)-inducible nuclear protein (and at the time was termed Interferon Consensus 
Sequence-Binding Protein – ICSBP). It is expressed exclusively in hematopoietic cells 
of both myeloid (monocytes, macrophages and dendritic cells) and lymphoid (B cells 
and activated T cells) lineages (Kantakamalakul et al., 1999; Nelson et al., 1996). The 
analysis of the Irf8-/- mice, generated in 1996, revealed its role in myeloid populations 
development, as these animals spontaneously develop chronic myelogenous leukemia-
like syndrome (Holtschke et al., 1996). Using cell lines derived from the bone marrow 
of Irf8-/- mice, Tamura and colleagues show that reintroduction of Irf8 using retroviral 
vectors into Irf8-/- myeloid progenitors (Lineage-negative cells), induced the stimulation 
of genes critical for monocyte production in vitro, as well as a restored macrophage 
colony forming potential, while suppressing genes involved in neutrophil development 
and correcting the abnormal overgrowth of granulocyte colonies from Irf8-/- cells, 
suggesting a role for Irf8 in monocyte/macrophage lineage specification in vitro 
(Tamura et al., 2000; Tsujimura et al., 2002).  
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   IRF8 can function as either transcriptional activator or repressor, depending on the 
heterodimer it forms with various molecules and the DNA region it binds to (Tamura 
and Ozato, 2002 ; Kanno et al., 2005), with an impact on myeloid cell development. 
IRF8 was shown to form a heterodimer with PU.1 to promote the expression of Klf4 
(Kurotaki et al., 2013), a gene critical for Ly6C+ monocyte differentiation (Alder et al., 
2008) in vivo. Hence, Irf8-/- mice almost completely lack Ly6C+ monocytes while their 
Ly6Clow population is partially reduced (Kurotaki et al., 2013). At the level of myeloid 
progenitors, the MDP and cMoP express high levels of IRF8 (Hettinger et al., 2013), 
and they accumulate in Irf8-/- mice (Schönheit et al., 2013). These data suggest the 
developmental arrest of Ly6C+ monocytes in Irf8-/- mice may be between the cMoP and 
the monocytes. In these cells, IRF8 functions as an inhibitor of C/EBPα, thereby 
blocking neutrophil differentiation ; in turn, Irf8-/- MDP and cMoP express high levels 
of C/EBPα, and aberrantly give rise to a large number of neutrophils (Kurotaki et al., 
2014). This also occurs in dendritic cell-restricted progenitor, and it was shown that 
even lymphoid progenitors in Irf8-/- mice could give rise to neutrophils (Becker et al., 
2012). These all participate to the important neutrophilia in Irf8-/- mice. One example 
showing the importance of Irf8 for Ly6C+ monocytes is a study showing that Irf8-/- mice 
have a defective response to West Nile Virus (WNV), after which the few remaining 
Irf8-/- monocytes were not recruited to the brain, and did not participate to the 
inflammatory myeloid population increase usually observed after WNV infection (Terry 
et al., 2015). 
   In humans, it has been reported that mutations affecting IRF8 binding to DNA 
resulted in a lack of circulating monocytes and either all or some subsets of dendritic 
cells (Hambleton et al., 2011), consequently, patients carrying such a mutation had 
increased susceptibility to mycobacterial infection during infancy. 
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• NR4A1 controls Ly6Clow monocyte differentiation  
   NR4A1 belongs to the NR4A subfamily of nuclear receptors that comprises NR4A1 
(also known as Nur77), NR4A2 (Nurr1) and NR4A3 (NOR-1), within the 
steroid/thryroid receptor family (Martínez-González and Badimon, 2005). These 
nuclear receptors have a very similar structure and all have a Ligand-Binding Domain 
(LBD); however, a study found that NR4A2, although having such a LBD, did not 
require the binging of a ligand for its function. Together with their similar genomic 
structure, this observation prompted the suggestion that the NR4A family members do 
not need ligand binding for their function (Wang et al., 2003). NR4A1 is coded in the 
mouse by Nr4a1, but was the first of this subfamily to be discovered, in 1988, as NGFI-
B (Nerve Growth Factor Induced gene – clone B), a gene rapidly and transiently 
induced in a rat cell line of differentiating neurons, that responded to NGF (Milbrandt, 
1988), and was therefore proposed as potentially involved in the differentiation of 
neurons at the time. The human NR4A1 (called TR3) was later found to translocate to 
the mitochondria upon apoptotic stimuli and induce the release of cytochrome c and 
apoptosis, independently of its binding to DNA (Li et al., 2000). This role in apoptosis 
has also been shown in the mouse for the selection of T cells, this time independently of 
mitochondria or cytochrome c, but through the induction of transcription of pro-
apoptotic genes such as Fas ligand (Rajpal et al., 2003). This role in apoptosis was 
found to be important in T cell negative selection in the thymus (Zhou et al., 1996). 
Recently, the thymic myeloid cells were studied in Nr4a1-deficient mice, and a 
population of CD11b- F4/80+ thymic macrophages was found to be reduced by two-
third in Nr4a1-/- compared to wt littermates, a population of cells implicated in the 
clearance of apoptotic thymocytes; however the other thymic myeloid populations were 
unaltered (Tacke et al., 2015). The three members of the NR4A family have been shown 
to be very rapidly induced by inflammatory stimuli such as Lipopolysaccharide (LPS) 
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or oxydized lipids on macrophages in vitro, and NR4A1 was found to be expressed in 
macrophages in atherosclerotic lesions (Pei et al., 2005).  
   In 2011, analysis of the expression of the different NR4A family members in 
monocytes revealed that Nr4a1 was expressed at high levels in Ly6Clow monocytes, 
although also present in Ly6C+ monocytes (Hanna et al., 2011). Higher expression of 
Nr4a1 in Ly6Clow monocytes than in the Ly6C+ subset in the bone marrow was also 
confirmed using flow cytometry, both by antibody staining (anti-NR4A1) and GFP 
expression in Nr4a1GFP mice (Hanna et al., 2011). In mice lacking Nr4a1 (Lee et al., 
1995), Ly6Clow monocytes, defined by flow cytometry as CD11b+ CD115+ and low side 
scatter, are almost absent from the bone marrow, spleen and blood; the remaining cells 
have lost the bean shape of their nuclei, are arrested in S-phase of the cell cycle and 
undergo apoptosis in the bone marrow (Hanna et al., 2011). Ly6Clow monocytes in these 
mice also showed downregulated effector molecules such as adhesion (LFA-1) and 
chemokine receptors (CCR2 and CX3CR1) at their surface. In contrast, Nr4a1 
expression is low in the MDP and progenitor populations including HSC, CMP and 
MDP, which were unaffected in numbers by Nr4a1-deficiency, an observation also 
applicable to Ly6C+ monocytes of the bone marrow and blood (Hanna et al., 2011). 
This suggested that although the MDP was known to give rise to both subsets of 
monocytes, they then had different genetic requirements and differentiated 
independently in the bone marrow downstream of the MDP. 
   Recently, CCAAT/Enhancer Binding Protein β (C/EBPβ) has been characterised as a 
critical actor in monopoiesis. A study by Mildner and colleagues found that C/EBPβ 
bound to the Nr4a1 promoter and regulated its expression (Mildner et al., 2017). This is 
consistent with other articles published over the last few years establishing a role for 
C/EBPβ in monocyte survival in the periphery, and in particular for Ly6Clow monocytes 
(Tamura et al., 2015, 2017). Mice lacking C/EBPβ were found to lack Ly6Clow 
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monocytes in the blood (and to a lesser extent blood Ly6C+ monocytes); Ly6Clow 
monocytes of the bone marrow were specifically missing, while all upstream monocyte 
progenitors examined remained unaffected (Tamura et al., 2017). The decreased 
numbers of monocytes in these mice were attributable to increased apoptosis, which is 
consistent with the apoptosis observed in Nr4a1-/- mice (Hanna et al., 2011).  
   1.3.4.2. Control of monocyte exit from the bone marrow 
• CCR2 and the egress of Ly6C+ monocytes from the bone marrow 
   When the mice lacking the C-C chemokine Receptor 2 (CCR2) were generated in 
1997, impaired myeloid leukocyte recruitment to the peritoneum following 
thioglycollate intraperitoneal injection was observed, as well as a decreased recruitment 
of monocytes following injection of beads coated with protein derivative of 
Mycobacterium bovis (Boring et al., 1997). Seminal work by Serbina and colleagues 
characterised further monocyte responses in Ccr2-/- mice (Serbina and Pamer, 2006). 
They observed fewer Ly6C+ monocytes in their circulation at steady state, while more 
numerous in the bone marrow, suggesting a control by CCR2 of Ly6C+ monocyte 
homeostasis. They then show that their response to Listeria monocytogenes, which is to 
migrate to infected tissues and produce TNFα and iNOS (Serbina et al., 2003b), was 
impaired in Ccr2-/- mice, and that TNFα-producing cells accumulated in the bone 
marrow, but blood monocytes numbers did not increase. Thus, this work showed that 
CCR2 was crucial for the egress of Ly6C+ monocytes upon infection with L. 
monocytogenes, though not for their migration from blood to tissues (Serbina and 
Pamer, 2006). This phenotype was not as marked in mice lacking one of the CCR2 
ligands, CCL2 (Lu et al., 1998), suggesting other ligands might be involved (Serbina 
and Pamer, 2006).  
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   A year later, a report by Tsou et al provided further insight into the role of CCR2 and 
its ligands for monocyte homeostasis and inflammatory response (Tsou et al., 2007). In 
this study, the lower levels of Ly6C+ monocytes in the blood in steady state was 
confirmed (Ly6C+ monocytes are identified as 7/4+ in this study, a marker known to be 
expressed by Ly6C+ monocytes, but not Ly6Clow, see Henderson et al., 2003). These 
low levels of circulating Ly6C+ monocytes in Ccr2-/- mice did not increase upon high 
fat diet feeding, like observed in the WT littermates and were retained in the bone 
marrow, similar to the response observed by Serbina and colleague after L. 
monocytogenes (Serbina and Pamer, 2006). Finally, the work of Tsou et al. suggested a 
role for MCP-1 and MCP-3, but not MCP-2 nor MCP-5, as the major ligands of CCR2 
for the homeostasis and responses of Ly6C+ monocytes (Tsou et al., 2007). This was 
confirmed in the context of L. monocytogenes by Jia and colleagues a year later (Jia et 
al., 2008). Using KO mice and various strains of L. monocytogenes, the authors found 
that sensing of cytosol invasion of the bacteria promoted the production of MCP-1and 
MCP-3, but also found that increased suceptibility of mice lacking these chemokines 
was due to reduced recruitment of Ly6C+ monocytes in the spleen rather than a defect in 
their production of TNFα and iNOS (Jia et al., 2008).  
• S1PR5 controls the exit of Ly6Clow monocytes from the bone marrow 
   S1PR5 (Sphingosine-1 Phosphate Receptor 5) is one of the five known S1P receptors, 
which are heterodimeric G protein-coupled receptors with high affinity for S1P (Chun 
et al., 2010). The role of these receptors in leukocyte trafficking was first suggested by 
the finding that a compound that binds four of these receptors inhibited the exit of T and 
B cells from thymus and secondary lymphoid organs (Cyster and Schwab, 2012). It was 
later found that NK cells express S1PR5 and that this receptor is involved in their 
	 64	
recirculation in the blood, from the bone marrow and lymph nodes (Jenne et al., 2009; 
Walzer et al., 2007).  
   In 2013, Debien, Mayol and colleagues found that S1pr5-/- mice lack Ly6Clow 
monocytes in the blood and periphery organs such as the spleen, lung and kidney, while 
showing normal numbers in the bone marrow (Debien et al., 2013). Ly6Clow monocytes 
express 30 times more S1pr5 than Ly6C+ monocytes, which remain at normal numbers 
in all organs studied by Debien, Mayol and co-workers (Debien, Mayol et al., 2013). 
Therefore, similarly to CCR2 for Ly6C+ monocytes, S1PR5 controls the egress of 
Ly6Clow monocytes from the bone marrow to the periphery. 
 
   1.4 Tissue Macrophages 
   1.4.1. Macrophage development and maintenance 
   1.4.1.1. Embryonic Hematopoiesis, overview 
    The production of hematopoietic cells, whether it be red blood cells, platelets or 
leukocytes, starts very early on, before birth, and the production of HSCs occurs during 
this period, once for the whole life, as in adults they only self-maintain (see section 
1.3.1). The establishment of hematopoiesis during embryonic and fetal life is a vast 
field of study ; once in place, embryonic hamatopoiesis is a complex process with 
unique features that distinguish it from its adult counterpart.  Because, as mentioned in 
the historical perspective, most tissue-resident macrophages arise during embryonic life 
(see section 1.1.4), it is important to understand these processes, which we will 
overview in this section. Many years of research in several animal models (mice, 
Xenopus, zebrafish and avian models notably) have uncovered a complex 
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spatiotemporal sequence leading to different waves of hematopoietic progenitors, which 
we will overview here. 
   The origin of the first HSC has been a matter of discussion for a long time, and early 
reports suggested their origin may be in the YS, based notably on the observation, made 
by Weissman and colleagues in the late 1970s, that injection of YS cells into the 
embryo circulation gave rise to T-cells of donor origin in the thymus of the recipients 
(Golub and Cumano, 2013). However, critical experimentations carried out in the 1970s 
by Françoise Dieterlen-Lievre and colleagues in chicken - quail chimeras showed an 
intra-embryonic origin of HSC ; these experiments were conclusive because of the 
distinctive shape of the nuclei of the cells of these two species. When quail embryos 
were grafted to the yolk-sacs of chicks of similar development stages (before or after 
the establishment of circulation), cells populating the hematopoietic organs of the quail 
embryos only contained quail cells, meaning these cells had to originate from the (quail) 
embryo proper, not the (chick) YS (Dieterlen-Lievre, 1975). Current understanding 
suggests that the hematopoietic system develops in two main distinct, but partially 
overlapping, waves: an HSC-independent production of cells that starts around 
embryonic day (E) 7.25 in the YS, and an HSC-dependent wave that starts with the first 
pre-HSC arising around E8 in the arterial vessels of the embryo. 
   The first wave consists of two heterogeneous sets of cells that arise in the YS as blood 
islands. These islands contain primitive erythrocytes, large nucleated cells containing 
haemoglobin produced only at this stage, for the transport of oxygen (Palis, 2016) and 
phagocyte progenitors, which will be the focus of the next section, and a mongst which 
the progenitors of adult tissue resident macrophages can be found from E8.5.  
   Several studies in the 1990s have established that the dorsal aorta is the site at which 
definitive hematopoietic stem cells first emerge, more precisely in the Aorta Gonad-
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Mesonephros (AGM). One approach consisted in the dissection of embryonic structures 
and their engraftment to adult, immuno-deficient mice : these experiments pointed to 
the anlage of the aorta, gonads and mesonephros, as containing cells with the capacity 
to generate not only lymphoid cells in the host, but also long term reconstitution (Godin 
et al., 1993; Medvinsky et al., 1993; Müller et al., 1994). In order to set aside the 
hypothesis that the isolated anlages may contain circulating precursors generated 
elsewhere, an organ culture system was used to more firmly test the organ of origin of 
definitive HSCs, which was confirmed to be the AGM at E8 (Cumano et al., 1996, 
2001). The study of inducible models of lineage tracing seem to indicate that HSCs 
found in the mouse adult are generated during a narrow window of time. Following the 
fate of cells expressing Cre under the control of the Runx1 or VE-Cadherin 
(Samokhvalov et al., 2007; Zovein et al., 2008) promoters between E8.5 and E9.5 
showed this was sufficient to label almost all HSCs of the adult, while pulses done 
before or after that window had a very poor efficiency of HSC labelling. Other sites for 
the generation of definitive HSCs have been proposed, such as the head (Li et al., 
2012c) or the placenta (Gekas et al., 2005; Robin et al., 2009), although they are still 
debated (Golub and Cumano, 2013). 
   Once generated in the AGM region, HSCs undergo steps of maturation (notably the 
acquisition of CD45 and MHC-I expression, allowing them to reconstitute NK-
competent mice upon transplantation, Kieusseian et al., 2012), and then migrate to the 
fetal liver between E10 and E11.5 (Houssaint, 1981), where they undergo proliferation 
and differentiation. The fetal liver then becomes the main site of hematopoiesis during 
embryogenesis ; it is notably from the fetal liver that two distinct waves of progenitors 
sucessively colonise the thymus, thus establishing T cell development progressively and 
in an orderly fashion, with distinct features of lymphopoiesis for each wave (Ramond et 
al., 2014). It is also from fetal liver HSCs that other embryonic-specific progenitors give 
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rise to cells that are generated during pre-natal life, such as populations of B cells 
(termed B1a lymphocytes, Hardy and Hayakawa, 1991), and of γδ T cells (which 
become the skin resident Dendritic Epidermal T Cells, or DETCs, (Ikuta et al., 1990). 
The production of embryo-specific immune populations is in part controlled by the 
micro-RNAs Lin28b and let-7, which are expressed in fetal but not adult HSCs (Yuan et 
al., 2012). Their ectopic expression in adult progenitors is sufficient to give them the 
potential to generate fetal immune cells (Yuan et al., 2012), and also allow, through one 
of their targets (Hmga2), the fetal HSCs to have a higher self-renewal capacity (Copley 
et al., 2013). Finally, HSCs start to migrate to the bone anlages around E15, where the 
marrow is formed and where they reside throughout the entire life. 
 
Figure 1.4. Overview of hematopoiesis sites during embryonic development. 
Adapted from (Medvinsky et al., 2011) 
 
   As mentioned in the historical perspective, deciphering the precise spacio-temporal 
development of hematopoietic progenitors has been critical to understanding the 
development of macrophages that are generated early in embryos. 
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   1.4.1.2. Development of tissue resident macrophages from an Erythro-Myeloid 
Progenitor (EMP) 
   As pointed out earlier, it has for a number of years now become well established that 
macrophages that reside in many organs are not primarily the product of a 
differentiation process of bone marrow HSC-derived monocytes in the steady state. 
Rather, they are generated in the embryo at very early stages while the hematopoietic 
system is developing, and at E10.5, while the definitive HSCs are still being generated 
and maturing in the AGM, macrophages have already seeded the entire embryo (Schulz 
et al., 2012).  
   As mentioned above, blood islands in the YS are the first sign of hematopoietic cells 
in the embryo. Blood islands notably contain large nucleated erythroid cells, which arise 
from Primitive erythroid colony-forming cells (EryP-CFC) at E7.5 (Palis et al., 1999; 
Wong et al., 1986). These EryP-CFC proliferate, and start to circulate after the onset of 
the first heartbeats at E8.25 (Ji et al., 2003; McGrath et al., 2003), before eventually 
enucleate between E12.5 and E16.5, and remain detectable up until a few days after 
birth (Kingsley et al., 2004, 2006). A transient wave of erythroid progenitors Burst 
Forming Units- Erythroid (BFU-E), which emerge at E8.25 in the YS (Wong 1986 ; 
Palis 1999), proliferate in the YS, enter the bloodstream and seed the FL before the 
AGM-derived HSCs, and generate the first definitive erythrocytes (McGrath et al., 
2011). Ncx-1 null embryos lack circulation and heartbeat; they have normal amounts of 
BFU-E in the YS but lack hematopoietic progenitors in the embryo proper, which 
suggests BFU-E may be part of the necessary elements to jump-start the production of 
blood cells before the establishment of an HSC-derived hematopoiesis (Lux et al., 
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2008). Myb is critical for definitive erythropoiesis, as Myb-/- embryos die of severe 
anemia at E15.5 (Mucenski et al., 1991). 
   Megakaryocyte Colony-Forming Cells (Meg-CFC), able to generate colonies of  
Megakaryocytes in vitro are first detected at E7.25 in the YS blood island, same time 
and place as EryP-CFC (Xu M et al., 2001). In fact, embryonic equivalent of MEP were 
detected at E7.25 in the YS (Tober et al., 2007). A subsequent wave of MEP was found 
in YS between 9.5 and 10.5. Meg-CFC proliferate between E8.5 and E10.5 and end up 
in the circulation and FL.  
   The first myeloid potential was detected at E7.25 in the YS (Moore and Metcalf, 
1970) as Macrophage Colony-Forming Cells (Mac-CFC), which expand in number in 
the YS (Palis et al.,1999). By E10.5, Mac-CFC are found in the circulation and FL. 
Beginning at 8.25, other myeloid lineage progenitor arise in the YS (Palis et al., 1999 ; 
Palis et al., 2001): neutrophil progenitors, granulocyte-macrophages bipotent 
progenitors (GM-CFC), mast cell progenitors, and high proliferative potential-CFC 
(HPP-CFC). HPP-CFC give rise in culture to macrophages, mast cells and basophils 
(Palis et al., 2001). These myeloid progenitors expand in the YS between E8.25 and 
E10.5, enter the bloodstream and seed the fetal liver (McGrath et al., 2015; Palis et al., 
2001). Thus the first maturing macrophages were found between E9 and E9.5 in the YS, 
before they seed the head of the embryo, and disseminate the entire embryo (Hume et 
al., 1995; Morris et al., 1991; Takahashi, 1989). Ex vivo culture of the macrophage 
progenitors found that these embryonic macrophages differentiated directly from 
progenitors, without going through a monocytic stage (Naito et al., 1989).  
   Spatiotemporal study of the emergence and lineage potential of these different waves 
of progenitors found that the E8.25 cells were ‘definitive’ progenitors of the YS, had 
erythroid and myeloid potential (Bertrand et al., 2005, 2013; Palis et al., 1999), and 
were therefore termed Erythro-Myeloid Progenitors (EMPs), phenotypically defined as 
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Kit+ AA4.1+ CD45lo CD41+, VE-Cadherin+ and FcγRII+ and FcγRIII+ (Bertrand et al., 
2005b ; McGarth et al., 2015). These cells were found to be distinct from the AGM-
derived HSCs, not only in regards to their tissue origin (YS vs AGM), but also by the 
fact that EMPs did not have lymphoid potential (Bertrand et al., 2005b), nor did they 
have long-term reconstitution potential or express Sca-1 (McGarth et al., 2015). 
Furthermore, although both the EMP (Frame et al., 2016; Miller et al., 2002; North et 
al., 1999) and HSCs (Bertrand et al., 2010; Boisset et al., 2010; Kissa and Herbomel, 
2010; Lam et al., 2010) arise via endothelial-to-hematopoietic transition, they do so via 
distinct hemogenic endothelial cells (Chen et al., 2011).  
   Both adult and fetal HSCs rely on the transcription factor c-Myb for their 
development (Mucenski et al., 1991; Mukouyama et al., 1999; Sumner et al., 2000), 
however a study by Schulz, Gomez Perdiguero and colleagues found that the F4/80hi 
CD11blow populations of macrophages in several tissues (E10.5 YS, E14.5 and E16.5 
liver, skin, spleen, pancreas, kidney and lung) developed in normal numbers in Myb-/- 
embryos (Schulz et al., 2012). Conversely, at these developmental stages in these 
organs, the F4/80low CD11bhi myeloid cells were strongly impaired in Myb-/- animals, 
suggesting they develop from HSC-derived progenitors. Additionally, gene expression 
profile analyses revealed similarities between E10.5 YS F4/80hi macrophages and E16.5 
F4/80hi macrophages from various tissues, which did not show alteration in Myb-/- 
F4/80hi macrophages, suggesting a developmental relationship, and was consistent with 
the maintained presence of F4/80hi macrophages in Myb-/- embryos (Schulz et al., 2012). 
Taking advantage of the early expression of CSF-1R in F4/80hi macrophages during 
development, the authors were able to pulse label these cells by injection of 4-OH 
tamoxifen to Csf1rMer-iCre-Mer Rosa26LSL-YFP at E8.5 (inducing Cre-mediated deletion of 
the STOP sequence on the Rosa26 locus and YFP expression in cells expressing CSF-
1R between E8.5 and E9.5) ; this resulted in the specific labelling of F4/80hi CD11blow 
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macrophages residing in various adult tissues, but not of F4/80low CD11bhi cells. 
Altogether, this work indicated that YS-derived precursors give rise to resident 
macrophages, which develop independently from HSCs and persist in adults (Schulz et 
al., 2012). 
   Fate mapping analysis has allowed the identification of the EMPs at E8.5 as the YS 
progenitors expressing CSF-1R that give rise to tissue-resident macrophages (Gomez 
Perdiguero et al., 2014). Indeed, phenotypic analysis of cells positive for Csf1riCre and 
Csf1rMer-iCre-Mer –mediated expression of YFP at E8.5 in the YS revealed a CD45lo Kit+ 
AA4.1+ progenitor (EMP) that originates in the YS, while absent in the AGM, seeds the 
fetal liver where it expanded, and differentiated into myeloid cells (macrophages, 
monocytes, granulocytes) and erythrocytes. To trace the progeny of AGM-derived 
HSCs, the authors analysed the Flt3Cre –mediated expression of YFP in different 
myeloid populations in parallel to the progeny of YS-derived Csf1rMer-iCre-Mer YFP+ 
cells. They found that while F4/80hi CD11blow cells such as brain microglia, lung 
alveolar macrophages, skin Langerhans cells or liver Kupffer cells were YS, EMP-
derived, increasing amounts from E14.5 to E18.5 and in adults of F4/80low CD11bhi 
cells were of HSC origin (Gomez Perdiguero et al., 2014). Finally, the use of Tie2Mer-
iCre-Mer mice (Busch et al., 2015) pulsed at various embryonic time points allowed to 
demonstrate that, although HSC-derived cells can be traced back to Tie2-expressing 
progenitors, adult tissue resident macrophages also originate from a Tie2-expressing 
progenitor, which arises earlier and therefore is temporally and locally distinct from the 
AGM HSCs. 
   Recent studies from various teams including Frederic Geissmann’s have deciphered 
how cells that reside in such a variety of tissues can possess tissue-specific identities, 
while originating from a common progenitor. There was speculation that tissues of the 
developing embryo were seeded by already committed subsets of macrophages or 
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EMPs. Rather, Mass, Ballesteros and colleagues have found that the EMPs generated in 
the YS colonize the fetal liver, where they acquire a core transcriptional program while 
differentiating into a cell type termed pre-macrophage, before seeding tissues in a 
CX3CR1-dependent manner; only once they are in their tissue of residence, do 
macrophages acquire specific gene signatures in response to tissue-restricted cues (Mass 
et al., 2016). Furthermore, different tissue environments determine gene expression 
programs at the level of enhancers, impacting chromatin state and transcriptional 
programs in tissue-resident macrophages (Gosselin et al., 2014; Lavin et al., 2014). 
These studies have uncovered the crucial role the micro-environment plays in the 
establishment of macrophages tissue-specific identities. 
   In summary, tissue resident macrophages, typically identified phenotypically as 
F4/80hi CD11blow, develop independently from HSCs, from YS-derived, CSF-1R+ 
EMPs found at E8.5.  Numerous studies of embryonic hematopoiesis and fate mapping 
analysis have allowed to show that the paradigm proposed in the early 1970s (van Furth 
et al. 1972), where tissue macrophages are the product of circulating monocyte 
differentiation, has shifted. Then, this sheds a new light on how myeloid dynamics are 
to be considered in the adult, during homeostasis and various other conditions such as 
pathogenic insult, sterile injury or cancer. 
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   Figure 1.5. Myeloid development in the mouse embryo. From Gomez Perdiguero 
and Geissmann, 2016 
 
	
   1.4.1.3. Macrophage maintenance throughout adult life 
   The studies mentioned above established an embryonic origin for most tissue-resident 
macrophages. Although this is a clear step away from the paradigm of the MPS (van 
Furth et al., 1972), it does not mean the separation between monocytes and 
macrophages in steady state is perfectly sharp. The use of various tools (fate mapping, 
immunodeficient mice, parabiosis) have allowed the composition of myeloid 
populations residing in tissues to be deciphered more precisely in terms of ontogeny. 
Generally speaking, it would seem HSC-derived contribution to tissue resident 
macrophages varies between organs, and increases with age (Perdiguero and 
Geissmann, 2015). 
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   Fate mapping analysis revealed that only a very small fraction of microglia were 
labelled by the Flt3Cre –driven expression of YFP in the aging adult suggesting that 
microglia remain independent of bone marrow derived cells imput. Conversely in the 
lung the proportion of alveolar macrophages derived from Flt3-expressing, HSC-
derived cells slowly increases over time (from 20% at 4 weeks to 40% at 1 year of age, 
Gomez Perdiguero et al., 2014).  
   The intestine is exceptional with regards to macrophage ontogeny: at birth the 
intestine is mainly populated by embryonic progenitor-derived F4/80hi CD11blow cells, 
but from the time of weaning, and driven by the settling of intestinal microbiota, these 
cells were found to be replaced gradually by Ly6C+ monocytes in a CCR2-dependent 
manner (Bain et al., 2014). A similar phenomenon was also observed in the peritoneum, 
where the resident F4/80+ GATA-6+ macrophages were of embryonic origin and 
renewed by local proliferation for the first 4 month of the mouse life, before being 
replaced by a constitutive CCR2-dependent influx of Ly6C+ monocytes, some of which 
eventually differentiate into F4/80+ GATA-6+ macrophages (Bain et al., 2016). A slow 
replacement of embryonic derived macrophages by monocytes has also been suggested 
for cardiac macrophages during the ageing process (Molawi et al., 2014). A recent study 
showed that in a model of experimentally induced lung fibrosis, monocyte-derived 
macrophages participated in the resolution of injury, and persisted in the lung 
afterwards, gaining a phenotype and gene expression profile similar to resident alveolar 
macrophages (Misharin et al., 2017).  
   Beside the varying fraction of tissue macrophages that are the result of replenishment 
by monocytes, for several years data has been accumulating to show that tissue-resident 
macrophages also maintain via local proliferation, such as in microglia (Bruttger et al., 
2015; Lawson et al., 1992), or Kupffer cells (Yamada et al., 1990). Parabiosis and fate 
mapping showed maintenance through local proliferation in several tissues, including 
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lung, peritoneum, spleen, bone marrow and brain (Hashimoto et al., 2013). Skin 
Langerhans cells expand locally their numbers by over 10-fold during the first post-
natal week, and can respond to tissue insult by local proliferation as well, driven by 
keratinocytes (Chorro et al., 2009). Peritoneal macrophages have also been shown to 
perform local proliferation to maintain their numbers, even after inflammation has 
induced the recruitment of leukocytes from the circulation (Davies et al., 2011). A 
recent study showed resident macrophages activate a program of self-renewal similar to 
that found in embryonic stem cells (Soucie et al., 2016). Recently, a study has examined 
the origin and maintenance of testicular macrophages, and found that while interstitial 
macrophages are embryonic-derived, BM progenitors contribute to this population later 
in life, and peritubular macrophages are only seeded post-natally by BM-derived 
progenitors during puberty (Mossadegh-Keller et al., 2017). 
   To summarize, it is now thought that most tissue-resident macrophages derive from 
embryonic progenitors distinct from HSCs, and maintain their steady state local 
numbers either by local proliferation, or via replenishment of various speed throughout 
adult life, and their response to inflammation may be mediated by one or the other 
mechanism depending on the organ. Importantly, critical periods of life also seem to 
impact the mechanisms of maintenance of macrophages in tissues, such as weaning and 
establishment of microbiota in the intestine (Bain et al., 2014) or puberty for the testis 
(Mossadegh-Keller et al., 2017). 
 
   1.4.2. Macrophage functions in various tissues and conditions 
   1.4.2.1 Macrophage function in homeostasis 
    As postulated well over a century ago by Metchnikoff (Metchnikoff, 1883), 
macrophages are not solely immune cells that perform their function during 
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inflammatory settings ; they have an impact in the development and function of their 
tissue of residence as well, which have been uncovered over the years. 
      Microglia are a well-studied myeloid population of the brain which develops during 
embryogenesis (Ginhoux et al., 2010; Gomez Perdiguero et al., 2014; Kierdorf et al., 
2013). Recent imaging techniques have notably uncovered their behaviour in vivo 
during steady state (Tremblay, 2011) : they have highly motile processes (Davalos et 
al., 2005), continuously sampling their micro-environment. Beyond their surveillance 
function during steady state, microglia and their surrounding neural network 
reciprocally regulate their activities (Li et al., 2012b; Tremblay et al., 2010), and 
microglia are also involved in the formation and activity of synapses (Tremblay et al., 
2010; Wake et al., 2009). Altogether, microglia have been found to be critical in the 
development of neurons, and to impact learning, memory and behaviour (Paolicelli et 
al., 2014; Tremblay, 2011; Tremblay et al., 2011).  
   While microglia provide a great example of macrophage importance in the 
homeostasis of its tissue of residence, it is not the only one. The intestine is a very large 
organ that is constantly renewed, and intestinal epithelial cells (IEC) are thought to have 
a life cycle of about 4 to 5 days, before undergoing apoptosis (Blander, 2016). Intestinal 
macrophages, together with the DC subsets that are found in this tissue, form a complex 
network (Gross et al., 2015) and these macrophages have been implicated in the 
homeostatic phagocytosis of apoptotic IEC (Cummings et al., 2016). They also 
participate in a molecular cross-talk with enteric neurons to regulate the pattern of 
intestinal smooth muscle contractions, therefore have a role in the gut motility (Muller 
et al., 2014).  
   To mention other examples, it was shown recently that embryonic derived 
macrophages in the T cell zone of lymph nodes (LN), which are slowly replaced 
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throughout life by monocyte-derived cells, are in charge of clearing apoptotic bodies, a 
role ascribed before to the resident DCs of the LN (Baratin et al., 2017). In the long 
bones and vertebrae, macrophages called osteoclasts are critiacal for the targeted 
digestion of mineral and matrix components of bone, to form microscopic trenches that 
allow bone marrow to fill the space, or osteoblasts to form new bone component (Boyce 
et al., 2009). In the adipose tissues, recruited macrophages have angiogenic roles crucial 
for the formation of the dense vascular network in this tissue (Cho et al., 2007), while 
resident cells regulate thermogenesis (Nguyen et al., 2011). Finally, the liver is one of 
the solid organs that is most densely populated by resident macrophages, as there are 1 
to 2 macrophages for every 5 hepatocytes (Lopez et al., 2011), and some of these cells, 
called the Kupffer cells, are notably critical for the clearance of red blood cell derived 
vesicles (Willekens et al., 2005), as well as iron metabolism (Theurl et al., 2008). 
   Therefore, resident macrophages form networks in many tissues, that during 
homeostasis participate in a general monitoring of their microenvironment and may also 
participate to the organ development and function.  
   1.4.2.2. Macrophage function during various perturbations of steady state 
   Based notably on in vitro work, two ends of a spectrum of activation states for 
macrophages has been proposed : ‘M1’ and ‘M2’ macrophages (Gordon, 2003; 
Martinez et al., 2009). It had long been recognised that lymphocytes were major actors 
in macrophage activation and in 1986, interferon-γ (IFN-γ) was shown to be a key 
factor in this interaction leading to increase monocyte-derived macrophages phagocytic 
activity (Nathan et al., 1983). Since that was the first anti-microbicidal mechanism of 
macrophages activation to be recognised, it was thereafter termed ‘classical activation 
of macrophages’, or ‘M1 macrophages’ (Martinez et al., 2009). IFN-γ is produced 
mainly by CD4+ T-helper 1 (Th1) cells and NK cells, while its immunological 
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counterpart, IL-4, is produced mainly by Th2 (Mosmann and Coffman, 1989), and was 
shown to inhibit the production of the respiratory burst and production of inflammatory 
cytokines such as IL-1β by macrophages (Abramson and Gallin, 1990), which 
correspond to another activation state. These observations set the basis for the ‘M1’ and 
‘M2’, or ‘classically’ and ‘alternatively’ activated macrophages. Subsequently, a large 
portion of the work on in situ macrophage function has been included in this framework 
(such as Nguyen et al., 2011) ; , and several nomenclature systems have been proposed 
in that regard (Mantovani et al., 2004; Martinez et al., 2009).   
   Although these terms might be useful to designate a particular set of molecule 
secreted or expressed by macrophages in a given condition, they may not entirely reflect 
macrophage biology in vivo. Recent studies taking into account the ontogeny of the 
mononuclear phagocytes to study their response to various contexts have been 
performed. In the lungs, bone marrow derived monocytes have been shown to 
participate to the resolution of fibrosis, and then remain in the tissue with a phenotype 
similar to tissue resident alveolar macrophages (Misharin et al., 2017). In the intestine, 
studying the inflammatory bowel disease, Bain and colleagues have found that both the 
resident macrophages producing anti-inflammatory signals like IL-10, and the ones 
capable of highly inflammatory states, were derived from circulating Ly6C+ monocytes 
that egress the bone marrow in a CCR2-dependent manner (Bain et al., 2013). In a 
model of pancreatic cancer, the macrophages found in the tumors were found to be 
heterogeneous and derived, some form Ly6C+ monocyte recruitment, and some from 
embryonic progenitors, with distinct functions for each subset (Zhu et al., 2017).  
   A new nomenclature has been proposed to include the ontogeny of myeloid cells in 
their identification (Guilliams et al., 2014). Overall, the content of various ‘activation’ 
stages should be considered, at least in part, through the spectrum of developmental 
lineage, i.e. embryonic-derived and locally maintained resident populations, as well as 
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monocyte-derived, short-lived or long-lived cells (Geissmann and Mass, 2015). The 
terms ‘resident’ and ‘passenger’ subsets have been proposed.  
   1.4.3. Kidney macrophages in health and disease 
   1.4.3.1 Tissue localisation and definition of myeloid populations in the kidney 
   Kidney macrophages were first identified in 1983 (Hume and Gordon, 1983), as part 
of a seminal series of publications by Siamon Gordon, David Hume and colleagues, 
who studied the distribution of macrophages using the antibody to F4/80 to stain 
various adult and embryonic tissues (Hume et al., 1983, 1984a, 1984a, 1984b; Perry et 
al., 1985). They found F4/80+ cells non-randomly distributed throughout the whole 
thickness of the organ, from the proximity to small capillaries in the cortex, throughout 
the surroundings of the tubes inside the medulla, and to the proximity to arterioles near 
the glomeruli and Bowman’s capsules (Hume and Gordon, 1983). Because these cells 
were defined by F4/80 expression, they were termed macrophages. In the 1990s, 
however, some reports defined these tubulo-interstitial cells as DCs due to their 
morphology and MHC-II expression (Austyn et al., 1994; Kaissling and Le Hir, 1994). 
The ‘debate’ about the naming of mononuclear phagocytes of the kidney became more 
pronounced when the use of Cx3cr1gfp/+ mice (Jung et al., 2000) allowed the 
identification of most of them are CX3CR1+ F4/80+ CD11c+ CD11b+, which can satisfy 
both the definition of DCs or macrophages (Kruger, 2004). Because the fields of DC 
biology and macrophage biology have evolved somewhat independent of each other 
(Gottschalk and Kurts, 2015), some confusion may arise when studying the literature of 
the past few decades regarding mononuclear phagocytes, notably of the kidney. In a 
recent study published by our laboratory, F4/80bright cells of the kidney were analysed 
by intravital microscopy in the Cx3cr1gfp/+ mice, flow cytometry analysis, RNA-
sequencing, and in parabiotic of mice (Stamatiades et al., 2016). There, F4/80bright 
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phagocytes were defined as resident macrophages, and these are the cells that are part of 
the focus of Chapter 4, where the reader may find further information about these cells. 
   1.4.3.2. Kidney macrophage functions in different contexts 
   The presence of macrophages or monocytes in the kidney has been a known clinical 
observation for several decades in the context of kidney diseases, such as glomerular 
nephritis (Atkins et al., 1976), in which the amount of tubular damage of the kidney is 
correlated with the severity of clinical signs (Risdon et al., 1968). The presence of 
macrophages in biopsies during systemic lupus erythematosus (SLE) is even a 
predictive tool of the disease’s outcome for patients (Hill et al., 2001). Therefore, the 
impact of macrophage populations and kidney phagocytes in general on the initiation, 
progression and resolution of kidney diseases has been extensively studied over the last 
few decades. The infiltration of cells described as macrophages has been a known 
feature of kidney diseases (Kluth et al., 2004; Rodríguez-Iturbe et al., 2001).  
   Cells expressing CX3CR1, CD11c and MHC-II, therefore termed DCs (Kruger, 2004), 
have been shown to depend on CX3CR1 and the expression of its ligand fractalkine 
(CX3CL1) by kidney cells to populate the kidney and to infiltrate the organ during 
experimental nephritis, during which these cells exert local Th cell stimulation and 
chemokine production for the recruitment of neutrophils (Hochheiser et al., 2013). It has 
been known for some time that macrophages isolated from kidneys can produce iNOS 
and ROS, as shown in the rat (Cook et al., 1989; Erwig et al., 2000) and rabbit (Boyce 
et al., 1989), notably, either upon in vitro stimulation or during various stages of 
glomerular nephritis. However, whether or not this production of iNOS is detrimental 
remain unclear, as some reports suggest its inhibition is beneficial (Ogawa et al., 2002), 
while others suggest its inhibition increases the proteinuria observed during nephritis, 
which is a sign of kidney damage (Cattell et al., 1991; Waddington et al., 1996).  
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   Cytokines such as TNFα (Lan et al., 1997) and IL-1β (Tipping et al., 1991) have also 
been implicated in kidney disease. Several studies have documented a positive effect on 
the progression of glomerulonephritis and a diminution of kidney damage signs such as 
proteinuria and kidney necrosis, when antagonists of the IL-1 receptor were 
administered during experimental glomerulonephritis (Lan et al., 1993, 1995). 
Inhibition of TNFα either before or during the induction of experimental glomerular 
nephritis allowed to prevent or reduce the clinical signs of kidney damage, and notably 
kidney levels of IL-1β (Karkar et al., 2001).  
   The implication of macrophages in kidney inflammation has been studied with 
various tools, which, while none are perfect to target a particular population, give 
weight to the hypothesis of their importance in the initiation and/or progression of 
disease. One technique is the administration of liposomal clodronate, which upon 
injection are phagocytosed by macrophages, which in turn will die (Van Rooijen and 
Sanders, 1997). When performed in the context of experimentally induced kidney 
ischemia, liposomal clodronate injection reduced signs of kidney damage such as levels 
of plasma creatinin (Day et al., 2005; Jo et al., 2006), kidney tubular cells apoptosis and 
whole kidney levels of TNFα and IL-1β (Jo et al., 2006). The use of an ‘anti-
macrophage serum’, generally obtained by injecting pre-cultured mouse peritoneal 
macrophages to rabbits (Gallily, 1971; Hirsch et al., 1969), has suggested a role of 
macrophages and monocytes in the kidney damage observed after experimental kidney 
ischemia (Holdsworth et al., 1981). Finally, the development of mice that express the 
human receptor to diphteria toxin (Diphteria Toxin Receptor, DTR) under the control of 
particular gene promoters, allows the depletion of populations that selectively express 
these markers. CD11b-DTR mice (Duffield et al., 2005a) showed decreased tubular 
damage and improved kidney function upon DT injection during glomerulonephritis 
(Duffield et al., 2005b). The use of either clodronate liposomes or CD11b-DTR to affect 
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myeloid populations during renal ischemia models in mice have shown different results 
(Ferenbach et al., 2012). These techniques are not specific for a given population of 
resident or recruited population, not specific to the kidney, and it is therefore necessary 
to consider these results with great caution, not having certainty for the role of a given 
population, nor very good control of the effect of these depletion techniques on myeloid 
cells of other organs.  
   Our laboratory has taken advantage of intravital microscopy and flow cytometry 
analyses to try to decipher the identity and organ-specific functions of a population of 
Cx3cr1-gfp expressing resident macrophage population in the context of circulating 
small immune complexes (ICs). Although immune complexes containing self-antigens 
are a common feature of a group of reactions called ‘type III hypersensitivity’, which 
encompass diseases such as serum sickness, glomerulonephritis or SLE, our laboratory 
attempted, rather than to study a disease model, to identify basic behaviours of kidney 
resident macrophages in response to the presence of ICs (Stamatiades et al., 2016). The 
results shown in Chapter 4 show some of the characterisation of this model of 
inflammation. 
       
 
   1.5. On mathematical modeling 
   The first part of the results presented in this work (Chapter 3) is showing the 
biological data that have been generated in order, not only to characterise the biological 
systems in question, but also to be analysed with a computer-assisted in silico 
mathematical model. Using mathematics to try understanding biological phenomena is 
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not new and we will briefly overview the use of mathematics in science in general, and 
in biology in particular. 
   1.5.1. On the efficiency of mathematics in science 
   Mathematics, often considered ‘the queen of sciences’, have been used as a tool to 
study the laws of Nature for centuries. The ‘mathematization’ of physics has been 
introduced by the Italian astronomer Galileo Galilei (1564 - 1642). In his book The 
Assayer (originally Il Saggiatore, 1623), he writes « [the book of Nature] is written in 
the language of mathematics, and its characters are triangles, circles, and other 
geometrical figures, without which it is humanly impossible to understand a single word 
of it ». This prompted the rise of modern physics. The use of mathematics to describe 
the laws of Nature meant that not only was the Universe governed by laws applicable 
for its entirety (unified Universe), but also that the laws of physics were now fully 
accessible to human intelligence, via this tool that had been developed for thousands of 
years. This constitutes what is now referred to as the Scientific Revolution of the 17th 
century (Koyré A., Etudes d’Histoire de la Pensée Scientifique).  
   The efficiency of mathematics in the description of the laws of physics has been 
proven and has allowed great discoveries. This efficiency can be described in several 
ways. Beyond their use in the description of phenomena within different theories, such 
as the description of motion in mechanics, they also have allowed to predict the very 
existence of new objects. This predictive power can be illustrated with two examples. 
First, let us consider the case of the 8th planet from the Sun, Neptune. Its existence was 
only postulated, in order to correct for the dicrepancies between the calculated and 
observed orbit of its neighbour Uranus. The French astronomer Urbain Le Verrier 
(1811-1877) calculated the position, mass and orbit of a planet that would correct for 
this dicrepancy, and in september 1864, the German Johann Goffried Galle turned his 
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telescope to where the planet should be according to calculations, and found it. There 
was Neptune. This is an impressive illustration of the predictive power of Mathematics, 
which allowed to predict the existence of a planet. Here is an example of Mathematics 
being used to discover, thanks to known laws of physics, a known type of physical 
object - a planet. 
   Another example seems even more striking. It is the discoveries made by the physicist 
Paul Dirac (1902 - 1984). He is one of the physicists who participated in the creation 
and development of particle physics, or quantum mechanics, in the first half of the 20th 
Century. And what he found, when calculating the Energy (E) of a particle, is that it 
varies in regards to its momentum « p » and its mass « m » such as E2=p2+m2. This is a 
simplified version of the equation, but the important aspect of it is preserved : one can 
see that the solution of this equation can be positive or negative, i.e. E= √(p2+m2)  or E= 
-√(m2+p2). Therefore, the rules of mathematics pointed Dirac to a solution of the 
equation that seemed irrelevant : a negative energy. Not accepting it at first, he was 
forced by his mathematician contemporaries to not discard this solution. This prompted 
him to understand the existence of anti-matter, consisting of particles with negative 
energies. 
   These two examples illustrate how mathematics have allowed Physics to describe a 
great number of new objects and phenomena. The discovery of Neptune is a spectacular 
example of maths’ predictive power within a well-established theory (that of 
gravitation). However, our second example shows that the mathematic rules have 
yielded a new type of physical object.  
   The reason behind the efficiency of mathematics in Sciences has baffled scientists for 
a long time. Nobel-prize winning physicist Eugene Wigner in a 1960 article says « the 
enormous usefulness of mathematics in the natural sciences is something bordering on 
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the mysterious and there is no rational explanation for it » (Wigner, 1960). Indeed, there 
are important questions raised by this effectiveness, which have been the topic of 
reflection for the philosophers of science and the theories of knowledge : how can a 
formal system of logical thought process, of such abstract nature, and completely 
invented by humans, be so well adapted to the description of all the physical objects and 
phenomena ? Does it mean Nature is indeed mathematical in its essence somehow, or is 
it just that some of mathematics fit well with the phenomena described ? We will not 
deal with such complex issues, but they are worth having in mind. 
   1.5.2. Modeling Biology with Mathematics 
   If Mathematics are the language of Physics, it appears very different in Biology. 
Indeed, this area of science is not taught through equations. Aside from statistics, which 
are an essential (though sometimes potentially misleading) tool to discern 
« significant » differences and trends in experimental data, it appears mathematics are 
not the primary means to accessing knowledge in Biology. It is not necessarily clear 
exactly why (or indeed if) biological phenomena cannot in principle be described by 
mathematics. It may be due to the nature of the subject of study itself, i.e. living 
organisms, which are composed by many interconnected elements, that interact at 
different levels of organization (molecular, cellular, tissue, organ, organism, 
ecosystems). These organisms, in terms used by physicists, are open systems very far 
from thermodynamic equilibrium (Prigogine et al., 1974), which makes them very hard 
to pin down in a quantitative manner.  
   This does not mean that biology as a whole has been kept away from any 
mathematical approach. On the contrary, many phenomena can be at least partially 
described using more or less sophisticated mathematical models. These include a wide 
range throughout the study of biology : agronomic systems (Keurentjes et al., 2013), 
	 86	
development biology (Economou and Green, 2014; Yu and Fernandez-Gonzalez, 2016), 
tissue organisation (Molitoris et al., 2016), vaccinology (Pappalardo et al., 2015), 
virology (Bocharov et al., 2015; Huber et al., 2017), oncology (Powathil et al., 2015) 
and many other domains. Many levels of biological activity can be modelled, from 
molecular interactions between a receptor and a ligand, to populations dynamics.  
   As we said above, there is no mathematical theory of biology ; our understanding of 
this field is guided by experimental data. When attempting to produce a mathematical 
model that is relevant to Biology, it is important for experimental data to be an integral 
part of the modeling activity. The interaction between mathematical models and 
biological experimental data has notably been the focus of the laboratory of Grégoire 
Altan-Bonnet, with whom we have collaborated for the work presented in Chapter 3. 
His work on T cell responses is a perfect example of what the mathematical 
interrogation of biological data, as well as the predictive power of properly 
experimentally parameterised models, can be. This allowed a better understanding of 
early T cell activation upon T Cell Receptor (TCR) recognition of peptide-MHC : data 
gathered on the response of specific T cells to agonists and antagonists allowed the 
formulation of mathematical models which could yield predictions that were 
successfully tested (Altan-Bonnet and Germain, 2005). Further generation of 
mathematical models and the use of important computing power can allow the 
formulation of a wide range of predictions for the behaviour of T cells in response to 
various agonists and antigonists, and these predictions can then be tested in an 
experimental setting (François et al., 2013). The combination of increasingly complex, 
however tightly controlled, experimental conditions in vitro allowed Altan-Bonnet’s 
group to shed light on the integration of different types of signals leading to various 
levels of T cell activation, and the precise regulation of intracellular signaling that 
allows their discrimination of antigens (Voisinne et al., 2015).  
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   Although the topic of monocyte development is quite distinct from that of T cell 
activation, the process of mathematical modeling followed by experimental testing is 
applicable for potentially any biological system within a certain limit of parameters. We 
will now present some of the key proceedings that had been done before the work 
showed in this thesis started, and will explain our general aim and approach. 
 
   1.6. Preceeding work, general aims, and experimental approach 
   1.6.1. Study of monocyte dynamics in the steady state toward anin silico model 
   1.6.1.1. Previous results in the laboratory regarding monocytes in the steady state 
    Previous work carried out by Hannah Garner in our laboratory has focused on 
characterising the monocytes and their progenitors in vivo, and notably investigating the 
role of Nr4a1 in the development of the patrolling Ly6Clow subset.  Her results lead to 
the identification of a cell population in the bone marrow that may constitute a direct 
precursor for Ly6Clow monocytes. Indeed, these cells are phenotypically very similar to 
Ly6Clow monocytes, and have the same genetic requirements. In addition to the 
description of this population, her work has re-examined genetic models, and refining 
one, for the study of monocyte subsets. Her results confirm that the two main monocyte 
subsets have dinstinct genetic requirements, and are compatible with distinct pathways 
of differentiation. For more details on these preceeding results, see Chapter 3, section 
3.1. Therefore, this thesis presents a collaborative approach that was undertaken in the 
laboratory to re-examine monocyte dynamics (see below). 
 
	 88	
   1.6.1.2. Aim, and experimental approach 
   We first aimed at probing monocyte and monocyte progenitor dynamics in order to 
further understand monocyte differentiation from the bone marrow to the circulation. 
   To study monocyte dynamics, we took advantage of nucleoside analogues, mainly 
EdU (Limsirichaikul et al., 2009). This allows to stain dividing cells (progenitors) and 
follow over time how the incorporated EdU is distributed towards differentiated 
monocytes, which don’t proliferate in the blood at steady state (Geissmann et al., 2003 ; 
Shand et al., 2014). This method has been used in the past on many occasions, and 
notably to study monocyte dynamics in the mouse (Yona et al., 2013). We sought to use 
the results from such methods to analyse in detail the quantitative information, in a way 
that would make use of more parameters and would be the least biased possible ; for 
this we collaborated with a laboratory specialised in generating experimentally 
parameterised, computer-assisted models (for a general presentation of this 
mathematical model, see Materials and Methods, section 2.9). Here the 
characterisation of our biological system, that is monocytes and progenitors in the bone 
marrow, blood and spleen, taking up EdU and analysed at various time points, will be 
presented. The process through which the analysis of that system was refined, in order 
to have the most predictive model possible, in the least biased way, though still in 
keeping with the results found in the literature and genetic data obtained in the 
laboratory, will be exposed. 
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   1.6.2. Study of monocyte and macrophage functions in the kidney 
   1.6.2.1. Monocytes as housekeepers of the vasculature, and kidney macrophages as 
monitors of circulation 
   We aimed at understanding further monocyte and macrophages functions in the 
kidney. Previous work from the laboratory showed their capacity to be retained by the 
capillary endothelium upon TLR7 signals, and recruit neutrophils which induced 
endothelial necrosis, and monocyte probably involved in the scavenging of the resulting 
debris (Carlin et al., 2013). Work carried out by Efstathios Stamatiades in the laboratory 
has allowed a characterisation, by intravital microscopy and flow cytometry, of the 
kidney macrophages, as resident cells with highly motile processes that probe their 
microenvironment constantly (Stamatiades et al., 2016). They also displayed the ability 
to take up circulating fluorescently labeled Bovine Serum Albumin (BSA) or chicken 
Ovalbumin (OVA), within the first few minutes following intravenous (i.v.) injection, 
and to do so more efficiently for in vitro prepared immune complexes, in a FcγR-IV-
dependent manner. This resulted in the recruitment of monocytes and neutrophils to the 
kidney within hours after inection.  
   1.6.2.2. Aim and experimental approach 
   We first interrogated the mechanism of patrolling and retention of monocytes by 
investigating a potential role of platelets, which have been increasingly recognised as 
active participants to the immune response, beyond their role in coagulation (Semple et 
al., 2011; Vieira-de-Abreu et al., 2012). We used the already characterised model of 
R848 (Resiquimode, a TLR7 agonist) ‘painting’ on the kidney, and intravital 
microscopy (Carlin et al., 2013), to probe for the role of platelet in the patrolling 
activity of monocytes, during steady state and inflammation. We also investigated the 
role of macrophages in the kidney, in the context of circulating immune complexes 
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(Stamatiades et al., 2016). We aimed at characterising some aspects of that model of 
inflammation, using Fast Protein Liquid Chromatography (FPLC), flow cytometry and 
intravital microscopy. These techniques allowed us to do a qualitative analysis of the 
immune complexes used in this model of study, to analyse uptake of immune 
complexes throughout several organs and to probe some mechanisms by which the 































   2.1. Mice 
      2.1.1. Animals used for this study 
   All animal procedures were performed in adherence to FG project license issued by 
the United Kingdom Home Office, under the Animals (Scientific Procedures) Act 1986, 
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and with the Institutional Review Board (IACUC 15-04-006) at Memorial Sloan 
Kettering Cancer Center (MSKCC), New York, NY, USA. Eight week-old male 
C57BL/6 mice were purchased form Charles River (strain 027). Cx3cr1gfp/+ Rag2-/- 
Il2rg-/- (Auffray et al., 2007) and Cx3cr1gfp/+ (Jung et al., 2000) were maintained in 
house. Nr4a1GFP (Moran et al., 2011) were generated by Kristin A. Hogquist and 
provided by George Kassiotis (NIMR). Nr4a1-/- (Lee et al., 1995) (B6.129S2-
Nr4a1tm1Jmi/J) were purchased from Jackson Laboratories as frozen embryos, rederived 
in house, and then crossed to Nr4a1GFP in order to generate Nr4a1GFP ; Nr4a1-/- and 
littermates. Csf1riCre mice (Deng et al., 2010) were crossed to Fcgr4f/f mice 
(Nimmerjahn et al., 2010) in house to generate Csf1riCre Fcgr4f/f mice. 
      2.1.2. Genotyping 
         2.1.2.1. Nr4a1GFP; Nr4a1-/- 
   Nr4a1 knock-out was assessed by genotyping using the following primers (5’ > 3’): 
CAC GAG ACT AGT GAG ACG TG (Mutant) and CCA CGT CTT CTT CCT CAT 
CC (Common). The Polymerase Chain Reaction (PCR) was then set up as follows: 
95ºC for 5 min, followed by 35 cycles of 94ºC for 30sec, 62ºC for 1min, 72ºC for 1min, 
and finally 72ºC for 2min. Mutant band was detected at 350 base-pairs (bp) in a 1.5% 
agarose gel in TBE. This genotyping was coupled to a blood phenotyping of the mice 
(tail vein bleeding followed by flow cytometry analysis) for the presence of GFP and 
circulating Ly6Clow monocytes.  
         2.1.2.2. Cx3cr1gfp/+ 
   Cx3cr1 and/or gfp were detected with the following primers (5’ > 3’): GTC TTC 
ACG TTC GGT CTG GT (Rev WT), CCC AGA CAC TCG TTG TCC TT (For), and 
CTC CCC CTG AAC CTG AAA C (Rev Mut). Then a PCR with the following 
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conditions was performed: 94ºC for 3min, followed by 35 cycles of 94ºC for 30sec, 
60ºC for 30sec and 72ºC  for 30sec, and finally 72ºC for 5min. A band at 450bp for the 
WT Cx3cr1 and 550bp for the knock-in gfp were detected in a 1.5% agarose gel in 
TBE. 
         2.1.2.3. Rag2-/- Il2rg-/- 
   Rag2 knock out was detected with the following primers (5’ > 3’): GGG AGG ACA 
CTC ACT TGC CAG TA (R011), AGT CAG GAG TCT CCA TCT CAC TGA (R012), 
and CGG CCG GAG AAC CTG CGT GCA A (R013). A combination of R011 and 
R012 was used to detect a 263bp band for the WT, and a combination of R013 and 
R012 was used to detect a 350bp for the mutant, in a 1.5% agarose gel in TBE. For both 
PCR, the conditions were as follows: first 94ºC for 3min, then 35 cycles of 94ºC for 
30sec, 60ºC for 30sec and 72ºC for 30sec and finally 72ºC for 7min. 
   Il2rg knock out was detected using the three following primers (5’ > 3’) in a single 
PCR reaction: CTT CTT AGT CCT TCA GCT GC (oIMR0301), AGG CTC AGA ACT 
GCT ATT CC (oIMR0302) and GTA TGG TAG TGT TCT CAC CG (oIMR0303). The 
following PCR reaction was then performed : 94ºC for 3min, followed by 35 cycles of 
94ºC for 20sec, 55ºC for 20sec and 72ºC for 35sec, then 72ºC for 2min. A band at 
400bp was detected for WT and 600bp for Mutant in a 1.5% agarose gel in TBE. 
         2.1.2.4. Csf1riCre Fcgr4f/f 
   Csf1riCre : Cre was detected using the following primers (3’ > 5’): TCT CTG CCC 
AGA GTC ATC CT (For) and CTC TGA CAG ATG CCA GGA CA (Rev). The 
following PCR reaction was then performed : 95ºC for 5min, followed by 30 cycles of 
95ºC for 45sec, 60ºC for 45sec, 72ºC for 45sec, then 72ºC for min. A band at 400bp was 
detected for the presence of Cre in a 1.5% agarose gel in TBE.  
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   Fcgr4f/f : the following primers were used (5’ > 3’) : TAT ATG TGG TCA GAC CCT 
TGC CTG C (R4flox-5, For), GGA GTT GGC AGG TCC AAG ACA GCC (R4flox-3, 
For), and CTT ATC ACC TTG CCT CCT TAG ACA GAT CC (R4Flox-2, Rev). A 
PCR with all three primers was performed with the following conditions : 95ºC for 15 
min, followed by 35 cycles of 94ºC for 30sec, 61ºC for 30sec, 72ºC for 30sec, then 72ºC 
for 10min. Bands were detected at 184bp for wt allele and 235bp for the floxed allele, in 
a 1.5% agarose gel in TBE. 
   2.2. Flow Cytometry 
      2.2.1. Tissue preparation for flow cytometry 
         2.2.1.1. Blood preparation  
   Mice were euthanized using CO2 and blood was collected by cardiac puncture using a 
1mL syringe (Beckon Dickinson  [BD], Cat#309659) and a 26Gx1/2” hypodermic 
needle (Exel, Cat#26402) containing 500 of 100mM EDTA. Volume of blood taken 
was measured directly with the syringe, before it was placed in 15mL conical tubes 
containing 50L  EDTA 100mM. Red blood cells (RBC) were lyzed by adding 5mL of 
RBC lysis buffer (0.5g NaHCO3 + 4.15g NH4Cl + 500µL EDTA 100mM in 500mL 
MilliQ H2O total volume). After 5min incubation, 5mL of FACS buffer (PBS 1X 0.5% 
BSA 2mM EDTA) was added and the cells were spun. This was repeated with 3mL, 
then 1mL of RBC lysis buffer, then FACS buffer after incubation. After the final step of 
RBC lysis, cells were resuspended in 70L of FcBlock (BD Cat#553141, clone 
2.4G2). 50µL of cells were placed in 96-well U-bottom plates, and 50L of antibody 
mix was added to the cells. See Common protocol for all organs for subsequent steps. 
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         2.2.1.2. Spleen preparation for monocyte staining  
   Spleens were dissected and mechanically disrupted through a 100m cell strainer 
(Falcon, Cat#352360) in 6mL FACS buffer, filtered through a 70m cell strainer into a 
15mL conical tube (BD, Cat#352070). After spinning the cells, red blood cells were 
lyzed with a resuspension in 3mL of RBC lysis buffer. 3mL of FACS buffer were added 
after a 5min incubation on ice, and cells were spun. Spleen cells were then resuspended 
in 500L FcBlock (BD Cat#553141, clone 2.4G2). 50L of cells were then plated in 
96-well U-bottom plates, and stained with the antibody mix. See Common protocol for 
all organs for subsequent steps. 
         2.2.1.3. Bone marrow preparation  
   Hind limbs were excised, the legs were dissected into femur and tibia and each end of 
the bones cut with a razor blade to allow flushing of the bone marrow. Bones were held 
with forceps and flushed using a 27Gx1/2’’ needle and 10mL syringe with RPMI into 
15mL conical tubes, and centrifuged at 320g 4˚C for 5 minutes. Cell pellet was 
resuspended with 1mL of FACS buffer (PBS, 0.5% BSA, 2mM EDTA and filtered with 
Stericup 0.22µm [Fisher Scientific Cat#SCGVU05RE]). Cells were filtered through 
70µm cell strainers (Fisher, Cat#08-771-2), tube and filter were washed with 2mL of 
FACS buffer. To deplete Ly6G+ granulocytes and Ter119+ red blood cells, the pellet 
was resuspended in the following antibodies: clone 1A8 (anti-Ly6G) at 10µg/ml 
(BioXcell, Cat#BE0075-1) and clone TER-119 (anti-Ter119) at 20µg/ml (BioXcell, 
Cat#BE0183) in a total volume of 500µL of RPMI 1640 (Life Technologies, 
Cat#11875-093) 10% FBS (Life Technologies, Cat#10438026), then incubated 15 min 
on ice and washed with 1mL of RPMI 1640 10% FBS. Dynabeads (Sheep anti-Rat IgG, 
Life Technologies Cat#11035), previously washed 2 times with RPMI 10% FBS, were 
added to the cells, before transfer into a polypropylene FACS tube. Tubes were capped 
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with FACS tube caps, sealed with Parafilm, and placed on roller for 45 minutes at 4°C. 
After incubation with beads, tube were placed in magnet (MPC-6 Magnet Life 
Technologies, Cat#12002D). 2 minutes after, the supernatant containing bone marrow 
cells depleted of Ly6G+ and Ter119+ cells was collected into 15mL conical tubes and 
centrifuged at 320 x g 4˚C for 7 minutes. Cells were resuspended in 200L of Fc block 
(BD Cat#553141, clone 2.4G2). 50L of cells were transferred into a 96-well U-
bottom plate, and 50L of antibody mix were added, and incubated for 20 minutes on 
ice.  
         2.2.1.4. Kidney, Liver, Spleen, Lungs, Brain for staining macrophages  
   All the organs were dissected out after the male C57BL/6 mice were sacrificed by 
cervical dislocation. Kidney capsules were removed manually. They were placed in 12-
well plates containing 2mL of the following enzymatic digestion mix: Hank’s Balanced 
Salt Solution (HBSS, no Ca2+/Mg2+, Gibco) containing 1mg/mL Collagenase D 
(Roche), 100U/mL DNAse I (Sigma), and FBS (Fetal Bovine Serum, Gibco). They 
were then cut into small (~ 1 - 5 mm3) pieces with scissors and incubated at 37ºC for 30 
min. They were then transferred into 6-well plates containing 6mL of FACS buffer on 
ice, and mashed through a 100µm cell strainer. Cells were spun at 320g for 7min at 4ºC 
and resuspended in 3mL RBC lysis buffer, incubated for 5min before rincing with 3mL 
FACS buffer and spun again. Cells were then incubated in FcBlock (clone 2.4G2) for 
15min on ice, followed by 30min incubation with the antibody mix. Cells were rinsed 
once in FACS buffers, spun, resuspended in FACS buffer and acquired at the flow 
cytometer (BD Fortessa). 
   For the measure of intracellular TNFα production by kidney macrophages, all 
reagents and media contained Brefeldin A (1/1000 dilution, eBioscience, Cat#00-4506-
51). After tissue isolation a reduction into a cell suspension, total kidney cells were 
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placed in 5mL of RPMI medium supplemented with 10% FBS, 1% 
Penicillin/Streptomycin (Sigma-Aldrich, Cat#P4458), and incubated for 5 hours at 
37ºC. Cells were then stained for extracellular antigens with fluorescently labeled 
antibodies for flow cytometry, fixed and permeabilized with buffers from eBioscience 
(Cat#88-8823-88), and stained with anti-TNFα APC, or APC-labeled isotype control. 
         2.2.1.5. Skin preparation for epidermal Langerhans cell and dermal macrophages 
isolation  
   Ears from C57BL/6 males sacrificed by cervical dislocation were cut and placed in 
ice-cold PBS. Then the two skin sheets were separated using forceps, and placed, 
dermis down, on top of (floating on) 2mL of HBSS containing 3% FBS and dispase 
(2.4mg/ml, Invitrogen) at 37ºC for 1h. Then the dermis was separated from epidermis 
using forceps, and each skin layer was separately cut into small (~1 – 5 mm3) pieces 
using scissors and incubated in 2mL of HBSS containing 3% FBS, 1mg/mL 
Collagenase D, 100U/mL DNAse I and 2.4mg/mL dispase at 37ºC for 45min. The 
suspensions were then transferred to a 6-well plate containing 6mL of FACS buffer, 
mashed through a 100µm cell strainer, and spun at 320g at 4ºC for 7min. Cells were 
then incubated with FcBlock (Clone 2.4G2) for 15min on ice and then in the antibody 
mix for another 30min. Cells were then rinsed once and resuspended in FACS buffer, 
before acquisition at the flow cytometer (BD Fortessa). 
      2.2.2 Flow cytometry acquisition  
   Cell acquisition was performed on a BD Fortessa (5 lasers: UV 355nm, Violet 405nm, 
Blue 488nm, Yellow-Green 561nm and Red 640nm). See Table 2.1 for the detail of 
fluorochrome to laser and PMT filter correspondance. The machine was run with DIVA 
software (BD). The resulting .fcs files were analysed using FlowJo v9.9 (FlowJo LLC, 
TreeStar).  
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   2.3. EdU incorporation Experiments.   
      2.3.1. EdU administration for single-pusle study 
   8 to 12 week old C57BL/6N mice (Charles River, strain 027) were injected 
intraperitoneally with 200L of a solution of 2.5mg/mL of EdU (10mM, in PBS) per 
mouse (Fisher Cat#C10420, Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay 
Kit). Blood, bone samples (femurs and tibiae) and spleens were collected at time points 
ranging from 15 minutes to 240  hours post injection, and prepared for FACS analysis. 
The organs were then prepared as for flow cytometry, and the manufacturer’s 
instructions were followed to stain the cells and reveal the EdU content, which 
constitute the common protocol for all organs as follows.  
      2.3.2. Common protocol for all organs for EdU detection 
   Briefly, cells were washed with incubated with pre-click antibody mixes conatining 
all antibodies except those coupled to PE or PECy7 as indicated by the manufacturer’s 
instruction. Then cells were fixed with 4% PFA (prepared from 16% in PBS [Thermo 
Scientific Cat#28908]), incubated for 15min at room temperature. Cells were then 
permeabilized with a resuspension in 200 L of the provided saponin-based 
Perm/Wash buffer 1X (diluted from 10X using FACS Buffer). Cells were then 
resuspended in 200L of a Click-reaction mix prepared following the manufacturer’s 
instructions (see content for 1mL below). After 30 min incubation at room temperature, 
cells were spun directly, then resuspended in 200L of saponin-based Perm/Wash 
buffer 1X, then spun again, before resuspension in 100L of antibody mix containing 
the PE and PECy7 coupled antibodies (prepared in FACS buffer), and incubated 20min 
on ice. Cells were then washed with 100µL of FACS buffer, spun and resuspended in 
200L of FACS buffer, before acquisition at a BD Fortessa.  
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   Content of Click-reaction Mix, following manufacturer’s instructions (Thermo Fisher, 
Cat#C10420 or C10419): 875µL PBS 1X + 20µL CuSO4 + 5µL Azide-A488 (or A647) 
+ 100µL Buffer Additive. 
Table 2.1. Antibodies used for this study, for flow cytometry 
Antibody name Clone Laser for excitation PMT filter 
Company – 
Catalog # 
c-Kit  BV605 2B8 Violet (405nm) 595LP à610/20 BD – 563146 
CD115  APC AFS98 Red (640nm) 670/30 eBiosciences - 17-1152-82 
Ly6C  BV421 HK1.4 Violet (405nm) 450/50 Biolegend – 128031 
MHC-II  AF700 M5/114.15.2 Red (640nm) 710LP à730/45 Biolegend – 107622 
CD45.2  APCCy7 104 Red (640nm) 750LP à780/60 BD - 560694 
F4/80  BV605 BM8 Violet (405nm) 595LP à610/20 BD 
CD43  BV510 S7 Violet (405nm) 495LP à525/50 BD – 564398  
CD3  PE 145-2C11 Yellow-Green (561nm) 586/15 
eBioscience – 12-
0031-82 
CD19  PE 1D3 Yellow-Green (561nm) 586/15 
eBioscience – 12-
0193-83 
NKp46  PE 29A1.4 Yellow-Green (561nm) 586/15 
eBioscience – 12-
3351-82 
Sca-1  PE D7 Yellow-Green (561nm) 586/15 Biolegend – 108108 
Ly6G  PE 1A8 Yellow-Green (561nm) 586/15 BD – 551461 
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CD11b  PECy7 M1/70 Yellow-Green (561nm) 750LP à780/60 BD – 552850 
F4/80 eFluor 450 BM8 Violet (405nm) 450/50 eBioscience - 48-4801-82 
TNFα APC MP6-XT22 Red (640nm) 670/30 BD – 554420 
Gr-1 APC RB6-8C5 Red (640nm) 670/30 BD – 553129 
CD16/CD32, purified 2.4G2 N/A N/A BD – 553142 
Siglec F PE E50-2440 Yellow-Green (561nm) 586/15 BD – 552126 
 
   2.4 Cytospin 
   Bone marrow cells from 8 week old C57BL/6 male mice were isolated and processed 
for flow cytometry as described above. Cell sorting was performed on a BD ARIA II, 
using a 100µm nozzle, as a 4-way sort into 1.5mL Eppendorf tubes containing 250L 
of FBS maintained at 4°C for the duration of the sort. The six “classical” bone marrow 
populations were sorted: MDP (5,000 cells), cMoP (2,000 cells), Ly6C+ pro-monocytes 
(10,000 cells), MHC-II+ monocytes (2,500 cells), Ly6Clow monocytes (1,500 cells), 
CD115low cells (1,500 cells). Cells were transferred into single funnels (Fisher scientific 
#10-354), clipped to L-Lysin coated slides using Shandon Cytoclips (Thermo Scientific 
#59910052), and spun using the Cytospin 4 Cytocentrifuge (Thermo Fisher Scientific) 
at 800rpm for 8min. Then, a May-Grünwald-Giemsa staining was performed, as 
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described previously (Gomez Perdiguero et al., 2014). Briefly, slides were air dried for 
30 minutes after the spin, followed by a 5min fixation with 100% Methanol (SIGMA). 
Then, the cytospin preparations were manually stained with a 50% May-Grünwald 
solution (Sigma-Aldrich Cat#MG500-500mL) for 10 minutes, rinced with Sorenson’s 
buffered distilled water (pH=6.8, 43.75mL Na2HPO4 + 56.25mL KH2PO4, both from 
Sigma), then stained with a 14% Giemsa solution (SLS, Cat# SLS 48900-100ML-F) for 
20 minutes. The stained slides were air dried before mouting in Entellan New mounting 
medium (Merck). Cells were observed and pictured with an Oil N-Achroplan 100x 
objective 1.25 N.A., mounted on an Axio Lab.A1 Bright Field microscope (Zeiss). 
 
   2.5. CyTOF 
   Blood and Bone Marrow cells were harvested from 8 week old C57BL/6 or 
Cx3cr1gfp/+ Rag2-/- Il2rg-/y males as for Flow Cytometry. Red blood cell for blood 
samples, as well as Ly6G+ and Ter119+ cells depletion for bone marrow samples, were 
performed as described above. For some experiments, half the cells were used for flow 
cytometry analysis, while the other half was processed as follows for CyTOF analysis. 
Cells were incubated in a solution of 5M Cell-ID Cisplatin in PBS (Fluidigm Cat 
#201064) for 10 minutes at room temperature, for staining of viable cells. After the 
blocking step with anti-CD16/32 (clone 2.4G2), cells were washed once in Maxpar 
Staining Buffer (Fluidigm, Cat #201068). The antibody mix (see Table 2.2) prepared in 
Maxpar Staining Buffer was added with a final volume of 50a, and incubated with 
the cells for 30 minutes on ice. After two steps of wash with Marpar Staining Buffer, 
cells were incubated in 500n of Marpax Fix and Perm Buffer (Fluidigm Cat #201067) 
containing DNA intercalator-Ir (Fluidigm Cat #201192A) at 125nM, for 1 hour at room 
temperature. After two steps of washing with Marpar Staining Buffer, cells were 
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resuspended of Maxpar Water (Fluidigm Cat #201069), counted manually using a 
Neubauer chamber, and the volume adjusted to 0.5x106/mL cells. 5000 of cells were 
added to 50e of  EQ Four Element Calibration beads (Fluidigm Cat #201078), loaded 
to a 1mL syringe and introduced to a CyTOF 2 (Fluidigm) for acquisition. 
   When staining organs form Cx3cr1GFP mice (Rag2-/- Il2rg-/- or Rag2+/+ Il2rg+/+), 
intracellular GFP was stained after extracellular antigens staining and fixation, using an 
anti-GFP antibody (see Table 2.2) 
 
Table 2.2. Antibodies used in this study, for CyTOF 
Antigen Tag Clone Fluidigm, Cat # 
CD11b 172 Yb M1/70 3172012B 
CD45 175 Lu 30-F11 3175010B 
CD11c 162 Dy N418 3162017B 
B220 176 Yb RA3-6B2 3176002B 
F4/80 159 Tb  BM8 3159009B 
cKit (CD117) 173 Yb 2B8 3173004B 
CD64 151 Eu X54-5/7.1 3151012B 
Sca-1 (Ly6A/E) 169 Tm D7 3169015B 
Ly6C 150 Nd HK1.4 3150010B 
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CD3e 165 Ho 145-2C11 3165020B 
NKp46 153 Eu 29A1.4 3153006B 
CD11b 143 Nd M1/70 3143015B 
CD43 146 Nd S11 3146009B 
Ly6G 151 Eu 1A8 3151010B 
Sca-1 (Ly6A/E) 164 Dy D7 3164005B 
Ly6G 141 Pr 1A8 3141008B 
CD11c 142 Nd N418 3142003B 
CD115 144 Nd AFS98 3144012B 
CD45.2 147 Sm 104 3147004B 
CD11b 148Nd M1/70 3148003B 
CD3e 152 Sm 145-2C11 3152004B 
Ly6C 162 Dy HK1.4 3162014B 
CD19 166 Er 6D5 3166015B 
NKp46 167 Er 29A 1.4 3167008B 
CD8a 168 Er 53-6.7 3168003B 
NK1.1 170 Er PK136 3170002B 
CD4 172 Yb RM4-5 3172003B 
MHC-II (IA/IE) 174 Yb M5/114.15.2 3174003B 
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GFP 169 Tm 5F12.4 3169009B 
 
 
   2.6. Absolute cell numbers 
      2.6.1. Cell preparation 
   Cells from each organ were isolated as indicated above for flow cytometry. Aliquots 
were taken once the cells were in Fc Blocking solution, as described below, and diluted 
to different extent: 
         2.6.1.1. Blood 
   An aliquot of cells was taken after the red blood cell lysis steps; 10L of cells were 
placed in 90L of FACS buffer (1/10 dilution), then 50L of that suspension was 
placed in 50L of Trypan Blue (1/2 dilution) before counting. Resulting dilution 
factor: 20 
         2.6.1.2. Bone Marrow  
   An aliquot of cells was taken after the Ter119+ and Ly6G+ cell depletion with 
Dynabeads and resuspension in Fc Block; 10L were placed in 190L FACS buffer 
(1/20 dilution); 50L of this suspension was placed in 50L Trypan Blue (1/2 
dilution) before counting. Resulting dilution factor: 40 
         2.6.1.3. Spleen  
   An aliquot of cell was taken after the red blood cell lysis step; 10L of cells were 
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placed in 190L of FACS buffer (1/20 dilution), and 50L of this suspension was 
placed in 150L of Trypan Blue (1/4 dilution) before counting. Resulting dilution 
factor: 80. 
      2.6.2. Cell count using Neubauer Chambers 
   Cells processed for flow cytometry were counted once in Fc Blocking solution (see 
Tissue Preparation for Flow Cytometry). Cells were counted using Neubauer chamber. 
10L of diluted cells mixed with Trypan Blue (Invitrogen Cat# 15250-061) – see cell 
preparation above for each organ – was introduced to the chamber, which was then 
observed under an Air 20x N-Achroplan 0.45 N.A. objective, mounted on an Axio 
Lab.A1 Bright Field microscope (Zeiss). Live cells (Trypan Blue – negative) were 
counted in the four outer grids (excluding two edges for each grid). The number of cells 
per mL in the original cell suspension was calculated using the following formula: 
Cells/mL = average cells/grid x dilution factor x 10,000 
   This number was then multiplied by the amount, in mL, of Fc Blocking solution, to 
reach the total number of cells being processed for flow cytometry (for 60L of cell 
suspension in Fc Block, the total number of cells was then equal to Cells/mL x 0.06).  
      2.6.3. Whole body cells numbers per organ 
   For each organ, a certain estimations was used to obtain whole body cell count. 
         2.6.3.1. Blood   
   Blood volume has been estimated as recorded by Hakness and Wagner (Hackness and 
Wagner, 2005) to be 80mL/kg for C57BL/6 mice, and 8-week old males were 
considered to be 25g (Mitruka and Rawnsley, Clinical biochemical and hematological 
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reference values in normal experimental animals and normal humans, 1981); hence, 
total blood volume was estimated at 2mL per mouse. Therefore the total amount of cells 
in Fc Block suspension was divided by the volume (in L) of blood withdrawn by 
cardiac puncture (usually between 500L and 1mL), and multiplied by 2,000L for 
the whole body blood cell count. 
         2.6.3.2 Bone Marrow  
   The study performed by Colvin and colleagues (Colvin et al., 2004) has shown (for 
Balb/c mice) that the two femurs constituted 10% of the whole body bone marrow, 
while the two tibiae constituted 4% of it. Therefore, we estimated that the two hind legs 
used for our flow cytometry studies represented 14% (10% + 4%) of the whole body 
bone marrow. Cells counted for the two hind legs using Neubauer chamber were 
therefore multiplied by 100/14, to reach the number of whole body bone marrow cells. 
      2.6.4. Absolute counts for each population of each organ and their representation 
   After acquisition and analysis, the frequency of each population among CD45+ cells 
was multiplied by the total number of cells obtained as described above, to obtain the 
absolute number of each population in the whole body of the mouse. In order to help 
visualize the relative sizes of the populations, each was represented by a coloured circle, 
the area (A) of which was equal to the population’s whole body count/106. To draw the 
circle, its diameter was deduced after remembering that the area of a circle (A) is 
calculated as A = π . r2 where  r is the radius of the circle, and r = D/2 where D is its 
diameter. 
Therefore, knowing its Area, we can deduce its diameter D: 
A = π . r2 
	 107	
A = π . (D/2)2 
A = π . D2/4 
D2 = 4A / π 
D = √(4A/ π), where A = whole body cell count/106 
 
2.7. Intravital microscopy 
      2.7.1. Imaging of the renal cortex 
   Male Cx3cr1gfp/+ Rag2-/- Il2rg-/Y mice (8 to 12 weeks old) were anesthetized by intra-
peritoneal injection of about 300-350µL of a cocktail of Ketamine (50mg/kg), xylazine 
(10mg/kg) and acepromazine (1.7mg/kg). The mice were kept on a heating pad during 
surgery. They received oxygen (0.5 L/min) and anesthesia was maintained by 
continuous inhalation of 0.5% isoflurane (Merial, Harlow, United Kingdom). Deep 
anesthesia was confirmed by loss of reflex (pinching the toe and tail) 
   In order to image the kidney of either Cx3cr1gfp/+ Rag2-/- Il2rg-/- or C57BL/6 mice, the 
fur from the left flank region was removed using a hair trimmer. The left kidney was 
surgically exposed after a small incision in the skin and body cavitiy was performed, 
without interrupting the blood flow or removing the capsule. The mouse was then 
placed in such a way the the kidney was positioned on a coverslip attached with high 
vacuum grease (VWR, Cat#DOWC636082B) to a custom-made aluminium tray stage 
(Life Imaging Services), coated with PBS-soaked strips of paper. The mice were further 
stabilized using two strips of adhesive tape gently applied on the front and back legs of 
the animal. The kidney was kept moist by applying pre-warmed (37ºC) PBS regularly. 
The whole microscope, mouse, stage and objectives were maintained at 37ºC for the 
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whole duration of the imaging sessions thanks to thermostat controlled heated chamber 
(Life Imaging Services). 
      2.7.2. Platelet study 
   Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice were prepared for intravital micrscopy of the kidney 
as described above ; after either 2h (steady state experiments) to measure the 
background number of monocytes, or 15 min of imaging (‘R848 experiments’) that 
allowed the stabilisation of the kidney in both YX plane and Z direction, 100µg of anti-
GPIbα F(ab)2 fragments (kind gift from Prof. Bernhard Nieswandt, University Clinic of 
Wuerzburg, Germany ; PBS as control) or full antibody (Emfret Analytics Cat#R300, 
non-immune rat IgG as controls, Emfret Analytics Cat#C301) were injected i.v. via the 
retro-orbital sinus while imaging, in order to block activation or deplete the platelets, 
respectively. For steady state experiments, the kidney was imaged for another 3h. For 
‘R848 experiments’, 1h after injection, R848 (Invitrogen Cat# tlrl-r848-5) 400µL was 
applied at 0.5mg/mL in PBS, and the kidney was imaged for another 5h.  
   For platelet depletion experiments, at the end of the imaging session, the platelet 
count was obtained after tail vein bleeding, the blood was diluted 1/2 in warm (37ºC) 
PBS, and loaded into an automated cell counter (KX-21N from Sysmex Corporation).  
      2.7.3. Immune complex study 
   To measure the recruitment of monocytes and neutrophils induced by circulating 
immune complexes, Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice were injected i.v. at time 0 via tail 
vein with either BSA-TRITC (Invitrogen, Cat# A23016) or BSA-ICs at 1 : 1 molar ratio 
(50µg BSA + 125µg anti-BSA), obtained by incubating BSA and anti-BSA IgG for 1h 
at 4ºC. At time 2h, mice prepared for kidney intravital microscopy as indicated above, 
and imaged with channels for GFP and TRITC open. After 4h of imaging, neutrophils 
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were stained with a Gr-1 - APC antibody and the mice further imaged for 30 min. 
      2.7.4 Neutrophil and platelet staining during intravital imaging 
   For neutrophil quantification in the kidney of Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice, the 
fluorescence of the channel in which the staining was to be done was measured by 
imaging the kidney with the relevant channel open for 5min, then 10µg of either anti-
Ly6G - PE (clone 1A8, BD Cat# 551461) or Gr-1 - APC (clone RB6 8C5, BD Cat# 
553129) were injeted i.v. via the retro-orbital sinus while imaging. The kidney was then 
imaged for a further 30 minutes.  
   For platelet staining, an anti-CD49b – PE antibody was injected i.v. via retro-orbital 
sinus while imaging the renal cortex, and the organ was further imaged for 30 minutes. 
      2.7.5. Vascular permeability assay  
   C57BL/6 mice were prepared for imaging of the renal cortex as above. The vascular 
bed was visualized by i.v. injection of 100 µl 70 µM 70kDa Dextran-TRITC 
(Invitrogen, Cat#D1819) at t=0h. After 5 to 7 min, sterile PBS, low-endotoxin BSA (50 
µg, Sigma #A8806), or BSA-ICs (50 µg BSA + 110 µg anti-BSA, prepared as described 
above) was administered intravenously, without interrupting the imaging. The kidney 
was imaged for a further 30 minutes to assess vascular leakage.  
      2.7.6. Intravital microscopy acquisition and analysis 
   Images were acquired using a 20x 0.5 NA PL Fluotar objective on a Leica TSC SP5 
DM6000 confocal inverted microscope, with the Argon ion laser (488nm) for GFP 
excitation, DPSS 561nm laser for PE or TRITC excitation, and the HeNe laser (633nm) 
for APC excitation. The resolution was 512x512 pixels (or 1024x1024 for the vascular 
permeability assay, see below) and each image averaged from 2 scans (line average of 
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2). Images of the chosen field of view (XY plane) were taken every 4µm on the Z 
(depth) axis, until no signal was perceptible, and leaving 20-30µm below the surface of 
the kidney, in order to compensate for potential lowering of the position of the kidney 
with regards to the objective, for a total of ~80µm width of the volume, and a 40-50µm 
depth into the kidney. This volume was imaged sequentially, each volume consituting a 
time frame, of 50-60 seconds. 
   Quantification of leukocytes was done as follows. In Cx3cr1gfp/+ Rag2-/- Il2rg-/-, were 
counted as patrolling monocytes cells that were around 15µm in diameter, GFP+, round, 
and mobile. This was in contrast to kidney resident macrophages, that were clearly 
larger (up to 100µm) cells with long, motile processes, though their cell bodies were 
still (Carlin et al., 2013; Stamatiades et al., 2016). Neutrophils were found as round, 
mobile PE+ cells when stained with Ly6G - PE, or GFP- APC+ when stained with Gr-1 - 
APC. The quantification of neutrophils, cells were counted when the staining was 
maximal, generally within 10 minutes after staining antibody i.v. injection. 
Quantification of their numbers was done at specific times during the imaging session, 
typically every hour following an injection of kidney painting. At each time point, 
monocytes or neutrophils were counted throughout 5 time frames that spread around 
this time point. For example, for a count at ‘1h’, the number of monocytes were counted 
at the time frames taken at 58min, 59min, 1h, 1h01 and 1h02. The numbers of cells for 
one mouse and one time point were the average of the counted cells during those 5 time 
frames.  
   2.8. Fast protein liquid chromatography (FPLC) analysis  
   BSA-ICs and OVA-ICs were generated as above (section 2.7.3) at Antigen:Antibody 
(Ag:IgG) ratios of 1:1, 5:1 or 10:1 (see Table 2.3). For controls, BSA, OVA, anti-BSA 
IgG or anti-OVA IgG were mixed with sterile PBS and incubated the same way, 
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keeping consistent volumes and concentrations. Using a 1 mL syringe the samples were 
then injected into a 100 µl loop linked to a Superose 6, 10/ 300 column placed in a 
ÄKTA FPLC system (GE Healthcare Life Sciences), where a constant flow rate of 0.5 
mL/min was applied. Protein content was assessed by measurement of absorbance at 
280 nm at the bottom of the column. The data was recorded and analyzed using the 
UNICORN software (GE Healthcare Life Sciences). The percentage of ICs was 
calculated by integrating the protein elution curve, and dividing the area under the black 
bars by the total area.  
   Table 2.3. In vitro preparation of immune complexes for FPLC 
Antigen amount Antibody amount Molar Ratio Ag:Ab 
BSA-TRITC 125µg Anti-BSA 312.5µg 1:1 
BSA-TRITC 625µg Anti-BSA 312.5µg 5:1 
BSA-TRITC 1,250µg Anti-BSA 312.5µg 10:1 
OVA 125µg Anti-OVA 437.5µg 1:1 
OVA 625µg Anti-OVA 437.5µg 5:1 
OVA 1,250µg Anti-OVA 437.5µg 10:1 
OVA 446.5µg Anti-BSA 312.5µg 5:1 
 
   2.9. Mathematical model developed by our collaborators 
   Grégoire Altan-Bonnet and Amir Erez (NIH, Washington DC) generated an in silico 
model which, in general terms, describes the bone marrow, blood and spleen as a closed 
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system. A single pulse of EdU given to the mice allows to label a single wavw of 
proliferating progenitors and subsequently their progeny. Each cell population is 
considered in terms of its size (absolute numbers in whole body), proliferation rate 
(calculated based on experiments, see chapter 3), intensity of EdU signal (gMFI of EdU 
signal, informs on the number of divisions since the initial EdU pulse), and kinetics of 
EdU uptake and ‘dilution’ over time, i.e. the proportion of EdU+ cells in each cell 
population over time (kinetics of EdU over 10 days, see chapter 3). A useful parallel, in 
our opinion, to understand the biological system as ‘seen’ by the mathematical model is 
that of communicating vessels. Each cell population constitutes a vessel, the size of 
which corresponds to the absolute number of cells for that population. The model aims 
at establishing communication between the various cell populations taking into account 
the speed at which content must flow from that cell type, determined by the 
proliferation rates. The flow between populations can be followed by using a single 
pulse of EdU: this not only informs on the proliferation rate, but also on the kinetic of 
dilution of EdU (gMFI of EdU signal) and its distribution throughout the different 
populations over time.  
   A major principle governing the model is that it must maintain the system 
‘homeostatic’: this simply means that all cells that are produced (by proliferation) must 
‘disappear’. The rate of proliferation is established experimentally with early analysis of 
EdU uptake (see chapter 3). Because the pulse of EdU is very short, cells that become 
EdU+ after ~1h post-injection must have acquired this proportion of EdU-labeled cells 
from cells upstream that have differentiated into them. The amount of time a cell remain 
EdU+ informs on its life-span. Concerning the rate of disappearance of cells, it is 
difficult to measure experimentally; when a cell population sees a decrease in its 
proportion of EdU+ cells it can correspond to four types of event: either the cell has 
divided enough times to bring the signal EdU below the threshold of detection by flow 
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cytometry; the EdU+ cells may have differentiated into another cell population, 
therefore “pouring” into another cell population analysed by flow cytometry, or into 
another one not considered in the gating strategy; the ‘disappearing’ EdU+ cell may also 
migrate into a tissue not isolated for flow cytometry analysis; finally, it may have died. 
Not all these events are measured experimentally, and therefore this parameter is 
allowed to vary.  
   Taking these elements into consideration, as well as many strictly statistical elements 
that can inform on the quality of the data set generated by flow cytometry (for example 
the stability of the measured sizes of populations during the various days of analysis), 
the mathematical model aims at establishing developmental relationships between the 
various cells. This way, it is hoped that the most mathematically relevant hypothesis 
will be most in line with the experimental EdU data. Once a hypothesis is yielded by the 
model, it has to be considered in light of data from the literature and the genetic data 















3 – Studying monocyte development and dynamics towards 
an in silico model 







   3.1 Introduction and aims 
   As discussed above (section 1.3.4), the two main subsets of monocytes rely on 
distinct transcription factors for their development in the bone marrow. They also 
depend on different chemokine receptors for their migratory properties. Nr4a1 has been 
shown to be necessary for Ly6Clow monocyte development and survival using the 
Nr4a1-/- mice and transfer experiments into irradiated hosts (Hanna et al., 2011). 
However, although transfer experiments have shown a cell-intrinsic role of Nr4a1 in the 
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development and survival of Ly6Clow monocytes, the ubiquitous expression of Nr4a1 
throughout the organism raises the worry of side effects of knocking out Nr4a1 outside 
of the hematopoietic system. 
   With this in mind, Csf1riCre mice were crossed with Nr4a1f/f mice, to generate 
Csf1riCre ; Nr4a1f/f and littermate controls, which are deficient for Nr4a1 in 
hemotopoietic cells only, in all lineages studied (Hannah Garner’s data, not shown). 
Analysis of the bone marrow of these mice revealed a population that was c-Kit- 
CD11b+ Ly6Clow MHC-II- similarly to BM Ly6Clow monocytes, but was CD115low at 
the surface protein level, while expressing similar levels of the CD115 transcript to that 
of Ly6Clow BM monocytes (Hannah Garner’s data, not shown). This BM CD115low 
population was critically Nr4a1-dependent, as lacking one allele of Nr4a1 was 
sufficient to reduce this population by almost 40%. The remaining cells of this 
population, similarly BM Ly6Clow monocytes, in conditional Csf1riCre+ Nr4a1Δ/Δ mice, 
proliferated intensively compared to their wt littermates, as seen by BrdU incorporation 
and Ki67/DAPI staining. Lack of Nr4a1 also induced a higher apoptosis rate of the 
remaining BM CD115low population. Finally, the BM CD115low population was found 
to express Nr4a1 at similarly high levels as Ly6Clow monocytes, and they specifically 
lack, in a haplo-deficient manner, in Nr4a1-/- mice. Together, these data obtained by 
Hannah Garner suggested that this BM CD115low population may represent a direct 
precursor to Ly6Clow monocytes in the bone marrow. Therefore, it was taken into 
account in the analyses presented in this work 
   The analysis during steady state of the blood, spleen and bone marrow of Csf1riCre+ ; 
Nr4a1Δ/Δ mice revealed, consistent with the results obtained in Nr4a1-/- mice (Hanna et 
al., 2011), that Ly6Clow MHC-II- monocytes were specifically missing, compared to 
Csf1riCre- ; Nr4a1f/f littermate controls, in all three organs. Interestingly, MHC-II+ 
monocytes, expressing various levels of Ly6C, including cells that are Ly6Clow MHC-
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II+, were not affected by hematopoietic-specific KO of Nr4a1. These cells may account 
for the remaining Ly6Clow monocytes seen in the full Nr4a1-/- mice as shown by 
Richard Hanna and colleagues (Hanna et al., 2011). Ly6C+ MHC-II- monocytes were 
unaffected by the conditional knock-out of Nr4a1. Finally, the BM CD115low 
population was also strongly reduced by Nr4a1 deficiency as presented above. 
   Conversely, when analysing the bone marrow, blood, and spleen of mice lacking Irf8 
(Irf8-/-), Ly6C+ MHC-II- monocytes in all organs were strongly decreased, as well as 
Ly6Cint MHC-II+ cells. Ly6Clow MHC-II- monocytes from bone marrow, blood and 
spleen were unaffected in terms of numbers. This lack of MHC-II+ monocytes, among 
which some cells are Ly6Clow, may reflect the slightly decreased numbers of total 
Ly6Clow monocytes observed previously. Also, bone marrow Ly6C+ monocytes were 
strongly reduced, while cMoP were strongly increased in number, seemingly 
accumulating, consistent with previous findings (Kurotaki et al., 2013 ; Kurotaki et al., 
2014 ; Schonheit et al., 2013). 
   Finally, analysis of Ccr2-/- mice and littermates allowed to find similar results as 
previously in steady state (Serbina and Pamer, 2006) : Ly6C+ MHC-II-, although not 
lacking in the circulation, were strongly reduced in the blood, and spleen, and very 
small changes were observed in the bone marrow in the steady state. Similar 
observations can be made for the Ly6Cint MHC-II+ cells ; however, Ly6Clow MHC-II- 
monocytes were unaffected in the Ccr2-/- mice compared to littermates. 
   Therefore, the separation of monocytes into MHC-II- and MHC-II+ cells, in addition 
to Ly6C, seems to overall help delineate monocyte population more precisely. These 
genetic data are compatible with two distinct pathways of differentiation for 
monocytes :  Ly6C+ MHC-II- cells that are Irf8-dependent, Nr4a1-independent ; Ly6Cint 
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MHC-II+ monocytes that have the same genetic requirements, and Ly6Clow MHC-II- 
monocytes, the patrolling subset, that are Irf8-independent Nr4a1-dependent.  
   This is not in line with the current model of monocytes development, which suggests 
that Ly6Clow monocytes are a product of Ly6C+ monocyte conversion in the circulation 
(Hettinger et al., 2013; Varol et al., 2007; Yona et al., 2013). However, the data 
presented so far may not be enough to fully support any hypothesis.  
   Therefore the aim of this thesis was to re-examine monocyte dynamics in 
hematopoietic compartments (bone marrow, blood and spleen) using experimentally 
parameterized and computer-assisted mathematical modeling, developed by Grégoire 
Altan-Bonnet and Amir Erez (National Institute of Health, Washington). Presented here 
are the results of some of the experiments that allowed to pin down some of the 
parameters of the model, as well as data that has been modeled. This was done with the 
intent to provide a hypothesis for monocyte dynamics, and notably the developmental 
origin of Ly6Clow monocytes, with the support of mathematical analysis of biological 




Figure 3.0. Different hypotheses for monocyte development.  
(A) Several studies suggest that monocytes exit the bone marrow as Ly6C+ cells, that 
mature, or convert, into Ly6Clow monocytes, in the periphery under the control of 
homeostatic and inflammatory cues (Yona et al., 2013). 
(B) Alternatively monocyte heterogeneity may result from a differentiation process in 
the bone marrow under the control of specific transcription factors and growth factors 
(Hanna et al., 2011). 





























   3.2. Characterisation of the biological system and of the methodology for study of 
monocyte dynamics 
   3.2.1. Gating strategy and morphology of the studied cell populations 
   Blood and bone marrow were analysed in adult C57BL/6 male mice, by flow 
cytometry. Monocytes and their known late progenitors MDP (Fogg et al., 2006) and 
cMoP (Hettinger et al., 2013) were gated as classically done, with the use of c-Kit, 
CD115 (CSF-1R), CD11b and Ly6C expression, as well as MHC-II to distinguish three 
monocyte populations in the blood and bone marrow (Figure 3.1). MDP and cMoP 
were defined as Lineage negative (CD3, CD19, NKp46, Sca-1, Ly6G), c-Kit+ CD115+, 
CD11b-, with MDP as Ly6C- and cMoP as Ly6C+ (Figure 3.1-A, top). The BM 
CD115low population was defined as Lineage negative, Ly6Clow CD11b+ MHC-II- c-Kit- 
CD43+ (Figure 3.1-A, bottom). Blood and bone marrow monocytes were defined as 
Lineage negative (CD3, CD19, NKp46, Ly6G), CD115+ CD11b+ and subdivided in 
Ly6C+ MHC-II-, Ly6Cint MHC-II+ and Ly6Clow MHC-II- (Figure 3.1-A, B). The same 
gating strategy as for blood samples was adopted for spleen monocytes (data not 
shown). 
   Each of these population was FACS sorted and their morphology was analysed by 
cytospin followed by May-Grünwald Giemsa staining. MDP, cMoP and the BM 
CD115low cells had a round shape, and small cytoplasm with a high nucleus/cytoplasm 
size ratio (Figure 3.1-A). BM Ly6C+ monocytes appeared slightly heterogeneous in 
terms of morphology ; most cells had similar morphology as blood monocytes, with a 
bean-shaped nucleus and small filipodiae, but some had a rounder shape. Some were 
isolated as they were dividing, as seen by the shape of their nucleus (Figure 3.1-A), a 
feature also seen for some MDP and cMoP (data not shown). Because monocytes of the 
blood do not proliferate (Geissmann et al., 2003 ; Shand et al., 2014), and in line with 
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previous findings (Chong et al., 2016; Menezes et al., 2016; Shand et al., 2014), this 
heterogeneity in morphology might be representative of the fact that BM Ly6C+ cells 
may not be best termed ‘monocytes’. They will from now on be referred to as ‘BM 
Ly6C+ cells’ to avoid confusion with blood or spleen monocytes. Ly6Clow monocytes of 
the BM had a classic monocyte morphology with a bean-shaped nucleus, and so did 
blood monocytes of both classical subsets. MHC-II+ monocytes of both bone marrow 
and blood had a similar morphology as classical monocytes, with small filipodiae, bean-
shaped nuclei and vacuoles (although these might be due to the cells staying too long in 
























Gated on CD45+ Lin-  
(Sca-1 CD3 CD19 





Gated on CD45+ Lin-  
















































 Gated on Kit- MHC II- 	
Blood	
Bone	Marrow	
Figure 3.1: Gating strategy and morphology of the bone marrow and blood 
prospective populations. (A) Bone marrow from C57BL/6 was collected and the 
indicated populations were FACS sorted (2000 to 10,000 cells), cytospun on L-Lysin-
coated slides, and a May-Grünwald-Giemsa staining was performed. Images are 
representative of at least 50 cells observed for each population, using a 100x oil 
objective. For the BM Kit- CD115+ Ly6C+ cells, representative images of the different 
morphologies observed are shown. (B) Blood from C57BL/6 mice was collected and 
the indicated monocyte populations were FACS sorted (5,000 to 10,000 cells) Scale 
bars = 10µm 
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   3.2.2. Size of the populations, blood and bone marrow as separate compartments 
   Because the size of the cell populations is a critical parameter of the mathematical 
model, the various populations of cells in blood and bone marrow in the whole body 
had to be quantified. These quantifications have been made by others, and their results 
were used as estimates. First, for the bone marrow, Colvin and colleagues (Colvin et al., 
2004) have estimated that femurs contain 10% of the bone marrow of the whole body, 
while tibiae contain 4% of whole bone marrow. Therefore, the sizes of the bone marrow 
cell populations for whole body BM were calculated considering that the absolute 
numbers obtained from two femurs and two tibiae constituted 14% of it. 
   For blood populations, estimations made previously were used: mice have 80mL of 
blood per kg of body weight, and weigh 25g on average (Hakness and Wagner, 1995; 
Mitruka and Rawnsley, 1981), therefore the estimation of 2mL of blood per adult 
mouse was used.  
   Finally, similar phenotypes are considered for blood monocytes and their apparent 
BM counterparts : these cells are gated as c-Kit- CD115+ CD11b+ in both organs, within 
which Ly6C+ MHC-II-, Ly6Cint MHC-II+ and Ly6Clow MHC-II- cells are present and 
gated as such (Figure 3.2-C). It is therefore relevant to ask whether some cells analysed 
in the bone marrow may actually be blood cells that were circulating in the bone 
marrow at the time of the mouse sacrifice. Estimations of the amount of blood in the 
bone marrow have been made previously : Osmond and colleagues found that 2% of the 
circulating blood was to be found in the bone marrow ; conversely, 5% of the bone 
marrow volume is made out of blood (Figure 3.2-B). Using these estimations, the 
amount of blood cells among bone marrow populations were calculated (Figure 3.2-C). 
‘Contamination’ of blood populations into BM cells was minimal, as 0.6 - 3% of cells 
found in the bone marrow cells are blood cells (Figure 3.2-C). Therefore the bone 
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marrow populations analysed were likely in the parenchyma of the bone marrow, and 
constitute a compartment distinct from the blood. 
   Finally, because modeling monocyte dynamics would be performed with long-term 
pulse-chase of nucleoside analog experiments, the identification of proliferating 
populations was first assessed by analysing EdU (5-ethynyl-2’-deoxyuridine) uptake at 
1h post intraperitoneal injection to adult C57BL/6 males (Figure 3.2-D). This allowed 
the identification of the MDP, cMoP and BM Ly6C+ cells as the main proliferative cells 
within the analysed compartments, consistent with the literature (Fogg et al., 2006 ; 
Hettinger et al., 2013 ; Shand et al., 2014 ; Geissmann et al., 2003), and with previous 
results obtained by Hannah Garner in the laboratory, by BrdU (5-bromo 2-
deoxyuridine) incorporation and Ki67/DAPI satining (data not shown). Therefore these 
populations were the focus of the next set of experiments. 
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Figure 3.2. Cellularity of Bone Marrow and Blood, two separate compartments, 
and proliferation at steady state. (A) Cellularity of the bone marrow was quantified in 
the whole skeleton of a Balb/c mouse; together, femurs and tibiae amount to 14% of the 
total bone marrow. Adapted from Colvin et al., 2004. (B) The volume of blood found in 
the bone marrow (red rectangle) represents 2% of the whole circulating blood volume, 
and constitutes 5% of the bone marrow volume. Estimations from Osmond et al., 1965. 
(C) Similar phenotypes for blood monocytes and bone marrow monocytes or pro-
monocytes, by flow cytometry (left). Bone Marrow and blood prospective populations 
as circles (right); the size of the circles reflects the size of the populations in vivo, for 
whole body bone marrow (in the estimation from (A)) and whole circulating blood 
(2mL, Hakness and Wagner, 1995; Mitruka and Rawnsley, 1981). Percentages represent 
the ‘contamination’ from blood cells within the bone marrow cell numbers, in the 
estimation from (B). (D) Proliferation of prospective populations, measured by EdU 
incorporation 1h after injection of 0.5mg EdU i.p. These data suggest that MDP, cMoP 
and BM Ly6C+ cells are the main proliferative populations of the bone marrow, among 
the cells analysed. 















































3.2.3. Characterisation of the EdU pulse and of the first division of proliferating cells 
   Another parameter that the model requires, and that can be measured experimentally, 
is the proliferation rate of the different populations considered. For this, it was first 
necessary to know for how long the i.p. injected EdU is available for the cells in S-
phase to take up. The intensity of the EdU signal in cells that did take it up was also an 
important measure, as it represents the amount of EdU contained in the cells. To 
investigate this issue, groups of three mice were injected with a single dose of 0.5mg of 
EdU i.p., and the EdU content (both the proportion of cells from the proliferative 
populations, and the intensity of the signal) was measured, in the MDP, cMoP and BM 
Ly6C+ cells, from 15min after injection, and every 15min until 2h (Figure 3.3-A). The 
results show that the percentage of EdU+ cells within the analysed populations was 
already maximal at 15min post-injection (Figure 3.3-B). This suggests a bio-
availability of EdU that is very short. Therefore the EdU pulse constitutes a very narrow 
window during which the cells are able to pick up EdU. Interestingly, however, the 
intensity of the EdU signal, measured by the geometric Mean Fluorescence Intensity 
(gMFI) in EdU+ cells, increased from 15 min to 1h (Figure 3.3-A, B), after which the 
gMFI values plateaued (Figure 3.3-B). This suggests that, although the cells only take 
up EdU for no longer than 15min, it takes around 1h for the EdU to be fully 
incorporated into the DNA during the S-phase.  
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   Figure 3.3. Characterisation of the EdU pulse. C57BL/6 mice were injected 
intraperitoneally with 0.5mg of EdU. At the indicated times after injection, their bone 
marrow was analysed by flow cytometry for EdU content in prospective populations 
(A) EdU content in prospective populations. Cells were gated as Lineage (CD3, CD19, 
NKp46, Sca-1, Ly6G) negative, CD115+ c-Kit+ (MDP and cMoP, Ly6C- and LyC+ 
respectively) or CD115+ c-Kit- (BM Ly6C+). Contour plots representative of 3 – 6 mice 
per time point. (B) Percentage of EdU+ cells in the MDP, cMoP and BM Ly6C+ cells at 
the indicated times after EdU injection (top); geometric Mean Fluorescence Intensity 
(gMFI) of the EdU signal in the EdU+ cells, among MDP, cMoP and BM Ly6C+ cells 
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Therefore, these experiments characterise a short EdU pulse of 15 minutes, and the 
maximum intensity of the signal is reached after 1h. Based on these experiments, our 
collaborators were able to calculate the proliferation rates of the various populations of 
the bone marrow, using a method similar to that of Schittler and colleagues (Schittler et 
al., 2013).  
   Next, EdU incorporation was investigated for up to 12h post EdU injection (Figure 
3.4). Following %EdU+ cells within MDP, cMoP and BM Ly6C+ cells, an increase in 
the proportion of EdU+ cells was observed starting at 2h and up to 12h (Figure 3.4, blue 
dots). Parallel to this increase in %EdU+ cells, a drop of around half in the intensity of 
EdU signal within the EdU+ cells was observed starting at 2h post EdU injection 
(Figure 3.4, red dots). This suggested two things. First, that starting at 2h post EdU 
injection, the cells that were caught in S-phase during the EdU pulse were starting to 
perform mitosis, giving rise to daughter cells with half the EdU content of that of first-
generation cells. Second, given the size of the populations (calculated in Figure 3.2-C), 
all cMoP that had taken up EdU during the pulse, had to each give rise to 2 daughter 
cells differentiating quickly to BM Ly6C+ cells. 
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Figure 3.4. Kinetics of EdU incorporation and dilution over 12 hours. C57BL/6 
mice were injected intraperitoneally with 0.5mg EdU. At the indicated times after 
injection (every 15min to the left of the dotted line – see also previous figure; every 2 
hours to the right of the dotted line), their bone marrow was analysed for EdU content in 
the indicated populations (MDP, cMoP and BM Ly6C+ ). Graphs show the proportion of 
EdU+ cells within each population (blue, read on left axis) and the gMFI of the EdU 
signal of the EdU+ cells (red, read on the right axis). Each dot represents an individual 
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   In order to investigate further whether a step forward in cell cycle was happening 
around 2 to 4h after EdU injection, the size of the EdU+ cells was analysed at the 
various time points between 1h and 12h (Figure 3.5). When analysing the Forward and 
Side Scattering of light (FSC/SSC), respectively informing on size and granularity of 
cells in flow cytometry, EdU+ cells at 1h (just after the pulse) had high FSC/SSC 
intensities, suggesting their cell cycle was still in progress. Starting at 2h, but mainly 
visible at 4h, EdU+ cells with lower FSC/SSC started to appear, showing they had 
completed cell division (Figure 3.5). This was consistent with the drop in gMFI of the 
EdU+ cells observed at 2h and 4h as shown in Figure 3.4. 
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Figure 3.5. FSC/SSC profile of proliferating cells after a single pulse of EdU. 
C57BL/6 mice were injected i.p. with a single dose of EdU (0.5mg), and their bone 
marrow was analysed for EdU content at the time points indicated on the right. EdU+ 
cells (red) from the populations indicated at the top (MDP, cMoP and BM Ly6C+) were 
backgated to show their FSC/SSC profile against the total BM cells (grey). 
Representative of 3-6 mice per time point. Cells of lower FSC and SSC start clearly 














    
Together, these data of EdU incorporation during the first 12h after injection showed 
that a single injection of EdU provided a very short pulse for cells to take up the 
nucleoside analog, and that cells started to undergo mitosis at 2 to 4h after injection, 
with the daughter cells seemingly differentiating very quickly from cMoP to Ly6C+ 
cells. In terms of information for the mathematical model, this informed the length of 
the labeling phase of EdU (15min), identified 1h post injection as the time for which the 
signal intensity was maximum and from which the proliferation rates could be 
calculated ; it also showed that both daughter cells from the late progenitors had to give 
rise to the next step of differentiation, as opposed to an ‘asymetric’ mitosis, where a 
progenitor would give rise to a daughter cell identical to the mother cell, and another 
daughter cell differentiating forward. 
   3.2.4. Kinetics of EdU incorporation and dilution over 10 days 
   After establishing some aspects of the biological system under study, a single pulse of 
EdU was given to groups of three male C57BL/6 mice and EdU content in the bone 
marrow, blood and spleen prospective populations of monocytes and late progenitors 
was analysed from 1h to 10 days after injection (Figure 3.6). For all populations in all 
organs, there was a phase during which the proportion of EdU content reached its 
maximum, followed by a decrease in %EdU+. For MDP and cMoP, maximum %EdU+ 
was at the very start and only decreased over time. For BM Ly6C+ and BM MHC-II+ 
cells, some cells were proliferating as shown by their EdU content at 1h, and proportion 
of EdU+ cells increased during the next 48h, before starting to decrease. This suggest an 
imput of EdU+ from upstream cells before futher differentiation. Finally, BM CD115low 
cells, BM Ly6Clow monocytes, as well as blood and spleen monocytes, started as EdU-, 
showing they don’t proliferate at steady state (consistent with the literature, Geissmann 
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et al., 2003 ; Shand et al., 2014). They only started to show a proportion of EdU+ cells 
later on ; the analysis of the pulse (Figure 3.3) shows that this cannot be due to these 
cells entering cell cycle and taking up EdU (the second analysed time point was 12h 
post EdU injection, long after the EdU has stopped being available for cells in S-phase). 
This rather suggests an imput of EdU-labeled cells from upstream of the differentiation 
process. Interestingly, blood and spleen monocytes had overlapping kinetics of EdU 
incorporation and dilution, excluding the spleen as a site of production for blood 
monocytes in the steady state.  
   Searching for succession of EdU peaks over time between two populations is not 
sufficient to establish a precursor-progeny relashionship between them. Indeed, such an 
analysis could result in various different and overlapping differentiation pathways. This 
data set (including the population sizes as shown in Figure 3.2-C, taking into account 
the results of the early EdU time points shown in Figures 3.3 and 3.4, as well as the 
gMFI of the EdU signal for the data set shown in Figure 3.6 – see Supplemental 
Figure 3.1), was therefore analysed with the in silico model by our collaborators 
Grégoire Altan-Bonnet and Amir Erez. However, their analysis showed that the 
production of Ly6Clow monocytes in the blood and bone marrow could not be explained 
by a mathematical analysis of the prospective populations as they were described in this 
experiment. Notably, it pointed to a potential population that would act as a ‘missing 
link’ in the bone marrow, between the actively proliferating populations (MDP, cMoP 
and BM Ly6C+), and the Ly6Clow monocytes of the blood and spleen. Therefore, a set 
of experiments was designed, aiming for the identification of such cells. 
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Figure 3.6. Kinetics of EdU incorporation and distribution over 10 days 
C57BL/6 mice were injected with a single dose of 0.5mg of EdU intraperitoneally, and 
sacrificed at the indicated time points after injection for analysis of their BM (top), 
Blood (middle) and Spleen (bottom) for EdU content in the indicated populations. n=3 
mice per time point. Bars represent mean ± SD 
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   3.2.5. Search of a potential ‘missing link’ in the bone marrow, by CyTOF 
   In order to identify a population that could act as a ‘missing link’ in the differentiation 
process of Ly6Clow monocytes, two transgenic mouse models were used : first the 
Cx3cr1gfp/+ knock-in mice (Jung et al., 2000), on a Rag2-/- Il2rg-/- background, in which 
monocytes are the only blood cells to express GFP under the control of the Cx3cr1 
promoter (Auffray et al., 2007). All prospective populations analysed express Cx3cr1-
gfp (Figure 3.7-A), consistent with previous results from the lab and with the literature 
(Geissmann et al., 2003 ; Fogg et al., 2006 ; Hettinger et al., 2013, Yona et al., 2013). It 
was therefore expected that if there was a population of interest to be found, it would 
also express Cx3cr1-gfp. The second model was that of Nr4a1GFP mice, because 
Ly6Clow monocytes express high levels of Nr4a1GFP (Figure 3.8-A, consistent with 
previous results from the lab) and are dependent on Nr4a1 for their development 
(Hanna et al., 2011). We took advantage of CyTOF (mass Cytometry by Time Of 
Flight), in which a large number of extracellular and intracellular markers can be 
detected with antibodies conjugated to heavy isotopes of various metals.  
   Staining the bone marrow of Cx3cr1gfp/+ Rag2-/- Il2rg-/- , and Rag2-/- Il2rg-/- as controls 
for the GFP staining, the bone marrow was analysed in two parallel ways. On one hand, 
the prospective populations were gated, within the GFP+ cells, with the same strategy as 
in Figure 3.1, which resulted in the isolation of the same populations as in the WT 
animals analysed by fluorescence flow cytometry (Figure 3.7-B). In addition, total 
Lineage negative GFP+ cells were subjected to a t-SNE (t-distributed Stochastic 
Neighbor Embedding) clustering analysis (Van Der Maaten and Hinton, 2008). This 
technique analyses each cell in a high dimensional space, where each marker 
measurement constitutes a dimension. Each cell is compared to all the other cells in 
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terms of all the markers it expresses, and cells that are phenotypically similar are 
clustered together, within this high dimensional space. The major interest of t-SNE is its 
ability to perform what is termed a dimension reduction, which means that the 
clustering of the cells in the high dimensional space is represented in a 2-dimensional 
dot plot, in which the relative distance between the cells, i.e. the clustering of cells, is 
conserved. Therefore, it allows to conserve the information gained in high dimensional 
space, that is taking into account all the cell markers, and to represent it in a dot-plot. 
This constitutes a tool for the clustering of cell populations that is less biased than 
classical gating. The result of the t-SNE performed on total lineage negative, Cx3cr1-
gfp+ cells is shown in Figure 3.7-C. Then, cells gated in Figure 3.7-B were overlayed 
on the t-SNE plot ; this shows that the populations gated in a ‘classical’ manner are 
mostly homogeneous, as they each correspond to one cluster of cells in t-SNE (Figure 
3.7-C). Similar clusters were found when performing t-SNE multiple times with various 
parameters (Supplemental Figure 3.2). Interestingly, three clusters of GFP+ cells did 
not correspond to any of the gates, or in other words, these cluster of cells were not 
taken into consideration by classical gating. 
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   Figure 3.7. Analysis of Cx3cr1-gfp expressing bone marrow cells by CyTOF. 
Cx3cr1gfp/+ Rag2-/- Il2rg-/- and Cx3cr1+/+ Rag2-/- Il2rg-/- mice were sacrificed and their 
bone marrow analysed for either flow cytometry (A) or CyTOF (B and C). (A) The 
indicated populations were gated by flow cytometry as indicated in Figure 3.1, and the 
expression of GFP analysed in GFP mice (black lines) and C57BL/6 mice (grey 
histograms) (B) Same gating strategy of bone marrow prospective populations by 
CyTOF, as used by flow cytometry in Figure 3.1. (C) t-SNE was performed on the 
Lineage negative, Cx3cr1-gfp+ bone marrow cells. The resulting clusters are shown, and 
total Lin- GFP+ cells are shown in grey, while the populations gated in (B) are 
overlayed. The GFP+ clusters not taken into account by classical gating are circled and 
their phenotype will be shown in Figure 3.9. 
A	
B	












































































































































   A similar process was applied to total lineage negative, Nr4a1-gfp+ cells (Figure 3.8). 
Because the MDP, cMoP and BM Ly6C+ cells express little to no Nr4a1-gfp (Figure 
3.8-A, consistent with previous results from the lab), they were not recovered when 
gating on total lineage negative Nr4a1-gfp+ cells. Only BM MHC-II+, BM CD115low 
and BM Ly6Clow cells, which express intermediate to high levels of Nr4a1-gfp (Figure 
3.8-A), were found within the Nr4a1-gfp+ gate (Figure 3.8-B). A t-SNE was performed 
on total lineage negative, Nr4a1-gfp+ cells, and cells gated in parallel were overlayed on 
the t-SNE dot plot (Figure 3.8-C). The clusters thus generated were found even when 
performing t-SNE multiple time, with various parameters (Supplemental Figure 3.3). 
Similar to results obtained in Cx3cr1gfp/+ Rag2-/- Il2rg-/-, not all GFP+ cells were taken 
into account by classical gating (Figure 3.8-C). 
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   Figure 3.8. Analysis of Nr4a1-gfp expressing bone marrow cells by CyTOF. 
Nr4a1
GFP
 mice and Nr4a1WT littermate controls were sacrificed and their bone marrow 
analysed for either flow cytometry (A) or CyTOF (B and C). (A) The indicated 
populations were gated by flow cytometry as indicated in Figure 3.1, and the expression 
of GFP analysed in Nr4a1GFP mice (black line) and Nr4a1WT littermates (grey 
histograms) (B) Same gating strategy of bone marrow prospective populations by 
CyTOF, as used by flow cytometry in Figure 3.1. (C) t-SNE was performed on the 
Lineage negative, GFP+ bone marrow cells of a Nr4a1GFP mouse. The resulting clusters 
are shown, and total Lin- GFP+ cells are shown in grey, while the populations gated in 
(B) are overlayed. The GFP+ clusters not taken into account by classical gating are 
circled and their phenotype will be shown in Figure 3.9. 
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   The clusters of cells that were either Cx3cr1-gfp+ (Figure 3.7-C) or Nr4a1-gfp+ 
(Figure 3.8-C), but not taken into account by a ‘classical’ gating startegy, were gated 
directly on the t-SNE plots (Figure 3.9). Their expression for all markers used in the 
CyTOF staining was analysed (Figure 3.9-A, B). The three clusters identified in 
Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice were termed C1, C2 and C3, while the two clusters 
identified in Nr4a1GFP mice were termed N1 and N2. All these cells were negative for 
CD11c, CD64, as well as lineage markers CD3, CD19, NKp46 and Ly6G (data not 
shown). Interestingly, two clusters of cells could be found in both GFP mice models : 
C2 had the same phenotype as N1, and C3 had the same phenotype as N2 (Figure 3.9-
A, B).  
   These cells were all potentially interesting in the context of a search for a ‘missing 
link’, therefore they were analysed further by classical flow cytometry and EdU 
incorporation assays. Because the cells found in Nr4a1GFP mice were similar in 
phenotype to two of the clusters found in Cx3cr1gfp/+ Rag2-/- Il2rg-/-, we will only refer 
to the populations as C1, C2 and C3 (since C2=N1 and C3=N2).  
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Figure 3.9. Phenotype of the identified GFP+ cells by  CyTOF. Cells identified in the 
GFP fraction of Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice (A) and Nr4a1GFP mice (B) in Figures 
3.7 and 3.8 respectively, were phenotyped by CyTOF. Their phenotype is represented as 
a series of 2D dot plots. Of note, C2 and N1 as well as C3 and N2 have similar 
phenotype. 
   
0 50 100 150 200 250


















































































































































































































   First, a gating strategy was designed in order to select these populations by 
fluorescence flow cytometry. C1 was gated as CD115low CD11blow Ly6Cint c-Kitlow 
MHC-II- CD43+, consistent with its phenotype found by CyTOF (Figure 3.10-A). C2 
was gated as CD115low CD11b+ Ly6Chigh c-Kit- MHC-II- CD43+, and C3 was gated as 
CD115+ CD11blow Ly6Chigh/int MHC-II- CD43+, also according to their phenotype by 
CyTOF analysis (Figure 3.10-B and C, respectively). The expression of Cx3cr1-gfp by 
these cells was confirmed by conventional flow cytometry as well (Figure 3.10-A, B 
and C). Next, EdU incorporation at 60h was analysed in these cells, as a population that 
would ‘peak’ in EdU content at this time point could constitute an interesting target for 
a ‘missing link’ population. All three populations were found to have an important 
proportion of EdU+ cells at 60h (Figure 3.10-A, B, C). 
   Therefore, populations C1 to C3 were gated as indicated in Figure 3.10 into the data 
set of EdU kinetics (10 days) presented in Figure 3.6 (data not shown, analysis 
performed by Hannah Garner). However, incorporating these three population into the 
in silico modeling by our collaborators Grégoire Altan-Bonnet and Amir Erez, showed 
that the production of Ly6Clow monocytes was still not properly explained by a 
mathematical analysis (data not shown). 
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  Figure 3.10. Gating in flow cytometry of the Cx3cr1-gfp+ populations identified by 
CyTOF, EdU analysis at 60h. Bone marrow of Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice was 
analysed by flow cytometry. Populations identified in the CyTOF experiments presented 
in Figures 3.7, 3.8 and 3.9 were gated according to the phenotypes found in Figure 3.9, 
and as rewritten under each population name for C1 (A), C2 (B) and C3 (C). Their level 
of GFP expression was measured (black lines), and compared to Cx3cr1+/+ control mice 
(grey histograms). Finally, Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice were injected with a single 
pulse of 0.5mg EdU and the EdU content of C1 (A), C2 (B) and C3 (C) was measured 








































































































































































    3.2.6. Inclusion of CXCR4+ pre-monocytes and standardisation of the protocol for 
bone marrow preparation  
   In the search for a better way of analysing the various populations, staining for 
CXCR4 was included in the analysis of bone marrow, following the recent publication 
of the work by Chong and colleagues (Chong et al., 2016). In this article, the authors 
use CXCR4 staining to identify cells termed ‘pre-monocytes’ in the bone marrow, 
which are within the BM Ly6C+ cells, and are highly proliferative. CXCR4+ Ly6C+ pre-
monocytes were suggested as a direct upstream population that gave rise to CXCR4- 
Ly6C+ cells in the bone marrow (Chong et al., 2016). Consistent with these results, 
CXCR4+ cells within the BM Ly6C+ cell population identified its proliferative fraction, 
as the CXCR4+ cells corresponded to the EdU+ cells 1h after EdU injection (Figure 
3.11-A).  
   In addition to the new staining of the bone marrow, the protocol for the preparation of 
the bone marrow was standardised with that of other organs. Up to this point, bone 
marrow cells were subjected to a magnetic beads-mediated depletion of Ly6G+ 
neutrophils and Ter119+ erythrocytes (see Materials and Methods, section 2.2.1.3). 
This was done in order to remove a large number of cells from the bone marrow, and 
help the identification of discrete populations, such as Ly6Clow monocytes or the BM 
CD115low cells. However, comparing the bone marrow of mice with or without 
including this depletion step before staining with surface antibodies, revealed that 
depleting Ly6G+ and Ter119+ cells lead to a loss of Ly6Clow monocytes in the bone 
marrow (Figure 3.11-B).  
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   Figure 3.11. Latest analysis of Bone marrow, Blood and Spleen population as 
continuum on the Ly6C expression axis. (A) Consistent with results from Chong and 
colleagues (Chong et al., 2016) CXCR4 expression in the bone marrow identifies the 
proliferating fraction of BM Ly6C+ cells. (B) Preparing bone marrow cells for flow 
cytometry without magnetic depletion of Ly6G+ neutrophils and Ter119+ erythrocytes 
allows to yield more Ly6Clow monocytes. (C) Subdivision of monocytes in BM (left), 
blood (middle) and spleen (right) into small voxels along the Ly6C and MHC-II axis. 
Ly6C expression is colour-coded from yellow (high expression) to blue (low 
expression). Gated on Lin- c-Kit- CD115+ CD11b+ CXCR4- (D) Kinetics of EdU 
incorporation and distribution over time for each voxel of Ly6C expression subdivided 
in (C). The EdU kinetic of bone marrow (blue lines), Blood (red lines) and spleen 
(green lines) are overlayed. (E) Flux of cells from Ly6Chigh (yellow) to Ly6Clow (blue) 
in bone marrow (left), blood (middle) and spleen (right). The width of ellispes 
represents the number of cells with a given level of Ly6C expression (colour-coded in 
yellow to blue). The width of the white rectangles represents the number of cells which 
transition, per day, from one level of Ly6C to the next, from high (yellow) to low (blue). 
Figures C, D and E generated by Amir Erez. 
We get the pulse-chase time-series for each voxel
Amir Erez (CIP/NCI) Di↵erentiation by EdU pulse chase 2017-Feb-07 2 / 8
ScatterSlice gates
We gate on CD3-/CD19-/NKp46-/Sca1-/Ly6G-/Ter119-/CD117-
/CXCR4-/CD115+/CD11b+ We begin by defining a phenotypic
continuum along Ly6C and MHC-II.
Amir Erez (CIP/NCI) Di↵erentiation by EdU pulse chase 2017-Feb-07 1 / 8
Di↵erentiation flux: comparison between tissues
































































































































































   A new time series of EdU kinetic analysis was performed by our collaborators on 
bone marrow, blood and spleen, this time staining the bone marrow with CXCR4, and 
without performing the depletion as mentioned above (data not shown). Groups of three 
mice were analysed from 1h to 180h (7.5 days) post EdU injection, and every 18h. 
Modeling of this new data set by our collaborators Grégoire Altan-Bonnet and Amir 
Erez, provided insight into monocyte dynamics in the different compartments. When 
considering bone marrow cells negative for CXCR4, hence excluding the proliferating 
fraction of BM Ly6C+ cells, the c-Kit- CD115+ CD11b+ cells were divided into small 
fractions of cells along the Ly6C and MHC-II fluorescence axis, termed ‘voxels’. This 
was performed in all three organs (Figure 3.11-C). Then, a computer assisted analysis 
of EdU content over time was performed for each of these voxels, in all three organs 
(Figure 3.11-D). Finally, modeling the kinetics of these voxels yielded the results 
presented in Figure 3.11-E. In this figure, Ly6C expression is represented by a colour-
code from yellow (high expression) to blue (low expression). The width of the ellipses 
represents the number of cells with the corresponding Ly6C level of expression, in each 
organ. Below each ellipse is a rectangle whose width represents the number of cells, per 
day, that ‘flow’ from the level of Ly6C expression above the rectangle, to the level of 
Ly6C expression represented below the rectangle. Therefore, the larger the rectangle, 
that more cells flow from Ly6Chigh expression to intermediate and then lower levels of 
Ly6C expression. Having more cells that express low levels of Ly6C in the bone 
marrow, and analysing in parallel all three organs using the same phenotypes (CXCR4- 
c-Kit- CD115+ CD11b+) thanks to the absence of the depletion step, allows a flow of 
cells that is explained with a mathematical analysis. Given the relative size of the 
rectangles representing the transitions from Ly6Chigh expression to Ly6Clow expression, 
these results suggest that this phenotypical transition occurs predominantly in the bone 
marrow (Figure 3.11-E). Additionally, analysis of CD115 expression in the voxels 
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along the Ly6C expression axis, shows that during Ly6C down-regulation, there is a 
transitory drop in CD115 expression, which is restored by the time cells reach a 
Ly6Clow phenotype (data not shown). This drop in CD115 expression was not observed 
in blood nor spleen. This suggests that cells that differentiate from a Ly6Chigh to 
Ly6Clow phenotype in the bone marrow may transition through a state similar to the BM 
CD115low population.  
   3.3. Discussion and future work 
   The work presented in this chapter aimed at a further understanding of monocyte 
dynamics. This issue was investigated with the support of a mathematical and computer 
assisted approach. Data from pulse-chase experiments were used. First, the biological 
system had to be established, as the modeling relies on several parameters, that could 
partially be fixed thanks to experiments. Therefore, the size of the populations were 
estimated for the wole body, and the EdU pulse was characterised in order to make sure 
the first, founding events that lauch the EdU incorporation was understood. A short or 
long labeling phase is not a trivial element, as a long labeling phase could potentially 
label many more cells at the start of the kinetics study, during the time following EdU 
injection. Indeed, there is no firm evidence that cells that are in the process of 
differentiating and proliferating in the bone marrow, do so in a staggered manner, where 
waves of progenitors undergo cell cycles together, and long breaks occur before another 
wave starts. However, the data showed in Figures 3.4 and 3.5 suggest that such a 
phenomenon may occur at the level of the progenitors under study, as there was a 
surprising coordination of EdU+ cells to start appearing low in FSC/SSC and drop in 
gMFI of EdU signal. However, the time points studied were relatively far apart (2h 
between each time point), and there is no information (i) about how reproducible this 
type of wave-suggesting result may be, and (ii) what happens between the time points, 
notably between 2h and 4h. Additionally, EdU and other nucleoside analogs have been 
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shown to influence cell cycle (Pereira et al., 2017). This is a caveat for this entire study 
in a sense, as monocyte dynamics might be partially flawed, due to the experimental 
tool itself influencing the phenomenon to measure. However, Pereira and colleagues 
show minimal to no influence of EdU on the cell cycle at the 10mM dose that was used 
in this thesis. 
   The biological system that was under investigation was based on literature (known 
populations for the most part) and results obtained up to that point in the laboratory. 
However, no gating strategy is perfect, and no population gated in one specific way is 
surely completely homogeneous, or constitutes a biological unit. Techniques such as t-
SNE allow to cluster the cells in an unbiased way – or at least in a less biased way : 
indeed, the high dimensional space, in which the algorithm calculates the phenotypical 
resemblance between cells, is constituted by the markers used in the antibody mix ; in 
other words, the experimentator still choses with which set of markers the cells are 
going to be placed in clusters. This is still a choice, hence partially biased (which does 
not mean necessarily wrong). Additionally, the method shown in Figures 3.7 and 3.8 is 
not an optimal way of taking full advantage of the t-SNE algorithm. Classical gating 
was performed and overlapped with the t-SNE plot. This had the advantage to confirm 
that based on the markers used for the cell clustering, classically gated populations were 
mostly homogeneous. However, it was also minimising the use of cell clustering, as the 
only clusters discovered were those not included in the gating strategy. Another way of 
using t-SNE in an even less biased way, is to set aside any known gating strategy, 
perform t-SNE on a selected, wide population of cells, for example GFP+ cells in a 
transgenic mouse model, and then gate directly on the clusters thus formed, and 
phenotype these cluster with either marker expression heat maps, or by a large selection 
of 2x2 dot plots showing expression of all markers selected for the staining. This latter 
method was used in the laboratory, and results generated by Hannah Garner (data not 
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shown). Some of the resulting populations were relatable to the known, more classical 
cells populations, but it was an entirely new look at the different compartments. 
Unfortunately, such analysis did not yield significant results from a mathematical 
analysis.  
   The last figure presents the latest analysis performed by our collaborators. This 
analysis took advantage of the newly discovered subdivision of BM Ly6C+ cells with 
CXCR4, published by Chong and colleagues last year (Chong et al., 2016), which 
allowed separating their proliferating fraction. The morphologies found in the BM 
Ly6C+ cells, as well as their very important size, and their constant proliferating fraction 
was indicative that this population was probably heterogeneous. It was only logical to 
follow up on the article by Chong et al. and stain the bone marrow with CXCR4. The 
protocol for the isolation of bone marrow cells was also an important improvement, 
allowing to recover more Ly6Clow monocytes. Up to that point, one of the issues faced 
when trying to model the cell dynamics in blood and bone marrow, was that the 
Ly6Clow monocytes of the bone marrow, as a ‘destination’, or ‘end product’ of the cells 
produced upstream, was too small a population to account for much of the cell 
production of bone marrow late progenitors. The proliferation rates, calculated based on 
the data shown in Figure 3.3, impose a form of ‘pressure’ of cell production, and in the 
closed system that was established as the prospective cell populations considered here, 
the output of this cell proliferation had to be found. When depleting the bone marrow of 
Ly6G+ and Ter119+ cells, the additional 1h15-1h30 of processing, as well as additional 
centrifugation steps, diminished significantly the amount of Ly6Clow monocytes 
retrived. Therefore the population appeared smaller than it actualy is, and the results 
proposed by the model were difficult to interpret. One example of hypothesis the model 
yielded when Ly6Clow monocytes were being decreased due to the protocol, was one 
where the Ly6C+ monocytes of the bone marrow would transit into the blood, give rise 
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to MHC-II+ monocytes before re-circulating into the bone marrow, where they would 
differentiate into MHC-II- Ly6Clow monocytes. Recirculation of monocytes to the bone 
marrow for their differentiation into Ly6Clow monocytes has been proposed and was 
observed upon transplantation of Ly6C+ monocytes into irradiated hosts (Varol et al., 
2007). However, this does not fit well with genetic data form Nr4a1, Ccr2 and Irf8-
deficient animals (MHC-II+ are Nr4a1-independent), and the regulation of MHC-II at 
the cell surface seems unlikely. But this hypothesis was put forth by the modeling 
analysis because the MHC-II+ cells of the blood seemed to constitute some form of 
output for the production of cells occurring in the bone marrow. With the increased 
number of Ly6Clow monocytes in the bone marrow when perfoming the isolation of 
cells without depleting Ly6G+ and Ter119+ cells by magnetic separation, the Ly6Clow 
monocytes of the bone marrow constituted a viable ‘destination’ for part of the cell 
production.  
   The modeling data support a flow of cells progressing from high Ly6C expression to 
Ly6Clow expression among c-Kit- CD115+ CD11b+ CXCR4-. Although this flow of cells 
seemingly occurs in parallel in the bone marrow, blood and spleen, the number of cells 
flowing per day (Figure 3.11-E, white rectangles below ellipses) suggests the most 
important flow occurs in the bone marrow. This seems to be distinct from the most 
prominent hypothesis described in the literature, which states that Ly6C+ monocytes 
give rise to Ly6Clow as a conversion in the circulation (see Figure 3.0, A), as one of the 
possible fates for Ly6C+ monocytes, the other being to migrate into tissues. Therefore, 
our data seem to point to a branching point for monocyte differentiation in the bone 
marrow (a hypothesis represented in Figure 3.0, B). 
   However, there are limits that should be considered, regarding this last analysis. The 
modeling focuses on a restricted number of cells, i.e. cells of a monocytic phenotype (c-
Kit- CD115+ CD11b+ CXCR4-), rather than including all the other populations of the 
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bone marrow (MDP, cMoP, BM Ly6C+ CXCR4+). Furthermore, even if these cells had 
been included to form a more general hypothesis, not all possibly relevant cells would 
be included ; the MDP also gives rise to dendritic cells through the CDP (Onai et al., 
2007), independent from a monocyte intermediate : this constitutes one of the ‘outputs’ 
of the production of cells (Fogg et al., 2006). Upstream progenitor populations of the 
hematopoiesis differentiation tree could also be taken into account, from long-term 
HSCs to GMPs.  
   Similarly, the ‘output’ for monocyte fate would be interesting to include, considering 
that Ly6C+ monocytes have been shown to participate to the pool of macrophages in 
some tissues, such as the intestine (Bain et al., 2014). The intestine is a very large organ 
which is in constant renewal, which means the constant replenishment of macrophages 
from monocytes involves a large number of cells. Other organs may be concerned, such 
as the lungs, in which up to 40% of alveolar macrophages can be fate-mapped using the 
Flt3-Cre driver at 1 year of age (Gomez-Perdiguero et al., 2014). Osteoclasts in long 
bones are thought to have a monocytic origin in the adults, and some studies have 
shown that the MDP had the potential to give rise to osteoclasts in vitro (Jacome-
Galarza et al., 2013; Jacquin et al., 2006) ; it would be therefore interesting to know 
how much Ly6C+ monocytes participate to the turnover of these cells in vivo. Of note, 
Ly6Clow monocytes do not seem to participate to the resident macrophage pool in any of 
the tissues studied, according to data from Hannah Garner in our laboratory. Overall, 























   4.1. Introduction and general aims 
   4.1.1. Ly6Clow monocytes as patrolling housekeepers of the vasculature 
   Ly6Clow monocytes have been characterised over the last decade as a patrolling cell 
population, found in various organs, crawling on the endothelium. Intravital microscopy 
studies have been instrumental for deciphering some of the functions of these cells. 
They were first observed crawling in the lumen of vessels of the skin (Auffray et al., 
2007). The relative low speed of this crawling, its independence from the blood flow 
direction and other aspects have coined the term « patrolling » for their behaviour. Since 
then, several studies have uncovered functions for the Ly6Clow monocytes directly 
linked to their ability to patrol vessels of various sizes, in many organs (Sumajin et al., 
2010 ; Li et al., 2012 ; Jung et al., 2013 ; Michaud et al., 2013 ; Daley-Bauer et al., 
2014 ; Quintar et al., 2017). The study by Carlin, Stamatiades and colleagues (2013) has 
shown that Ly6Clow CX3CR1hi patrolling monocytes are retained by the vasculature of 
the kidney capillaries in a CX3CR1-dependent manner upon stimulation with a TLR7 
agonist. Following their retention, patrolling monocytes recruit neutrophils to the 
kidney, where these granulocytes induce necrosis of endothelial cells, the resulting 
debris of which Ly6Clow monocytes phagocytose. Some questions remained to be 
investigated about this model of inflammation.  
   One of these questions is the involvment of platelets in the vascular housekeeping 
functions of monocytes. Indeed, platelets have been increasingly well recognised over 
the last 20 years as fundamental actors of inflammation (Schulz et al., 2013; Semple et 
al., 2011), notably as they are part of a cross-talk with monocytes and neutrophils. 
Therefore, the first set of experiments presented in this chapter will tackle the issue of 
platelets in Ly6Clow monocyte patrolling activity. 
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   4.1.2. Kidney macrophages as resident cells with motile filipodiae 
   Previous work carried out in the laboratory by Efstathios Stamatiades characterised 
kidney macrophages using intravital microscopy and flow cytometry. These cells 
represent ~50% of the total hematopoietic cells of the kidney (Stamatiades et al., 2016). 
Phenotypic analysis of F4/80bright CD11blow cells revealed they express Cx3cr1-gfp, as 
well as MHC-II, CD11c and FcγRI, IIb, III and IV. They do not exchange between 
parabionts and do not rely on CCR2, suggesting these cells do not rely on replenishment 
from circulating cells such as monocytes (Stamatiades et al., 2016). Furthermore, 
intravital microscopy of Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice showed that Cx3cr1-gfp+ 
macrophages form a dense network of cells, located in the intertitium of the kidney 
cortex and around glomeruli, in close association with the capillaries. These cells are 
sessile, as little to no movement from their cell body could be observed during imaging 
sessions of up to 6 hours. However, they show long processes that are very motile, 
which suggests a survey activity during steady state (Stamatiades et al., 2016). 
Together, these data show that kidney F4/80bright Cx3cr1-gfp+ macrophages are tissue-
resident cells. 
   Given the known implication of macrophages in various chronic inflammatory 
diseases (see Introduction, section 1.4.3.2.), as well as their privileged localisation 
within their tissue of residence, it appeared relevant to study basic mechanisms 
regarding their response to circulating immune complexes. In the context of these 
investigations, experiments were performed that will be presented in this chapter. 
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   4.2. Results 
   4.2.1. Platelets are required for retention of patrolling monocytes but not steady 
state crawling 
   In order to asses the potential role of platelets in the function of Ly6Clow monocytes in 
the vasculature, the glycoprotein GPIbα was targeted, as it is a mediator of platelet 
activation present at their surface (Romo et al., 1999), which normally binds to von 
Willebrand Factor  (vWF). First, anti-GPIbα F(ab’)2 fragments were injected during 
steady state and the superficial cortex of kidneys of Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice 
were imaged in live mice, as previously performed in the laboratory (Carlin et al., 
2013 ; Stamatiades et al., 2016). In these mice, Ly6Clow CX3CR1hi monocytes appear to 
crawl on the endothelium of the small capillaries of the kidney cortex. Injection of the 
anti-GPIbα F(ab’)2 fragments did not alter the number of patrolling monocytes, when 
imaging the kidney for up to five hours at steady state (Figure 4.1-A, top). Next, the 
TLR7 agonist R848 (Resiquimod) was topically applied onto the exposed kidney during 
intravital microscopy sessions, as described previously (Carlin et al., 2013); this has 
been shown to induce the retention of patrolling monocytes, leading to their 
accumulation in the kidney, and the recruitment of neutrophils (Carlin et al., 2013). 
When injecting anti-GPIbα F(ab’)2 fragments before topically applying R848 to the 
kidney, no change in the retention of Ly6Clow monocytes, nor of the recruitment of 
neutrophils, was oberved (Figure 4.1-A, bottom). These results suggest that GPIbα-
mediated activation is not necessary for either steady state crawling, nor TLR7-
dependent retention of patrolling monocytes.  
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   Figure 4.1. Patrolling monocytes depend on platelets for their TLR7 dependent 
retention in the renal capillaries. Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice were anesthesized 
and their renal cortex imaged by intravital microscopy. (A) Effect of platelet 
inactivation by anti-GPIbα F(ab’)2 fragments injection (black dotted line) on steady 
state patrolling (top) and TLR7 agonist-induced (bottom, green dotted line) retention of 
Ly6Clow monocytes. (B) Effect of platelet depletion by Full anti-GPIbα antibody 
injection (black dotted line) on steady state patrolling (top) and TLR7 agonist-induced 
(bottom, green dotted line) retention of Ly6Clow monocytes. 3 mice per condition, bars 
represent mean±SEM. * denotes p<0.05 in Two-way ANOVA. (C) Neutrophil numbers 
at the end of imaging sessions during steady state (left) and after TLR7 agonist painting, 
following full anti-GPIbα injection for platelet depletion. Neutrophil recruitment is 
impaired, consistent with impaired monocyte retention observed in (B). each dot 
represent a single mouse. (D) Monocyte-platelet  aggregate following anti-CD49b-PE 
injection during steady state Platelets appear as very small round structures in red 











































































































































































































Neutrophils (after 5h of R848)























































   Next, platelets were depleted, using a full antibody directed against GPIbα (Bergmeier 
et al., 2000). The depletion was controlled at the end of each experiment and 
systematically brought the number of platelets in the blood to below the detection 
threshold of the cell counter (data not shown). During steady state, platelet depletion did 
not alter the crawling of monocytes in the capillaries of the kidney, as their number 
remained stable over a 3-hour period after injection (Figure 4.1-B, top). Consistently, 
neutrophil numbers, as measured at the end of the imaging sessions, were not affected at 
steady state after platelet depletion (Figure 4.1-C, left). However, when applying the 
TLR7 agonist R848 topically on the kidney while imaging, patrolling monocytes did 
not accumulate in the kidneys of mice injected with the platelet depleting antibody 
(Figure 4.1-B, bottom). Furthermore, neutrophil recruitment was impaired (Figure 4.1-
C, right).  
   Together, these results suggest that, while GPIbα-mediated activation of platelets is 
not necessary for Ly6Clow monocyte function, platelets are required for their TLR7-
mediated retention and recruitment of neutrophils, but not steady state crawling.  
   Next, patrolling monocytes and macrophages were studied in another inflammatory 
setting : their early response to circulating small immune complexes. 
   4.2.2. Characterisation of immune complexes prepared in vitro 
   The next set of experiments presented in this thesis rely on the use of immune 
complexes prepared in vitro, by mixing albumin (either bovine serum Albumin – BSA – 
or chicken ovalbumin - OVA) with polyclonal immunoglobulins directed against these 
proteins (see Materials and Methods, section 2.7.3 and Table 2.3). As a quantification 
of the antigen : antibody (Ag : Ab) immune complexes generated with this method, 
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various Ag : Ab molar ratios of OVA + anti-OVA (Figure 4.2-A) or BSA-TRITC + 
anti-BSA (Figure 4.2-B) were loaded into a Fast Protein Liquid Chromatography 
(FPLC) column. In order to control for the weight of individual protein (OVA, BSA-
TRITC, anti-OVA and anti-BSA), each of them were mixed with PBS using the same 
protocol as for the generation of immune complexes, and loaded separately into the 
column.  
   The results are shown in Figure 4.2. In this representation, the amount of protein 
detected at the bottom of the column is represented on the Y-axis as arbitrary units 
(A.U.) for the absorbtion of ultraviolet light of 280nm wavelength. The elution volume 
that passes through the chromatography column is indicated on the X-axis ; the higher 
the elution volume, the longer it takes for the constant pressure on the liquid (flow rate 
of 0.5 mL/min) to bring the protein down the column, therefore the lighter the protein. 
Conversely, the smaller the elution volume, the heavier the protein. 
   In order to set up the column and as a control for the consistency of sizes for various 
proteins, a mixture of known sized-proteins was injected to the column prior to the 
experimental samples, i.e. standards were run (Figure 4.2-D). Based on these values, 
the results presented in Figures 4.2-A, and B are consistent, with IgGs detected at 
elution values similar to the 158 kDa (kilo-Dalton) IgG from the standards (Figure 4.2-
D, ‘2’). Similarly, the sizes observed for OVA (40k Da) and BSA (60 kDa) were 
consistent. Of note, samples containing only BSA showed two peaks, one 
corresponding to single BSA at 16.2 mL elution (i.e. 60 kDa), and another at 15 mL 




   Figure 4.2. Characterisation of immune complexes generated in vitro at various 
Ag:Ab ratios. Two types of albumin (OVA and BSA) were mixed with polyclonal 
antibodies directed against them at various Ag:Ab molar ratios for 1h at 4ºC, and were 
acquired in an FPLC column to measure the amount of immune complexes formed in 
vitro with this method. (A) Chromatography of OVA+anti-OVA mixture at Ag:Ab molar 
ratios of 1:1 (top), 5:1 (middle) or 10:1 (bottom) shown as blue curves, and the 
corresponding amounts of  OVA alone (red) or anti-OVA alone (black). The resulting 
ICs form a peak around 13.3mL elution (blue double arrow). (B) Similar runs of 
chromatography for BSA+anti-BSA or each separately. Percentages of immune 
complexes are shown for each molar ratio (see Materials and Methods for calculation). 
(C) Specificity test (D) A mixture of proteins with known weights was run on the 
cromatography column as standards. Each line represents a single run on the machine. 









































































































































































   The results show that mixing albumins with their respective antibodies results in the 
formation of immune complexes (Figure 4.2-A, B, blue double arrow), of about 700 
kDa (~13.3mL elution). When integrating the area under the curve corresponding to the 
IgG peak in the ‘IC’ samples, and calculating the ratio with the area under the total 
curve, it was estimated that 19 to 25% of IgGs were engaged in immune complexes 
(percentages in Figure 4.2-A, B). This was found for all Ag : Ab molar ratios tested (1 : 
1, 5 : 1 and 10 : 1). As a control for the specificity of the immune complex formation, 
OVA was mixed with anti-BSA IgGs at 5 :1 molar ratio (Figure 4.2-C). This resulted 
in no immune complex formation (Figure 4.2-C, black curve), which suggests a good 
specificity of the antibodies used to generate immune complexes. The opposite mix 
(BSA + anti-OVA) was tested as well, resulting in no immune complex formation either 
(data not shown). 
   Together, these results show that the method used to generate immune complexes in 
vitro is relatively efficient, and immune complexes at 1 : 1 molar ratios were used for 
the rest of this work. 
   4.2.3. Replication of results obtained in the laboratory : uptake by kidney 
macrophages of immune complexes in a FcγRIV-dependent manner results in the 
production of TNFα and recruitment of leukocytes 
   Replicating results previously obtained in the laboratory by Efstathios Stamataides 
(Stamatiades et al., 2016), mice were injected with either fluorescently labeled BSA-
TRITC or immune complexes (ICs) of BSA-TRITC + anti-BSA IgG (BSA-ICs), 
prepared as described above at 1 :1 molar ratio. Measuring their uptake by flow 
cytometry 2h after injection confirmed that TRITC fluorescence was detected in 
F4/80bright CD11blow macrophages of the kidney, and that this uptake was more efficient 
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when BSA was in immune complexes (Figure 4.3-A, left and middle). Mice with a 
hematopoietic cell-specific deletion of the gene coding for FcγRIV (Csf1riCre+ Fcgr4Δ/Δ) 
and littermate controls (Csf1riCre- Fcgr4f/f) were injected with either BSA or BSA-ICs. 
Control mice showed a more efficient uptake of BSA-TRITC when BSA was in 
immune complexes, consistent with results from the C57BL/6 wild-type mice. 
However, conditional knock-out mice did not show increased uptake of BSA-ICs, 
which shows uptake of immune complexes by kidney macrophages is Fcgr4-dependent 
(Figure 4.3-A, right).  
   Next, C57BL/6 adult mice were injected with immune complexes (BSA-ICs), and 
sacrificed 1h after injection. Their kidney cells were placed in culture at 37ºC for 5 
hours in a culture medium containing Brefeldin A, which inhibits the activity of the 
Golgi apparatus, hence prevents protein release from the cell. Then TNFα production 
was measured by intracellular staining and flow cytometry (see Materials and 
Methods, section 2.2.1.4). The results show TNFα production by kidney macrophages 
following BSA-ICs uptake (Figure 4.3-B), with >40% of F4/80bright macrophages on 
average showing positivity for TNFα.  
   Finally, results from the laboratory generated by flow cytometry or intravital 
micrscopy showed injection of immune complexes resulted in the recruitment of 
monocytes and neutrophils in the kidney (Stamatiades et al., 2016). Experiments were 
carried out by intravital microscopy in Cx3cr1gfp/+ Rag2-/- Il2rg-/- mice. Mice were 
injected i.v. with either BSA or BSA-ICs, and 2h later were prepared for intravital 
microscopy of the superficial cortex. These experiments showed that injection of 
immune complexes resulted in recruitment of monocytes (Figure 4.3-C, left), as well as 
neutrophils (Figure 4.3-C, right), as measured at the end of the imaging sessions with 
injection of anti-Gr-1 APC (neutrophils were identified as GFP- Gr-1+).  
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   Figure 4.3. Uptake of immune complexes by macrophages results in TNFα and 
leukocyte recruitment, as previously shown in the lab. Repeating experiments 
performed previously, mice were injected with either PBS, 50µg of BSA, or 50µg BSA-
ICs (see Methods), and measurements of uptake, cytokine production and leukocyte 
recruitment were performed. (A) FcγR-IV-dependent uptake of BSA-ICs by 
macrophages. After injection of either BSA or BSA-ICs, mice were sacrificed and their 
kidney processed for flow cytometry. BSA fluorescence in F4/80bright macrophages 
(left) is higher when BSA is in immune complexes (middle), which is dependent on 
FcγR-IV as shown by the absence of uptake increase in the conditional KO for Fcgr4 
(right). Each dot corresponds to a single mouse. Bars represent mean ± SEM. n=3-6 
mice per condition. (B) TNFα production was measured after injection of 50µg BSA-
ICs by flow cytometry (percentage of TNFα+ macrophages is shown). Top panels 
represents staining of TNFα with isotype control, bottom panel with anti-TNFα 
antibody. Representative of 3 mice, %TNFα+ macrophages is 42.7%±4.82. (C) 
Leukocyte recruitment after BSA or BSA-ICs. 2h after injection, Cx3cr1gfp/+ Rag2-/- 
Il2rg-/- mice were prepared for intravital microscopy and their kidney imaged for 4h. At 
the end of this imaging session, 10µg of Gr-1 – APC antibody was injected and 
neutrophils (GFP- Gr-1+) were quantified. n=4-5 mice per condition. * represent p<0.01 
in two-way ANOVA, *** represents p=0.0001 in Student t-test. Each dot on the right 
























































































































   Together, these data recapitulate some of the results obtained in the laboratory by 
Efstathios Stamatiades and published last year (Stamatiades et al., 2016), showing that 
F4/80bright macrophages in the kidney uptake immune complexes in a FcγRIV-
dependent manner, which leads to their production of TNFα, and results in the 
recruitment of leukocytes to the kidney. 
   4.2.4. Uptake of immune complexes in other organs 
   In order to investigate whether uptake of circulating immune complexes is a unique 
property of kidney macrophages, C57BL/6 mice were injected with either PBS, BSA or 
BSA-ICs, and populations of macrophages were analysed for BSA uptake in kidney 
macrophages, lung alveolar macrophages, brain microglia, epidermis Langerhans cells, 
dermis F4/80bright macrophages, spleen red pulp macrophages (RPMΦ), and liver 
Kupffer cells. Uptake of BSA and BSA-ICs was observed only for kidney, spleen and 
liver macrophages, but not in lungs, brain, epidermis nor dermis (Figure 4.4). Similar to 
kidney macrophages, Kupffer cells and red pulp macrophages took up BSA-ICs more 
efficiently than BSA alone (Figure 4.4). 
	 163	
 
   Figure 4.4. Uptake of immune complexes in various organs. C57BL/6 male mice 
were injected i.v. with either PBS, BSA-Alexa488, or BSA-ICs, and their kidney, lungs, 
brain, epidermis, dermis, spleen and liver were analysed by flow cytometry. The left 
panel shows the F4/80 vs CD11b profile of CD45+ cells, and resident macrophages 
populations are gated as shown by the black oval. The middle panel show the BSA-
Alexa488 content of the cells gated in the left panel, and PBS (black line), BSA (blue 
line) and BSA-ICs (red line) injected mice are shown, representative of 3 -6 mice per 
condition. The right panel showns the quantification of BSA-Alexa488 content as 
measured by the Mean Fluorescence Intensity (MFI) in the Alexa488 channel. Each dot 
represents a single mouse, bars represent mean ± SEM. 





















































































































































   This prompted the question of the means of access of circulating proteins (such as 
albumin or immune complexes) to the resident macrophages of the kidney. Indeed, the 
structure of the sinusoid endothelial cells of the spleen and liver allow the RPMΦ and 
Kupffer cells, respectively, to be in direct contact with the circulating blood (Aird, 
2007; Florey, 1966; Mebius and Kraal, 2005). However, this is not the case for the 
kidney (Stamatiades etal., 2016). Therefore, the last experiment presented in this thesis 
was designed to investigate this issue. 
   4.2.5. No vascular permeability observed after immune complex injection 
   The next experiment aimed at understanding how small circulating proteins such as 
albumins and immune complexes may access kidney resident macrophages despite their 
position behind the endothelium of capillaries. A study by Binstadt and colleagues 
showed that autoantibodies from arthitis-prone transgenic mice induced important and 
fast vascular leakage (Binstadt et al., 2006). The hypothesis that immune complexes 
may induce vascular leakage in our model was tested as follows. C57BL/6 were 
anesthesized, and their superficial renal cortex imaged by confocal microscopy in live 
animals. To visualse blood vessels, 70 kDa Dextran-TRITC was injected intravenously 
while imaging the kidney (Figure 4.5-A, left panels). Then, PBS, BSA or BSA-ICs 
were injected (all at a fixed volume) i.v. while continuously imaging (Figure 4.5-A, 
second panels), and the kidney was imaged for 30 more minutes.  
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   Figure 4.5. Vascular permeability assay. Kidney of C57BL/6 mice were imaged for 
a few minutes to measure background fluorescence. Then 70kDa Dextran-TRITC was 
injected i.v. in order to visualise the blood vessels. 5min after, either PBS, BSA or BSA-
ICs was injected i.v. and the kidney was imaged for a further 30min. (A) Representative 
still frames of kidney volumes of PBS, BSA or BSA-ICs –injected mice. From left to 
right, the images show the vessels just before injection, just after injection, and two 
representative time points until 10min after injection. Bars represent 100µm. (B) 
Representative image of when tubule staining is maximal for BSA-ICs injected mice. 
left shows the whole field of view while right shows the inserts areas before injection 
(8min21) and at 10min34. bars represent 100µm (left) or 20µm (right). Time is shown 























   Analysis of the capillaries of the kidney cortex showed no observable vascular leak 
throughout the imaging time (Figure 4.5-A). An apparent increase in tubular 
fluorescence in BSA-ICs-injected mice was observed (Figure 4.5-B), but no vascular 
leakage. This increased fluorescence was observed in the three mice injected with BSA-
ICs (data not shown), but may represent an experimental artefact. Fluorescence of the 
tubules following injection of Dextran-TRITC of various sizes (including 70kDa as 
used here) was observed on many occasions in the laboratory (data not shown), 
therefore no conclusion may be drawn from this observation. 
   These data rule out the hypothesis that immune complexes gain access to the 
macrophages underlining the endothelial cells. Intravital confocal microscopy and 
electron microscopy revealed another mechanism, as will be discussed in the next 
section.  
   4.3. Discussion and further work 
   The results presented in this chapter helped uncovering some aspects of Ly6Clow 
monocyte and resident macrophage functions in the kidney.  
   Platelets have a well-characterised role in hemostasis, as the key players during the 
process of coagulation. However, work from many groups over the last two decades or 
so, has allowed the emergence of platelets as crucial actors of inflammation as well 
(Schulz et al., 2013; Semple et al., 2011; Weyrich et al., 2003). An active crosstalk 
between platelets and cells of the innate arm of immunity has been found, notably 
between platelets and monocytes and neutrophils (Schulz et al., 2013). In the case of 
Deep Vein Thrombosis (DVT), a major cause of morbidity and mortality worldwide, 
the intravascular thrombus contains large numbers of leukocytes, 30% of which are 
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monocytes, and 70% of which are neutrophils, where they are found in association with 
platelets (von Bruhl et al., 2012). Platelets also play a critical role in infections, such as 
Staphylococcus aureus and HIV (Youssefian et al., 2002). In the liver, Kupffer cells 
constitutively express von Willebrand factor at their surface, and platelets have dynamic 
interactions with this vWF during steady state (termed ‘touch-and-go’ interactions, 
Wong et al., 2013). In the context of bacterial infection, the capture of microbes by the 
Kupffer cells involves platelets that accumulate at the focal site of capture, and platelet 
depletion leads to a worsen bacterial load (Wong et al., 2013). 
   Given the increasingly recognized role of platelets in inflammation, it was relevant to 
assess their role in the patrolling monocyte activity in the kidney. The results presented 
in this thesis (Figure 4.1) indicate that platelets are necessary for the retention of 
monocytes upon TLR7 signals, notably consistent with in vitro results showing 
increased adherence of monocyte to Human Umbilical Vein Endothelial Cells 
(HUVEC) when engaged in aggregates with platelets via P-selectins (Da Costa Martins 
et al., 2004). The absence of neutrophil recruitment observed after platelet depletion in 
the context of TLR7 agonist topical application on the kidney is consistent with the 
absence of retention of monocytes, are patrolling Ly6Clow CX3CR1hi monocytes have 
been shown to be responsible for neutrophil recruitment in this model (Carlin et al., 
2013). Because platelets also express a wide range of pattern recognition receptors at 
their surface (Takeuchi and Akira, 2010), investigating whether platelets engage them in 
our model would be interesting (Koupenova et al., 2014). Recently, a study has used 
similar models to the ones presented in Figure 4.1, though in the mesenteric vessels, to 
show very elegant results on the interactions between Ly6Clow monocytes patrolling the 
endothelium and recruiting neutrophils upon R848 treatment, all through close 
interactions with platelets (Imhof et al., 2016). 
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   Of note, the staining performed on platelets as shown in Figure 4.1-D, and suggesting 
monocyte-platelets-aggregates, is to be considered with care. First, the use of CD49b is 
not optimal, as other cells are known to express this marker, and cells of a size too large 
to be platelets were observed in that staining (data not shown). Such aggregates have 
been observed, notably when using fluorescently labeled antibodies directed at another 
platelet surface glycoprotein, GPIIbIIIa (CD41, Hidalgo et al., 2009). Second, 
monocytes express all FcγR (Biburger et al., 2011), and have been shown to be major 
actors of antibody-mediated platelet depletion. Therefore, it is also possible that the 
snapshot shown in Figure 4.1-D represents a monocyte in the process of phagocytosing 
platelets. This is also the reason why it was important to analyse the effects of the 
platelet depletion antibody used for Figure 4.1-B. in order to make sure that monocytes 
were not actively involved in platelet depletion. Fortunately, the platelet depletion 
mediated by the anti-GPIbα (Emfret analytics, Cat#R300, see Methods) used for this 
study was shown by the group that generated them (Nieswandt et al., 2000) to be FcR-
independent, which is consistent with our results (Figure 4.1-B).  
   The next portion of results presented in this chapter shed light on certain aspects of 
another inflammatory setting, the circulation of immune complexes. The first step 
undertaken was to make sure that immune complexes were formed in a specific and 
reproducible fashion using a simple in vitro method, which was shown to be the case in 
Figure 4.2. The specificity of the polyclonal antibodies to the two types of albumin was 
shown by mixing OVA to anti-BSA IgGs. Interestingly, this confirms the great 
specificity of anitbody production, showing that when producing an antibody in rabbits 
(our polyclonal IgG are from rabbits), the IgGs are generated aginst the portion of 
albumin that is specific to the other species. The immune complexes formed were of 
700kDa, which suggests that several IgGs are involved for each molecule of albumin. 
Around 20 to 25% of the immunoglobulins were involved in immune complexes 
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according to a semi-quantitative analysis. This posed the question of the impact of the 
free IgGs still present in the injected solution, on uptake, activation of macrophages and 
production of inflammatory cytokines. Experiments were performed in the laboratory 
by Efstathios Stamatiades to elucidate this, and injection of IgGs alone had no effect in 
terms of TNFα production or macrophage activation (Stamatiades et al., 2016, Figure 
5H and S5H). This suggested that IgGs have to be involved in immune complexes, 
engaging sevral Fc receptors, for there to be sufficient intracellular signaling 
downstream of FcγRIV, and inducing macrophage activation and cytokine production.  
   Some of the results regarding FcγRIV-mediated uptake, leukocyte recruitment and 
TNFα production were successfully reproduced in this thesis (Figure 4.3) ; 
reproducibility of results is always important, and sometimes underrated aspect of 
research, when the pressure for publication relegates this type of work to a ‘less urgent’ 
category of planned experiments. Regarding the TNFα results presented in this thesis, 
they do not constitute in themselves a well controlled experiment, as only control for 
APC fluorescence is shown with the isotype staining. However, TNFα production was 
established by better controlled experiments in the laboratory, as shown in Stamatiades 
et al., 2016 (see the Figure 5E, F). Injection of BSA alone does not induce cytokine 
production by F4/80bright macrophages of the kidney, showing that constant uptake of 
circulating particules is not inflammatory in itself.  
   The uptake of circulating immune complexes in several organs was investigated, and 
found only in liver Kupffer cells and spleen RPMΦ, in addition to kidney resident 
macrophages (Figure 4.4). This phenomenon in the liver and spleen was consistent with 
the structure of the sinuisoidal endothelium of these tissues, where the macrophages lie 
in direct contact with the bloodstream. However, intravital microscopy studies 
suggested that kidney, although sitting close to the capillary vessels of the kidney 
cortex, may not be in direct contact with the circulating blood. The resolution of this 
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technique was however not quite sufficient to indicate whether processes of the 
macrophages cells could go through the vessel wall to contact the bloodstream. 
Experiments performed as shown in Figure 4.5 ruled out the possibility that access of 
circulating immune complexes may be mediated by an induced vascular leakage, as 
observed in other conditions (Binstadt et al., 2006). Transmission electron microscopy 
experiments performed by Marie-Eve Tremblay (University of Laval, Canada) very 
elegantly showed that macrophages lie directly between the basement membranes of 
kidney tubules and the endothelial cells. Furthermore, in accordance with seminal work 
performed notably by Palade and colleagues in the 1960s to 1990s (Bruns and Palade, 
1968; Milici et al., 1985; Predescu and Palade, 1993), endothelial cells of the kidney 
were found to be rich in caveolae, clathrin-coated vesicles and trans-endothelial 
channels (Stamatiades et al., 2016, figure 3). Experiments with immunogold-labeled 
BSA indicated the presence of immunogold staining in the caveolae and endosomal 
compartments of kidney macrophages, consistent with (i) trans-endothelial transport of 
circulating proteins, and (ii) with intravital experiments using BSA labeled with pH-
sensitive dyes showing the uptaken BSA was ingested and processed in endocytic 
compartments.  
   Altogether, the work presented in this chapter participated to the characterisation of 
the function of kidney resident macrophages, which constitute a functional unit with 
endothelial cells, through the caleolae of which circulating particles are pumped and 
being delivered to the underlying macrophages. Therefore these cells perform an 
immune monitoring of the circulation in the kidney, while Ly6Clow monocytes patrol 
the capillaries of the kidney, requesting the help of platelets in the context of TLR7-
mediated inflammation. These results may carry some relevance for disease models of 






















   5.1. A multidisciplinary approach to tackle the question of monocyte dynamics 
   Previous work in the laboratory carried out by Hannah Garner has prompted a re-
examination of monocyte dynamics in relation to their progenitors in the bone marrow. 
Genetic data showing that one subset of monocytes could be strongly decreased without 
a major influence on the other in terms of number, as well as a description of a potential 
precursor cell for Ly6Clow monocytes, seemed to be away from the current model for 
Ly6Clow monocyte generation in vivo, supported by several publications (Yona et al., 
2013 ; Varol et al., 2007 ; Hettinger et al., 2013, notably), and which suggests that 
Ly6C+ monocytes convert into Ly6Clow monocytes in the blood circulation. However, 
quantitative data to support any other hypothesis was missing. Therefore, the approach 
presented in Chapter 3 was followed. 
   An examination of this issue with a mathematical, computer-assisted model was 
performed. Experimentally parameterized models have yielded new results in several 
areas of research in biology as discussed in the introduction chapter of this thesis. A 
similar approach has been adopted recently to decipher monocyte subsets relationship in 
human (Patel et al., 2017), as will be discussed below.  
   As described in the Materials and Methods, the model generated by our 
collaborators Grégoire Altan-Bonnet and Amir Erez regards populations of the various 
organs considered (BM, Blood and Spleen) as a closed, dynamic system. Therefore, 
specific cell populations had to be chosen to be analysed as a group; this prompted the 
consideration of the known progenitors for monocytes: MDP (Fogg et al., 2006), cMoP 
(Hettinger et al., 2013), as well as monocytes of blood and spleen, and monocyte-like 
populations of the bone marrow (Figure 3.1). Determining their size was of critical 
importance, as this is one of the parameters the model takes into account. Indeed, let us 
consider a pair of cell populations, with is a potential lineage relationship between them. 
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Then if the upstream population is small compared to the second one, it will need to 
proliferate very actively, in order to generate the second one. Conversely, a large 
population that would be giving rise to a small population of cells would not need to 
dedicate much of its proliferative capacity to generate its downstream population. Time 
is also of the essence, as the kinetics of EdU increase and decrease within the different 
populations dictates the speed at which differentiation needs to occur. This is why the 
calculations and estimates were perfomed for Figure 3.2. 
   Subsequently, identification of the main proliferating populations was needed in order 
to establish where the EdU uptake would take place (Figure 3.2), and this also guided 
the analysis of the next set of experiments (Figures 3.3 to 3.5), designed to characterise 
the early events of proliferation and differentiation. Our data show that a single 
injection of EdU provides a very short time window for cells in S-phase to uptake 
(~15min). The bioavilability of EdU following i.p. injection was shown previously to be 
as efficient as the i.v. route (Sun et al., 2016). This means a restricted wave of 
progenitor/precursor cells were labelled with EdU, and that all the EdU detected 
subsequently would have to come from these early uptake events. Analysis of the 
intensity of the EdU signal was also performed in order to inform on what ‘generation’ 
of cells were analysed at any given time point, since each cell division will decrease the 
EdU content by half in the daughter cells. Unfortunately, the precision of the 
measurement of EdU content was not high enough in our hands, to provide specific 
information about the number of divisions, consistent with previous reports indicating 
the difficulty of such measurements (Pereira et al., 2017). However, it was estimated 
that the EdU levels would fall below detection threshold after around 5 divisions.  
   The various analysis presented from Figure 3.6 to 3.10 describe attempts to analyse a 
data set of EdU kinetics over 10 days, in three organs, in three mice per time point. 
Indeed, less ‘biased’ gating was attempted through the use of the algorithm t-SNE. This 
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tool allows the clustering of cells solely based on the intensity of staining for the cell 
markers used in cytometry, whether it is fluorescence based or mass cytometry 
(CyTOF). Using this technique, potential ‘missing link’ were identified in the sequence 
of differentiation from the proliferating late progenitors/precursor cells (MDP, cMoP, 
BM Ly6C+) to the mature, non-proliferating Ly6Clow populations (BM CD115low and 
BM Ly6Clow cells). However, a more solid mathematical analysis was finally obtained 
when the preparation of the cells was optimised, allowing to recover more Ly6Clow 
monocytes in the bone marrow. This dismissed the need for a ‘missing link’, as Ly6Clow 
monocytes of the BM constituted a viable ‘destination’ population. 
   This latest analysis, presented in Figure 3.11, is consistent with a transition from 
Ly6Chigh monocytes to the Ly6Clow populations occurring in parallel in bone marrow, 
blood and spleen. However, the quantification of the ‘flow’ of cells from high to low 
expression of Ly6C seems to indicate this transition is most prevalent in the bone 
marrow, while less intense flow occurs in the blood, and a very small one in the spleen 
(Figure 3.11-E). This is consistent with previous adoptive transfer experiments 
performed by Hannah Garner in the laboratory (data not shown) : when injecting sorted 
BM Ly6C+ cells into a non irradiated host, Ly6Clow Nr4a1bright monocytes were 
recovered in the circulation of the hosts. However, this could not be achieved by 
transferring Ly6C+ monocytes sorted from the circulating blood. This suggested that the 
precursor to Ly6Clow monocytes resides within the BM Ly6C+ cells. In addition, careful 
analysis of Irf8-/- mice, which lack most Ly6C+ monocytes in blood and bone marrow, 
show that a relatively small number of Ly6C+ cells remains in the bone marrow. These 
cells, being Irf8-independent, might represent the fraction that gives rise to Ly6Clow 
monocytes; however, more investigation will be needed to determine this.  
   This latest analysis suggesting a transition from Ly6Chigh to Ly6Clow is not fully in 
line with the current model of monocyte development, which states a conversion from 
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one subset to the other in the circulation. However, more work will be necessary to 
confirm it. Moreover, the discussion in Chapter 3 (see section 3.3) provides an 
overview of the limits associated with these latest result, and points to directions that 
future investigations could take in order to more firmly establish a strong model. Should 
the hypothesis of a differentiation from Ly6Chigh to Ly6Clow monocytes in the bone 
marrow be confirmed, it will be very interesting to look at the published corpus of work 
that points to a conversion in the blood, in light of this new hypothesis. Adoptive 
transfer experiments of BM Ly6C+ cells, or of cMoP (Hettinger et al., 2013) have been 
published, and the sequential generation of Ly6C+ followed by Ly6Clow monocytes has 
so far been interpreted as the manifestation of the fact that Ly6C+ monocytes give rise 
to Ly6Clow monocytes. An alternative interpretation, in light of our results, could be that 
within heterogeneous BM Ly6C+ cells (Chong et al., 2016), rapidly differentiating cells 
give rise to Ly6C+ monocytes in the blood, while a fraction differentiates slower in the 
bone marrow to give rise to Ly6Clow monocytes. This is also the case for the 
interpretation of EdU or BrdU kinetic data, showing successive peaks of EdU (or BrdU) 
appearing for Ly6C+ cells and then Ly6Clow cells (Yona et al., 2013). However, more 
work will be needed to confirm or infirm the validity of this latest analysis, in order to 
decipher the molecular control that dictate monocyte differentiation. 
   Interestingly, a modeling approach has been adopted and published recently, for the 
investigation of human monocyte subsets differentiation (Patel et al., 2017), where the 
authors have analysed the kinetics of uptake and distribution throughout time of 
Deuterium at various time points following a single injection. Mathematical 
modelisation of the monocyte compartment supports a transition from CD14+ CD16- to 
CD14dim CD16+ monocytes, through an intermediate CD14+ CD16+ stage. These kinetic 
analyses were also supported with experiments of inflammatory challenges leading to 
monocytopenia and repopulation of the monocyte compartment (Patel et al., 2017), 
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where sequential generation of the three subpopulations were observed, consistent with 
the modeling analysis. This is consistent with results published for mouse monocytes, 
which as mentioned above are believed to convert from Ly6Chigh monocytes 
(homologues of human CD14+ CD16-) to Ly6Clow (homologues of human CD14dim 
CD16+). The sequence of differentiation through an intermediate stage is also consistent 
with mouse data showing transition form Ly6Chigh to Ly6Clow through a Ly6Cint 
intermediate stage (Mildner et al., 2017). This study implements a multidisciplinary 
approach like our own, where mathematics are used as an unbiased, ‘blind’ tool to put 
hypothesis to the test of experimental data. It is also an interesting by-pass to the 
difficulty of experimenting on humans, where approaches such as adoptive transfer are 
impossible.  
   Overall, the work presented in this thesis regarding monocyte dynamics participates to 
the growing body of work in biology, as nicely exemplified with the work of Patel and 
colleagues, which attempts to bring together experimental data, with its impredictible 
set of unknowns, and its necessarily present lack of exactitude, with the most exact of 
sciences, mathematics. The work shown here presents a multidisciplinary effort from 
various investigators of different backgrounds, which hopefully will continue to 
progress. 
 
   5.2. Description of a tissue-specific function for kidney resident macrophages, 
with potential relevance in disease 
   The results presented in chapter 4 participated to the uncovering of platelet-monocyte 
cooperation, and to the identification of a functional unit formed by the endothelial cells 
and resident macrophages in the kidney.  
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   Monocyte-platelet cooperation for good or ill has been increasingly well characterised 
over the last couple of decades (Semple et al., 2011; Schulz et al., 2013), although the 
specific interactions of platelets with the patrolling Ly6Clow monocyte subset remained 
to be examined. Here it was shown that although GPIbα engagement is not crucial, 
platelet depletion prevents normal Ly6Clow monocyte retention and subsequent 
recruitment of neutrophils (Figure 4.1). The specific receptor/ligand interactions 
between the two cell types would be interesting to investigate, as there has been show to 
be several potential molecular bridges between them, such as through P-Selectin 
(Higashiyama et al., 2008), or tissue factor produced by monocytes and neutrophils 
during deep vein thrombosis (von Bruhl et al., 2012). Platelet-neutrophil aggregates 
have also been observed in vivo when injecting anti-CD49b i.v. to mice while imaging 
(data not shown), so it would also be an interesting topic of investigation to uncover the 
specific interactions between platelets and neutrophils in the context of TLR7 signals. 
The recruitment of neutrophils by patrolling monocytes following topical application of 
the TLR7 agonist R848 has been shown to induce necrosis of endothelial cells (Carlin et 
al., 2013). Therefore, using transmission electron microscopy to analyse endothelium 
structure following platelet depletion would inform on whether it also prevents these 
later events. The results presented here are consistent with a recent study showing 
similar results and characterising the system in larger vessels (Quintar et al., 2017). 
   The rest of the results presented in Chapter 4 of this thesis focus on another 
inflammatory stimulus: the presence of small immune complexes in the circulation, and 
the way kidney resident macrophages respond to them. Characterising the products of 
the in vitro preparation method (Figure 4.2) was important, in combination with the 
various injections of immunoglobulin performed by Efstathios Stamatiades 
(Stamatiades et al., 2016), to discard the hypothesis that the components (albumin, 
IgGs) alone were responsible for the inflammatory response. Indeed, it was shown in 
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vitro that macrophages can produce iNOS in response to endotoxin-free albumin, and 
notably BSA (Poteser and Wakabayashi, 2004).  
   Investigating uptake of albumin and immune complexes in organs other than the 
kidney demonstrated that only two others harbor macrophages that have the ability to do 
so: liver and spleen. These two organs have fenestrations of endothelium that allow 
direct contact of the macrophages (Kupffer cells and RPMΦ) with the blood flow; 
however, intravital microscopy and transmission electron microscopy studies showed 
no such contact between kidney resident macrophagesand the circulation (Stamatiades 
et al., 2016). Therefore, the access of macrophages to the circulating proteins was 
investigated and found that it was not due to vascular leakage in the kidney (Figure 4.5), 
but allowed by a caveolae system which performs a sampling of the circulation by the 
endolthelial cells, which transport circulation content to the underlying macrophages, 
which extend long (up to ~100µm) processes and receive the endocytosed particles. 
Discarding the vascular leakage hypothesis was interesting, as it has been shown to 
occur in the context of a mouse model of Rheumatoid Arthritis (Binstadt et al., 2006). 
Moreover, these data, and more generally the work of Stamatiades and colleagues 
(Stamatiades et al., 2016), shed light on a broader question regarding type III 
hypersensitivity. This group of autoimmune disorders is characteried by the circulation 
of immune complexes due to autoimmune reaction to nucleic acid antigens. Kidney 
inflammation and damage follow, and it was unclear whether the deposit of immune 
complexes on the interstitium was a cause for inflammation, or following kidney 
damage induced through another mechanism. The data provided by Stamatiades and 
colleagues provides a mechanism for early inflammation in the kidney due to immune 
complexes, showing that the immune complexes are taken up by kidney resident 
macrophages via FcγRIV, which in turn produce inflammatory cytokines. Monocytes 
and neutrophils also express FcγRIV (Nimmerjahn et al., 2005), while endothelial cells 
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do not, as seen by qPCR analysis of sorted CD45- CD31+ cells from the kidney 
(Stamatiades et al., 2016). However, the engagement of FcγRIV on the surface of 
circulating leukocytes does not impact the inflammatory process in this model of study 
(Stamatiades et al., 2016). 
   Together, these results shed light on the functional unit formed by kidney resident 
macrophages and endothelial cells of the kidney, which monitors the content of 
circulation and triggers an inflammatory reaction. This may have interesting relevance 
in the context of deseases of type III hypersensitivity; the mechanism uncovered is 
distinct form the Arthus reaction (Hazenbos et al., 1996; Nimmerjahn et al., 2010), or 
immune complex-mediated peritonitis (Hasenberg et al., 2015). It may also participate 
to the understanding of SLE. 
 
   5.3. General conclusion 
   The work presented in this thesis provided some insight into the biology of myeloid 
populations, both regarding development and function. A multidisciplinary approach to 
data analysis allowed the production of a new hypothesis for the development of 
Ly6Clow monocytes, which may occur in the bone marrow rather than the circulation. A 
collaborative effort has allowed the identification of a tissue-specific function of kidney 
resident macrophages, in line with the hypothesis that Metchnikoff formulated in the 
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Supplemental Figure 3.1. Kinetics of EdU signal intensity over 10 days 
C57BL/6 mice were injected with a single dose of 0.5mg of EdU intraperitoneally, and 
sacrificed at the indicated time points after injection for analysis of their BM (A), Blood 
(B) for EdU content in the indicated populations. Coloured lines represent %EdU+ cells 
(same data as Figure 3.6), while black lines represent the gMFI of the EdU signal in 
EdU+ cells. gMFI was only measured when at least ~2% of EdU+ cells were present. 
Data from Spleen was also analysed, but not shown here. n=3 mice per time point. Bars 
represent mean ± SD			
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Supplemental Figure 3.2. Multiple t-SNE performed on Cx3cr1-gfp+ cells. All dot 
plots show 2-dimensional plots of GFP+ cells, with classical populations gated 








































































Supplemental Figure 3.3. Multiple t-SNE performed on Nr4a1-gfp+ cells. All dot 
plots show 2-dimensional plots of GFP+ cells, with classical populations gated 
separately and overlayed as in Figure 3.8.  	
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